RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Animal Disease Models
Accession: DOID:9006205
browse the term
Definition: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
Synonyms: exact_synonym: Animal Disease Model
primary_id: MESH:D004195
G
ABCB4
ATP binding cassette subfamily B member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16472600 PMID:29808285
NCBI chr 9:93,171,371...93,262,124
G
ABCC6
ATP binding cassette subfamily C member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23415960
NCBI chr 3:28,260,935...28,356,706
Ensembl chr 3:28,261,282...28,356,646
G
ACSL4
acyl-CoA synthetase long chain family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr X:89,760,863...89,838,103
Ensembl chr X:89,760,866...89,806,274
G
AHCY
adenosylhomocysteinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr17:37,726,084...37,744,378
Ensembl chr17:37,726,084...37,744,461
G
AHR
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr 9:86,511,866...86,555,950
Ensembl chr 9:86,511,369...86,555,943
G
AIF1
allograft inflammatory factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 7:23,711,752...23,731,191
Ensembl chr 7:23,726,787...23,731,671
G
AKT1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25658812 PMID:32045588
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16642209 PMID:17963606
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
G
ALDH18A1
aldehyde dehydrogenase 18 family member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:107,174,062...107,221,373
Ensembl chr14:107,170,689...107,221,215
G
ALDH5A1
aldehyde dehydrogenase 5 family member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29031482
NCBI chr 7:19,351,485...19,375,515
Ensembl chr 7:19,351,361...19,379,098
G
ALPL
alkaline phosphatase, biomineralization associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27466191
NCBI chr 6:79,589,695...79,649,646
Ensembl chr 6:79,589,045...79,649,644
G
ANP32A
acidic nuclear phosphoprotein 32 family member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:166,664,251...166,703,814
G
APEX1
apurinic/apyrimidinic endodeoxyribonuclease 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 7:78,451,845...78,454,938
Ensembl chr 7:78,451,851...78,454,938
G
APP
amyloid beta precursor protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12746438 PMID:16651627 PMID:25881725 PMID:27567873 PMID:31939705
NCBI chr13:189,434,854...189,716,120
Ensembl chr13:189,435,094...189,716,056
G
AQP4
aquaporin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:111,407,632...111,422,169
Ensembl chr 6:111,407,639...111,422,109
G
ARG1
arginase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:32,006,035...32,028,983
Ensembl chr 1:32,006,046...32,028,988
G
ARTN
artemin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27869817
NCBI chr 6:167,356,363...167,361,370
Ensembl chr 6:167,357,662...167,360,729
G
ATP7A
ATPase copper transporting alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17483305
NCBI chr X:61,972,544...62,110,058
Ensembl chr X:61,972,991...62,110,048
G
ATP7B
ATPase copper transporting beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11803042 PMID:15911138 PMID:21146535 PMID:21364284
NCBI chr11:15,892,549...15,942,070
Ensembl chr11:15,876,612...15,942,064
G
AXIN2
axin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr12:12,311,293...12,343,207
Ensembl chr12:12,311,298...12,343,200
G
BDKRB2
bradykinin receptor B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr 7:117,438,622...117,472,005
Ensembl chr 7:117,438,713...117,472,005
G
BSCL2
BSCL2 lipid droplet biogenesis associated, seipin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25462787
NCBI chr 2:9,052,676...9,064,890
Ensembl chr 2:9,052,070...9,064,886
G
BZW2
basic leucine zipper and W2 domains 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:85,887,801...85,947,414
Ensembl chr 9:85,886,158...85,947,410
G
CA2
carbonic anhydrase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15816485
NCBI chr 4:51,194,686...51,211,436
Ensembl chr 4:51,193,756...51,211,259
G
CACNA1D
calcium voltage-gated channel subunit alpha1 D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26831068
NCBI chr13:35,568,534...35,911,483
Ensembl chr13:35,436,519...35,909,662
G
CALCB
calcitonin-related polypeptide beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 2:44,043,135...44,048,651
G
CALY
calcyon neuron specific vesicular protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30753204
NCBI chr14:141,307,092...141,316,460
Ensembl chr14:141,307,684...141,316,292
G
CCT5
chaperonin containing TCP1 subunit 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr16:72,211,452...72,223,202
Ensembl chr16:72,208,012...72,223,114
G
CDH2
cadherin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27811057
NCBI chr 6:112,396,713...112,629,073
Ensembl chr 6:112,396,721...112,628,432
G
CLDN11
claudin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chr13:109,075,672...109,089,097
Ensembl chr13:109,075,452...109,090,111
G
CLN6
CLN6 transmembrane ER protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23789114
NCBI chr 1:166,107,895...166,126,054
Ensembl chr 1:166,107,228...166,126,808
G
CLN8
CLN8 transmembrane ER and ERGIC protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22302580
NCBI chr15:33,282,524...33,325,598
Ensembl chr15:33,288,301...33,304,631
G
CNR1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23072421
NCBI chr 1:56,466,022...56,493,275
Ensembl chr 1:56,467,835...56,492,602
G
CNR2
cannabinoid receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27317300
NCBI chr 6:81,659,162...81,692,550
Ensembl chr 6:81,659,169...81,692,550
G
COL2A1
collagen type II alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17299831
NCBI chr 5:78,350,131...78,380,893
Ensembl chr 5:78,350,137...78,380,718
G
CSF3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27737899
NCBI chr12:22,333,445...22,335,949
Ensembl chr12:22,333,449...22,338,753
G
CSRP3
cysteine and glycine rich protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:40,219,288...40,240,614
Ensembl chr 2:40,215,353...40,240,616
G
CTNNB1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311
G
CTU2
cytosolic thiouridylase subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27811057
NCBI chr 6:964,551...976,881
Ensembl chr 6:964,566...976,832
G
DEK
DEK proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27811057
NCBI chr 7:13,901,562...13,935,477
Ensembl chr 7:13,872,775...13,935,173
G
DHCR7
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29698737
NCBI chr 2:2,377,352...2,391,846
Ensembl chr 2:2,377,416...2,391,447
G
DMD
dystrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22795790 PMID:26930420 PMID:30074247
NCBI chr X:27,028,223...29,650,728
Ensembl chr X:27,028,231...28,383,840
G
DSTN
destrin, actin depolymerizing factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr17:25,998,830...26,050,354
Ensembl chr17:26,043,079...26,050,353
G
EIF2B1
eukaryotic translation initiation factor 2B subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:29,355,497...29,367,918
Ensembl chr14:29,332,233...29,367,918
G
EIF3E
eukaryotic translation initiation factor 3 subunit E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:29,288,878...29,343,593
Ensembl chr 4:29,264,042...29,352,902
G
ELP3
elongator acetyltransferase complex subunit 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27811057
NCBI chr14:11,832,947...11,940,080
Ensembl chr14:11,832,962...11,940,070
G
ENO1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:69,385,879...69,401,664
Ensembl chr 6:69,385,879...69,401,151
G
ERBB2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22302033
NCBI chr12:22,591,621...22,621,384
Ensembl chr12:22,590,725...22,621,351
G
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20962747
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
G
F7
coagulation factor VII
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21127298
NCBI chr11:78,512,389...78,518,668
Ensembl chr11:78,512,137...78,518,668
G
FAS
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22536412 PMID:26590112
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FASN
fatty acid synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:922,405...937,560
Ensembl chr12:920,509...937,561
G
FBL
fibrillarin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:48,314,782...48,326,433
Ensembl chr 6:48,314,783...48,326,436
G
FKBP11
FKBP prolyl isomerase 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:14,959,305...14,964,231
Ensembl chr 5:14,961,518...14,963,546
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 7:98,449,508...98,451,971
Ensembl chr 7:98,449,349...98,455,554
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:64,129,678...64,135,194
Ensembl chr 5:64,129,679...64,133,991
G
GAR1
GAR1 ribonucleoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 8:112,401,114...112,414,277
Ensembl chr 8:112,400,005...112,414,033
G
GART
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:197,130,898...197,158,797
Ensembl chr13:197,130,904...197,161,891
G
GATA4
GATA binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr14:14,858,470...14,938,156
Ensembl chr14:14,884,662...14,939,941
G
GFAP
glial fibrillary acidic protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr12:18,456,268...18,466,594
Ensembl chr12:18,456,263...18,466,592
G
GLI2
GLI family zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27585885
NCBI chr15:30,312,528...30,580,272
Ensembl chr15:30,313,817...30,579,306
G
GNPNAT1
glucosamine-phosphate N-acetyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:182,404,460...182,423,453
Ensembl chr 1:182,407,229...182,423,441
G
GOLM1
golgi membrane protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr10:29,117,578...29,219,024
Ensembl chr10:29,118,314...29,219,018
G
GPI
glucose-6-phosphate isomerase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:44,038,374...44,069,331
Ensembl chr 6:44,038,357...44,069,328
G
GRIN1
glutamate ionotropic receptor NMDA type subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
G
GRWD1
glutamate rich WD repeat containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:53,849,673...53,856,229
Ensembl chr 6:53,849,852...53,859,385
G
H1-10
H1.10 linker histone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:71,760,464...71,762,035
Ensembl chr13:71,760,467...71,761,839
G
HAND2
heart and neural crest derivatives expressed 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr14:16,460,089...16,462,979
Ensembl chr14:16,459,971...16,462,207
G
HBEGF
heparin binding EGF like growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21937979
NCBI chr 2:142,102,455...142,115,192
Ensembl chr 2:142,102,458...142,115,174
G
HCN1
hyperpolarization activated cyclic nucleotide gated potassium channel 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747469
NCBI chr16:29,439,294...29,808,855
Ensembl chr16:29,439,264...29,808,993
G
HELLS
helicase, lymphoid specific
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:105,923,727...105,967,003
Ensembl chr14:105,924,536...105,955,430
G
HK1
hexokinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:72,383,328...72,460,927
Ensembl chr14:72,351,246...72,460,924
G
HK2
hexokinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:68,155,656...68,231,187
Ensembl chr 3:68,153,835...68,231,615
G
HMGB2
high mobility group box 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:16,709,966...16,712,288
Ensembl chr14:16,710,047...16,717,101
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:19,485,033...19,491,418
Ensembl chr 5:19,485,096...19,491,417
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27469509
NCBI chr 7:55,654,298...55,675,571
Ensembl chr 7:55,651,609...55,675,554
G
IFIT3
interferon induced protein with tetratricopeptide repeats 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36071497
NCBI chr14:101,214,730...101,225,169
Ensembl chr14:101,214,710...101,225,164
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16845661
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27580383 PMID:28411859
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IMPDH2
inosine monophosphate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:31,658,642...31,663,660
Ensembl chr13:31,658,650...31,663,552
G
IPO4
importin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 7:75,109,844...75,118,739
Ensembl chr 7:75,110,082...75,118,733
G
IPO5
importin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr11:67,019,299...67,059,375
Ensembl chr11:67,004,109...67,060,551
G
IRAK4
interleukin 1 receptor associated kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28003376
NCBI chr 5:74,842,184...74,858,125
Ensembl chr 5:74,834,600...74,859,344
G
ITPR3
inositol 1,4,5-trisphosphate receptor type 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:37047547
NCBI chr 7:29,835,922...29,901,305
Ensembl chr 7:29,835,922...29,901,309
G
KL
klotho
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25550330
NCBI chr11:9,427,236...9,479,251
Ensembl chr11:9,427,037...9,479,228
G
KNG1
kininogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr13:124,521,276...124,557,384
Ensembl chr13:124,521,340...124,557,958
G
KPNA2
karyopherin subunit alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:14,283,092...14,296,749
Ensembl chr12:14,283,087...14,296,746
G
KRAS
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26390243 PMID:27588471 PMID:33380422
NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
G
LDHA
lactate dehydrogenase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:40,814,163...40,827,284
Ensembl chr 2:40,814,169...40,826,715
G
LEF1
lymphoid enhancer binding factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27811057
NCBI chr 8:113,824,511...113,944,078
Ensembl chr 8:113,825,161...113,944,070
G
LEPR
leptin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35235096
NCBI chr 6:146,802,297...146,896,152
Ensembl chr 6:146,801,954...146,895,995
G
LMNB1
lamin B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:129,807,228...129,862,211
Ensembl chr 2:129,807,318...129,872,270
G
LOC100516084
cytoplasmic tRNA 2-thiolation protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27811057
NCBI chr 6:58,388,646...58,396,509
G
LOC110258578
interleukin-1 beta-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
G
MAPK1
mitogen-activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MAPK8
mitogen-activated protein kinase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr14:88,988,914...89,108,875
Ensembl chr14:88,988,949...89,108,874
G
MAPK9
mitogen-activated protein kinase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 2:78,338,466...78,399,108
Ensembl chr 2:78,338,376...78,399,100
G
MAPT
microtubule associated protein tau
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24556215
NCBI chr12:17,098,259...17,211,483
Ensembl chr12:17,095,587...17,211,373
G
MECP2
methyl-CpG binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28592917 PMID:33010341
NCBI chr X:124,735,523...124,789,063
Ensembl chr X:124,735,656...124,738,659
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32045588
NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21051829
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
MRE11
MRE11 homolog, double strand break repair nuclease
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:26,572,352...26,634,596
Ensembl chr 9:26,572,361...26,634,567
G
MRPL12
mitochondrial ribosomal protein L12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:1,200,458...1,203,817
Ensembl chr12:1,200,461...1,203,822
G
MRPS5
mitochondrial ribosomal protein S5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:46,137,566...46,169,403
Ensembl chr 3:46,137,509...46,169,807
G
MX1
MX dynamin like GTPase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36071497
NCBI chr13:204,843,049...204,868,927
Ensembl chr13:204,843,754...204,868,922
G
MYBPC3
myosin binding protein C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25566086
NCBI chr 2:15,247,679...15,269,714
Ensembl chr 2:15,247,340...15,270,104
G
MYC
MYC proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078
G
NAA10
N-alpha-acetyltransferase 10, NatA catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr X:124,658,429...124,662,744
Ensembl chr X:124,658,158...124,662,702
G
NCL
nucleolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:132,163,453...132,174,214
Ensembl chr15:132,162,516...132,174,172
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:27012417 PMID:29255069
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
G
NOP56
NOP56 ribonucleoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr17:32,960,099...32,965,396
Ensembl chr17:32,960,102...32,965,370
G
NOP58
NOP58 ribonucleoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:105,893,589...105,930,458
Ensembl chr15:105,893,637...105,930,459
G
NPHP3
nephrocystin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12089381
NCBI chr13:73,843,770...73,901,020
Ensembl chr13:73,858,427...73,900,967
G
NPM1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr16:52,767,263...52,781,862
Ensembl chr16:52,765,298...52,781,771
G
NPM3
nucleophosmin/nucleoplasmin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:112,819,390...112,822,244
Ensembl chr14:112,819,393...112,821,367
G
NPPB
natriuretic peptide B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr 6:71,930,374...71,931,843
Ensembl chr 6:71,930,382...71,932,254
G
NR1H4
nuclear receptor subfamily 1 group H member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29142166 PMID:32062620
NCBI chr 5:83,607,222...83,732,668
Ensembl chr 5:83,604,294...83,684,604
G
NUDT21
nudix hydrolase 21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:29,339,893...29,359,596
Ensembl chr 6:29,339,841...29,363,312
G
NUS1
NUS1 dehydrodolichyl diphosphate synthase subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33812996
NCBI chr 1:44,156,771...44,186,224
Ensembl chr 1:44,156,778...44,186,194
G
P2RX7
purinergic receptor P2X 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27466191
NCBI chr14:31,415,188...31,476,502
Ensembl chr14:31,415,193...31,476,472
G
PABPC4
poly(A) binding protein cytoplasmic 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:95,382,295...95,399,452
Ensembl chr 6:95,382,302...95,399,080
G
PCBD1
pterin-4 alpha-carbinolamine dehydratase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr14:73,769,339...73,807,278
Ensembl chr14:73,800,765...73,807,281
G
PDE6B
phosphodiesterase 6B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17213800
NCBI chr 8:80,378...111,960
Ensembl chr 8:80,378...110,672
G
PIGN
phosphatidylinositol glycan anchor biosynthesis class N
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:159,317,734...159,417,335
Ensembl chr 1:159,317,734...159,417,327
G
PIM1
Pim-1 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25812446
NCBI chr 7:32,788,246...32,793,882
Ensembl chr 7:32,788,291...32,793,878
G
PKD1
polycystin 1, transient receptor potential channel interacting
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25877301
NCBI chr 3:39,849,579...39,899,455
Ensembl chr 3:39,849,609...39,899,455
G
POLR1D
RNA polymerase I and III subunit D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr11:5,044,274...5,045,921
Ensembl chr11:5,044,329...5,089,766
G
PPAN
peter pan homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:68,958,906...68,962,657
Ensembl chr 2:68,958,906...68,962,657
G
PRKCG
protein kinase C gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 6:56,213,479...56,235,683
Ensembl chr 6:56,213,480...56,234,210
G
PRKN
parkin RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15882845
NCBI chr 1:5,698,508...6,731,132
Ensembl chr 1:5,465,312...6,730,872
G
PSAT1
phosphoserine aminotransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:231,142,673...231,172,364
Ensembl chr 1:231,142,625...231,172,360
G
PSEN1
presenilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16651627 PMID:27567873
NCBI chr 7:96,478,179...96,567,884
Ensembl chr 7:96,478,190...96,569,130
G
PTH
parathyroid hormone
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30639440
NCBI chr 2:45,757,398...45,760,433
Ensembl chr 2:45,757,398...45,760,415
G
RANGRF
RAN guanine nucleotide release factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:53,484,584...53,486,716
Ensembl chr12:53,485,265...53,486,713
G
RCL1
RNA terminal phosphate cyclase like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:217,142,965...217,204,960
Ensembl chr 1:217,142,966...217,204,965
G
RFC4
replication factor C subunit 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:124,589,292...124,604,421
Ensembl chr13:124,589,295...124,604,426
G
RHOA
ras homolog family member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25783350
NCBI chr13:31,918,484...31,991,207
Ensembl chr13:31,918,834...31,986,607
G
ROCK2
Rho associated coiled-coil containing protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr 3:125,353,063...125,493,368
Ensembl chr 3:125,352,920...125,493,362
G
RPL10A
ribosomal protein L10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 7:31,327,763...31,330,624
Ensembl chr 7:31,327,440...31,333,638
G
RPL13A
ribosomal protein L13a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:54,551,772...54,568,752
Ensembl chr 6:54,551,533...54,561,489
G
RPL27A
ribosomal protein L27a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:708,531...712,410
Ensembl chr 9:707,693...711,219
G
RPSA
ribosomal protein SA
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:24,072,551...24,081,536
Ensembl chr13:24,072,527...24,081,541
G
RRM1
ribonucleotide reductase catalytic subunit M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 9:6,026,151...6,065,211
Ensembl chr 9:6,025,073...6,065,143
G
RRM2
ribonucleotide reductase regulatory subunit M2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:126,357,198...126,367,145
Ensembl chr 3:126,347,819...126,365,644
G
RRS1
ribosome biogenesis regulator 1 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:68,285,803...68,288,213
Ensembl chr 4:68,285,803...68,288,195
G
RSAD2
radical S-adenosyl methionine domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36071497
NCBI chr 3:128,880,853...128,897,809
Ensembl chr 3:128,877,186...128,897,815
G
S100A10
S100 calcium binding protein A10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21682946
NCBI chr 4:97,261,752...97,272,517
Ensembl chr 4:97,261,815...97,272,513
G
S100B
S100 calcium binding protein B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12888777 PMID:34792689
G
SATB1
SATB homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:5,315,985...5,410,686
Ensembl chr13:5,314,148...5,417,610
G
SERPINE1
serpin family E member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21051829
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
G
SFXN1
sideroflexin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:82,025,799...82,057,629
Ensembl chr 2:82,025,820...82,057,564
G
SH3PXD2B
SH3 and PX domains 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28719234
NCBI chr16:51,733,170...51,858,774
Ensembl chr16:51,733,135...51,858,772
G
SHMT1
serine hydroxymethyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:60,414,421...60,435,451
Ensembl chr12:60,416,463...60,435,450
G
SLC15A2
solute carrier family 15 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:138,595,942...138,634,473
Ensembl chr13:138,595,958...138,632,675
G
SLC19A1
solute carrier family 19 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:207,986,094...208,007,855
Ensembl chr13:207,986,098...208,007,675
G
SLC29A1
solute carrier family 29 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27567601
NCBI chr 7:39,217,974...39,234,683
Ensembl chr 7:39,218,051...39,234,685
G
SLC4A4
solute carrier family 4 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 8:67,768,955...68,177,213
Ensembl chr 8:67,706,874...68,177,212
G
SLC4A7
solute carrier family 4 member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:13,933,552...14,043,108
Ensembl chr13:13,933,711...14,043,058
G
SMARCC1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:30,409,979...30,576,270
Ensembl chr13:30,409,983...30,601,441
G
SNCA
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21892157 PMID:26075822
NCBI chr 8:129,247,724...129,388,307
Ensembl chr 8:129,248,819...129,271,128
G
SNRPG
small nuclear ribonucleoprotein polypeptide G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 3:72,198,722...72,208,053
Ensembl chr 3:72,198,756...72,208,865
G
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12586733 PMID:12684256 PMID:19227972 PMID:20177826 PMID:21867702 PMID:23583883 PMID:24885036 PMID:28038988 PMID:28123103 PMID:29374221 PMID:29434186 More...
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
G
SRM
spermidine synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:71,246,895...71,253,534
Ensembl chr 6:71,246,876...71,253,508
G
STAT3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25812446
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
STK39
serine/threonine kinase 39
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:74,441,019...74,757,851
Ensembl chr15:74,447,787...74,758,122
G
STRBP
spermatid perinuclear RNA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 1:264,030,135...264,195,908
Ensembl chr 1:264,045,669...264,195,883
G
SUCLG2
succinate-CoA ligase GDP-forming subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr13:48,650,851...49,090,521
Ensembl chr13:48,823,733...49,090,468
G
TBX20
T-box transcription factor 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr18:38,635,603...38,681,690
Ensembl chr18:38,635,617...38,678,133
G
TCF7L2
transcription factor 7 like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29394407
NCBI chr14:123,343,695...123,547,332
Ensembl chr14:123,343,412...123,546,417
G
TFAM
transcription factor A, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28595911
NCBI chr14:92,261,713...92,279,731
Ensembl chr14:92,259,403...92,279,731
G
TG
thyroglobulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30373627
NCBI chr 4:8,158,395...8,382,435
Ensembl chr 4:8,158,396...8,382,435
G
TGFBR1
transforming growth factor beta receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27228633
NCBI chr 1:240,842,735...240,918,267
Ensembl chr 1:240,860,156...240,918,528
G
TIMM10
translocase of inner mitochondrial membrane 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 2:13,393,225...13,396,241
Ensembl chr 2:13,393,282...13,396,439
G
TIMM8A
translocase of inner mitochondrial membrane 8A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr X:82,978,128...82,981,038
Ensembl chr X:82,974,270...82,980,769
G
TIMP1
TIMP metallopeptidase inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21051829
NCBI chr X:42,103,251...42,106,289
Ensembl chr X:42,102,172...42,106,296
G
TK1
thymidine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:3,785,997...3,794,824
Ensembl chr12:3,786,031...3,795,917
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27093858
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
TOMM40
translocase of outer mitochondrial membrane 40
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:51,359,948...51,369,932
Ensembl chr 6:51,359,595...51,369,908
G
TOP2A
DNA topoisomerase II alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr12:22,001,300...22,028,452
Ensembl chr12:22,001,282...22,028,450
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23873029
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
TPI1
triosephosphate isomerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:63,839,473...63,842,853
Ensembl chr 5:63,838,506...63,843,134
G
TTPA
alpha tocopherol transfer protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11095717 PMID:11752462
NCBI chr 4:70,960,580...70,980,883
Ensembl chr 4:70,961,465...70,980,876
G
TYMS
thymidylate synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 6:105,642,730...105,660,279
Ensembl chr 6:105,642,381...105,660,578
G
UCK2
uridine-cytidine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 4:84,838,793...84,919,231
Ensembl chr 4:84,838,802...84,919,236
G
VCP
valosin containing protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25884947
NCBI chr 1:235,854,532...235,869,712
Ensembl chr 1:235,851,206...235,869,634
G
VIM
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16831193
NCBI chr10:43,516,441...43,526,172
Ensembl chr10:43,517,307...43,526,170
G
WNT11
Wnt family member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25783350
NCBI chr 9:10,413,182...10,435,158
Ensembl chr 9:10,413,263...10,435,100
G
XRCC5
X-ray repair cross complementing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr15:118,354,943...118,451,974
Ensembl chr15:118,354,796...118,451,960
G
XRCC6
X-ray repair cross complementing 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27602772
NCBI chr 5:6,903,496...6,929,162
Ensembl chr 5:6,903,495...6,929,052
G
MAG
myelin associated glycoprotein
ISO
protein:decreased expression:optic nerve
RGD
PMID:9820787
RGD:9685300
NCBI chr 6:44,794,197...44,809,933
Ensembl chr 6:44,794,204...44,809,926
G
ZC3H12A
zinc finger CCCH-type containing 12A
disease_progression
ISO
RGD
PMID:26320658
RGD:11534569
NCBI chr 6:93,541,334...93,551,200
Ensembl chr 6:93,541,334...93,551,193
G
ATP2A2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
treatment
ISO
RGD
PMID:18416460
RGD:13782074
NCBI chr14:31,674,659...31,744,981
Ensembl chr14:31,674,757...31,744,969
G
BCL2L1
BCL2 like 1
ISO
protein:increased expression:pancreas, mitochondrion (rat)
RGD
PMID:19331832
RGD:11353791
NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694
G
BECN1
beclin 1
treatment
ISO
RGD
PMID:22850625
RGD:11560530
NCBI chr12:20,041,914...20,054,249
Ensembl chr12:20,041,956...20,054,373
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
RGD
PMID:10451498
RGD:10043817
NCBI chr 7:32,354,776...32,363,771
Ensembl chr 7:32,359,455...32,363,761
G
EDNRA
endothelin receptor type A
treatment
ISO
RGD
PMID:12799311
RGD:1581841
NCBI chr 8:81,210,750...81,279,053
Ensembl chr 8:81,209,327...81,276,853
G
FAS
Fas cell surface death receptor
severity
ISO
protein:increased expression:Kupffer cell:
RGD
PMID:15797225
RGD:14700708
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FASLG
Fas ligand
severity
ISO
protein:increased expression:Kupffer cell:
RGD
PMID:15797225
RGD:14700708
NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
G
GSS
glutathione synthetase
ISO
RGD
PMID:17897920
RGD:11353819
NCBI chr17:38,316,199...38,342,253
Ensembl chr17:38,312,720...38,342,298
G
HMGB1
high mobility group box 1
treatment
ISO
RGD
PMID:23706497
RGD:10402063
NCBI chr11:7,195,556...7,321,071
G
HSPA5
heat shock protein family A (Hsp70) member 5
ISO
protein:increased expression:neutrophil:
RGD
PMID:26464680
RGD:11354914
NCBI chr 1:265,930,044...265,934,959
Ensembl chr 1:265,930,045...265,934,894
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:10201790 PMID:23706497
RGD:10402063 RGD:11520782
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:25323753
RGD:11049477
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL4
interleukin 4
treatment
ISO
RGD
PMID:24876883
RGD:10402805
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
G
JAK1
Janus kinase 1
treatment
ISO
RGD
PMID:21369693
RGD:19165136
NCBI chr 6:147,320,288...147,567,188
Ensembl chr 6:147,429,056...147,567,182
G
KMO
kynurenine 3-monooxygenase
disease_progression
ISO
RGD
PMID:26752518 PMID:28398044
RGD:11342439 RGD:13703053
NCBI chr10:12,442,877...12,489,417
Ensembl chr10:12,434,769...12,490,409
G
KRAS
KRAS proto-oncogene, GTPase
ISO
RGD
PMID:8913708
RGD:11062095
NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
G
LAMP2
lysosomal associated membrane protein 2
ISO
protein:decreased expression:pancreas
RGD
PMID:22850625
RGD:11560530
NCBI chr X:98,586,718...98,623,939
Ensembl chr X:98,556,710...98,623,940
G
MAP1LC3A
microtubule associated protein 1 light chain 3 alpha
treatment
ISO
RGD
PMID:22850625
RGD:11560530
NCBI chr17:37,957,830...37,959,505
Ensembl chr17:37,957,507...37,959,505
G
MIR155
microRNA mir-155
treatment
ISO
RGD
PMID:29937734 PMID:30497068
RGD:21403683 RGD:21408596
NCBI chr13:189,138,822...189,138,902
Ensembl chr13:189,138,822...189,138,902
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
RGD
PMID:16127429
RGD:11075069
NCBI chr10:14,203,157...14,241,164
Ensembl chr10:14,203,160...14,241,196
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:19680809
RGD:11100040
NCBI chr15:25,043,543...25,054,310
Ensembl chr15:25,043,545...25,056,595
G
PROCR
protein C receptor
treatment
ISO
protein:increased expression:blood
RGD
PMID:24749346 PMID:25688263
RGD:13515127 RGD:13515128
NCBI chr17:38,532,530...38,537,397
Ensembl chr17:38,532,763...38,537,394
G
PTAFR
platelet activating factor receptor
treatment
ISO
RGD
PMID:21633536
RGD:9999225
NCBI chr 6:85,235,390...85,272,360
Ensembl chr 6:85,235,394...85,261,760
G
SERPINC1
serpin family C member 1
treatment
ISO
RGD
PMID:19546838
RGD:11035262
NCBI chr 9:116,181,988...116,193,100
Ensembl chr 9:116,181,670...116,193,201
G
SPINK1
serine peptidase inhibitor Kazal type 1
treatment
ISO
RGD
PMID:15765407
RGD:10043090
NCBI chr 2:149,072,652...149,079,529
Ensembl chr 2:149,071,703...149,079,499
G
TNF
tumor necrosis factor
ISO
associated with Anemia, Hemolytic
RGD
PMID:12845374 PMID:15164724
RGD:10449461 RGD:1580295
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
protein:increased expression:serum
RGD
PMID:15164724
RGD:1580295
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
protein:increased expression:serum
RGD
PMID:15164724
RGD:1580295
NCBI chr 6:72,195,420...72,231,146
Ensembl chr 6:72,195,435...72,231,147
G
VWF
von Willebrand factor
ISO
protein:increased expression:plasma:
RGD
PMID:17708840
RGD:11079229
NCBI chr 5:64,516,627...64,655,938
Ensembl chr 5:64,519,186...65,002,452
G
RHOB
ras homolog family member B
ISO
RGD
PMID:1710770
RGD:704375
NCBI chr 3:117,773,400...117,777,569
Ensembl chr 3:117,773,405...117,777,574
G
C3
complement C3
treatment
ISO
RGD
PMID:16947020
RGD:7401280
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
G
COQ7
coenzyme Q7, hydroxylase
susceptibility
ISO
RGD
PMID:23166727
RGD:10402105
NCBI chr 3:26,366,006...26,373,604
Ensembl chr 3:26,366,000...26,373,584
G
CSF1R
colony stimulating factor 1 receptor
ameliorates
ISO
mouse cell line in a mouse model
RGD
PMID:20008303
RGD:150524291
NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
G
IL18
interleukin 18
treatment
ISO
RGD
PMID:16767432
RGD:8655941
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
G
IL2
interleukin 2
treatment
ISO
RGD
PMID:9399664
RGD:8663451
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
IRAK3
interleukin 1 receptor associated kinase 3
ISO
RGD
PMID:21278795
RGD:36049796
NCBI chr 5:30,524,704...30,601,067
Ensembl chr 5:30,526,793...30,609,921
G
JAM3
junctional adhesion molecule 3
ISO
RGD
PMID:15994945
RGD:7488936
NCBI chr 9:60,629,245...60,738,979
Ensembl chr 9:60,613,400...60,738,924
G
LECT2
leukocyte cell derived chemotaxin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30453282
NCBI chr 2:138,109,537...138,120,285
Ensembl chr 2:138,109,351...138,124,464
G
MAPK14
mitogen-activated protein kinase 14
ameliorates
ISO
mouse cell line in a mouse model
RGD
PMID:29907597
RGD:151665504
NCBI chr 7:31,791,398...31,861,544
Ensembl chr 7:31,790,877...31,862,031
G
MYD88
MYD88 innate immune signal transduction adaptor
treatment
ISO
mouse cell line in a mouse model
RGD
PMID:26111447
RGD:150521531
NCBI chr13:22,976,951...22,979,568
Ensembl chr13:22,966,137...22,983,109
G
TXNRD1
thioredoxin reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16565519
NCBI chr 5:80,170,334...80,213,889
Ensembl chr 5:80,172,260...80,236,219
G
DLL4
delta like canonical Notch ligand 4
treatment
ISO
RGD
PMID:21526177
RGD:155663484
NCBI chr 1:130,376,720...130,386,411
Ensembl chr 1:130,376,721...130,386,411
G
SERPINE1
serpin family E member 1
treatment severity
ISO
human gene in mouse model mRNA:increased expression:retina (mouse)
RGD
PMID:11292663 PMID:12766088 PMID:26610445
RGD:11073722 RGD:8547735 RGD:8547737
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
G
SMO
smoothened, frizzled class receptor
treatment
ISO
RGD
PMID:21063852
RGD:12859045
NCBI chr18:19,450,730...19,478,796
Ensembl chr18:19,450,743...19,478,898
G
CBS
cystathionine beta-synthase
ISO
protein:increased expression:arcuate nucleus (rat)
RGD
PMID:27778022
RGD:38456012
NCBI chr13:206,205,942...206,231,363
Ensembl chr13:206,205,946...206,230,248
G
GLI1
GLI family zinc finger 1
ISO
RGD
PMID:24782623
RGD:12879405
NCBI chr 5:22,736,325...22,747,421
Ensembl chr 5:22,739,900...22,747,421
G
LOC110258578
interleukin-1 beta-like
ISO
RGD
PMID:22173919
RGD:10044253
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
RGD
PMID:22359633
RGD:11035224
NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590
G
PTCH1
patched 1
ISO
RGD
PMID:24782623
RGD:12879405
NCBI chr10:26,627,165...26,703,225
Ensembl chr10:26,627,425...26,703,223
G
SMO
smoothened, frizzled class receptor
ISO
RGD
PMID:24782623
RGD:12879405
NCBI chr18:19,450,730...19,478,796
Ensembl chr18:19,450,743...19,478,898
G
SPINK1
serine peptidase inhibitor Kazal type 1
treatment
ISO
protein:increased secretion:pancreatic juice:
RGD
PMID:12123090 PMID:19904222 PMID:22173919
RGD:10043091 RGD:10044253 RGD:10044261
NCBI chr 2:149,072,652...149,079,529
Ensembl chr 2:149,071,703...149,079,499
G
TGFB1
transforming growth factor beta 1
ISO
RGD
PMID:26645248
RGD:14995470
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
G
CCL2
chemokine (C-C motif) ligand 2
ISO
mRNA:increased expression:spinal cord (rat)
RGD
PMID:12098510
RGD:8655962
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
NEFH
neurofilament heavy chain
ISO
protein:decreased expression:spinal cord:
RGD
PMID:12742652
RGD:27226817
NCBI chr14:46,559,698...46,568,686
Ensembl chr14:46,559,860...46,568,088
G
PLP1
proteolipid protein 1
ISO
human sequence peptide in a mouse model; associated with Herpesviridae infections
RGD
PMID:12811845
RGD:30296670
NCBI chr X:84,676,627...84,683,517
Ensembl chr X:84,666,733...84,685,058
G
SERPINE1
serpin family E member 1
ISO
RGD
PMID:17983428
RGD:13208507
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
G
CD40
CD40 molecule
treatment
ISO
RGD
PMID:19269163
RGD:11352683
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
G
CD40LG
CD40 ligand
treatment
ISO
RGD
PMID:19269163
RGD:11352683
NCBI chr X:111,778,666...111,788,901
Ensembl chr X:111,778,493...111,789,709
G
CEACAM20
CEA cell adhesion molecule 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34605108
NCBI chr 6:51,010,317...51,031,579
Ensembl chr 6:51,009,689...51,031,550
G
ACSL3
acyl-CoA synthetase long chain family member 3
ISO
RGD
PMID:23526225
RGD:13831300
NCBI chr15:124,741,986...124,816,955
Ensembl chr15:124,765,854...124,816,960
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:29713367
RGD:13792581
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
CD86
CD86 molecule
treatment
ISO
RGD
PMID:25344652
RGD:11354965
NCBI chr13:138,427,573...138,504,307
Ensembl chr13:138,427,533...138,504,310
G
FAS
Fas cell surface death receptor
treatment
ISO
RGD
PMID:29713367
RGD:13792581
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FASLG
Fas ligand
treatment
ISO
RGD
PMID:29713367
RGD:13792581
NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
G
IL23A
interleukin 23 subunit alpha
ISO
RGD
PMID:19935773 PMID:26344076
RGD:11251537 RGD:5037240
NCBI chr 5:21,732,416...21,733,981
Ensembl chr 5:21,732,165...21,734,267
G
A2M
alpha-2-macroglobulin
ISO
protein:increased expression:serum
RGD
PMID:6163339
RGD:10046032
NCBI chr 5:62,406,928...62,483,690
Ensembl chr 5:62,440,810...62,483,678
G
ABCB1
ATP-binding cassette, sub-family B (MDR/TAP), member 1
ISO
mRNA:decreased expression:intestinal mucosa (rat) mRNA:altered expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17827786 PMID:19152228
RGD:11040994 RGD:2315573
NCBI chr 9:93,049,955...93,146,469
G
ABCC6
ATP binding cassette subfamily C member 6
ISO
mRNA:decreased expression:kidney
RGD
PMID:22974786
RGD:11038789
NCBI chr 3:28,260,935...28,356,706
Ensembl chr 3:28,261,282...28,356,646
G
ABCG2A
ATP binding cassette subfamily G member 2A
ISO
mRNA:decreased expression:small intestine
RGD
PMID:19152228
RGD:2315573
NCBI chr 8:130,853,414...130,945,388
Ensembl chr 8:130,889,684...130,945,393
G
ACAN
aggrecan
treatment
ISO
RGD
PMID:25821409
RGD:12879456
NCBI chr 7:54,449,830...54,520,606
Ensembl chr 7:54,449,816...54,519,194
G
ACE
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
ISO
RGD
PMID:20213806
RGD:2325221
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
G
ACSL1
acyl-CoA synthetase long chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18988084
NCBI chr15:45,866,858...45,936,327
Ensembl chr15:45,866,857...45,963,729
G
ACSL4
acyl-CoA synthetase long chain family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18988084
NCBI chr X:89,760,863...89,838,103
Ensembl chr X:89,760,866...89,806,274
G
ACSL5
acyl-CoA synthetase long chain family member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18988084
NCBI chr14:122,777,135...122,828,054
Ensembl chr14:122,777,130...122,828,052
G
ADAM10
ADAM metallopeptidase domain 10
ISO
RGD
PMID:23897050
RGD:13703039
NCBI chr 1:113,289,480...113,407,940
Ensembl chr 1:113,289,209...113,412,798
G
ADAM17
ADAM metallopeptidase domain 17
ISO
RGD
PMID:23897050
RGD:13703039
NCBI chr 3:126,795,513...126,853,995
Ensembl chr 3:126,795,426...126,853,995
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum
CTD RGD
PMID:19026984 PMID:21681567 PMID:23326410
RGD:5685385 RGD:5686814
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
G
ADK
adenosine kinase
ISO
RGD
PMID:11160636
RGD:6482663
NCBI chr14:76,836,072...77,320,586
Ensembl chr14:76,836,095...77,322,416
G
AHCY
adenosylhomocysteinase
ISO
RGD
PMID:11123369
RGD:1598898
NCBI chr17:37,726,084...37,744,378
Ensembl chr17:37,726,084...37,744,461
G
AHR
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25194622
NCBI chr 9:86,511,866...86,555,950
Ensembl chr 9:86,511,369...86,555,943
G
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:22391142
RGD:10041007
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20472598
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
G
AMCF-II
alveolar macrophage-derived chemotactic factor-II
severity
ISO
RGD
PMID:10358204
RGD:5135272
NCBI chr 8:70,008,225...70,010,360
Ensembl chr 8:70,008,162...70,010,358
G
ANXA1
annexin A1
ISO
RGD
PMID:10403283 PMID:23267026
RGD:2306928 RGD:7421573
NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279
G
ANXA2
annexin A2
ameliorates
ISO
RGD
PMID:24819400
RGD:150519886
NCBI chr 1:111,588,721...111,635,064
Ensembl chr 1:111,588,306...111,635,059
G
APOA4
apolipoprotein A4
ISO
protein:decreased expression:blood serum (rat)
RGD
PMID:10892728
RGD:5685694
NCBI chr 9:44,201,587...44,204,072
Ensembl chr 9:44,201,508...44,204,206
G
ARRB1
arrestin beta 1
ISO
protein:increased expression:knee, synoviocyte (rat)
RGD
PMID:20965243
RGD:5509895
NCBI chr 9:9,516,944...9,597,446
Ensembl chr 9:9,516,947...9,597,976
G
ARRB2
arrestin beta 2
ISO
protein:increased expression:knee, synoviocyte (rat)
RGD
PMID:20965243
RGD:5509895
NCBI chr12:52,161,776...52,170,362
Ensembl chr12:52,161,778...52,170,342
G
ATIC
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
ISO
RGD
PMID:17408934
RGD:5144054
NCBI chr15:117,617,584...117,649,063
Ensembl chr15:117,617,502...117,649,107
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:21199477 PMID:22978269
RGD:10054249 RGD:10054498
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:21199477 PMID:22978269
RGD:10054249 RGD:10054498
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
BDKRB1
bradykinin receptor B1
ISO
RGD
PMID:15001555
RGD:1625760
NCBI chr 7:117,491,350...117,492,410
Ensembl chr 7:117,491,350...117,492,410
G
BTK
Bruton tyrosine kinase
treatment
ISO
RGD
PMID:22228807 PMID:32083858
RGD:11040701 RGD:151665122
NCBI chr X:82,981,512...83,014,475
Ensembl chr X:82,981,515...83,014,573
G
C3
complement C3
treatment
ISO
RGD
PMID:7347767 PMID:20051658
RGD:11041098 RGD:7411688
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
G
C5
complement C5
ISO
RGD
PMID:12355496 PMID:20975959
RGD:1600637 RGD:5130175
NCBI chr 1:260,995,662...261,088,868
Ensembl chr 1:260,995,668...261,133,483
G
CABIN1
calcineurin binding protein 1
ISO
RGD
PMID:22275266
RGD:10054391
NCBI chr14:49,686,196...49,787,723
Ensembl chr14:49,686,196...49,787,688
G
CALCB
calcitonin-related polypeptide beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16690336
NCBI chr 2:44,043,135...44,048,651
G
CAT
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22450443
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CBL
Cbl proto-oncogene
treatment
ISO
RGD
PMID:16984225
RGD:2306289
NCBI chr 9:46,416,937...46,512,855
Ensembl chr 9:46,416,938...46,512,834
G
CBLB
Cbl proto-oncogene B
ISO
RGD
PMID:16984225
RGD:2306289
NCBI chr13:153,480,525...153,700,115
Ensembl chr13:153,395,978...153,700,056
G
CCL2
chemokine (C-C motif) ligand 2
treatment
ISO
mRNA, protein:increased expression:synovium
RGD
PMID:17052673 PMID:18292571 PMID:18726678 PMID:24583103
RGD:11526142 RGD:2307008 RGD:2307052 RGD:2307143
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
CCL3L1
chemokine (C-C motif) ligand 3-like 1
ISO
mRNA, protein:increased expression:synovium, monocytes
RGD
PMID:17052673
RGD:2307143
NCBI chr12:39,491,999...39,493,345
Ensembl chr12:39,491,914...39,493,774
G
CCL5
C-C motif chemokine ligand 5
ISO
mRNA, protein:increased expression:synovium, monocytes
RGD
PMID:9637726 PMID:17052673
RGD:2307143 RGD:4889940
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
G
CCN1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:27653023
RGD:150429754
NCBI chr 4:130,392,404...130,395,179
Ensembl chr 4:130,392,407...130,395,150
G
CCR1
C-C motif chemokine receptor 1
ISO
RGD
PMID:14674010 PMID:18608173
RGD:1582346 RGD:5688144
NCBI chr13:29,227,218...29,233,862
Ensembl chr13:29,227,222...29,233,960
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:16320322
RGD:4144893
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,285,012...29,376,343
G
CCR5
C-C motif chemokine receptor 5
treatment
ISO
mRNA:increased expression:ankle (rat)
RGD
PMID:14674010 PMID:22289897
RGD:1582346 RGD:5687744
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
G
CD28
CD28 molecule
ISO
RGD
PMID:18601859
RGD:2307202
NCBI chr15:107,128,103...107,155,431
Ensembl chr15:107,128,203...107,162,935
G
CD4
CD4 molecule
treatment
ISO
RGD
PMID:12010568 PMID:15479897
RGD:10058957 RGD:10058960
NCBI chr 5:63,892,129...63,918,547
Ensembl chr 5:63,892,137...63,918,519
G
CD40
CD40 molecule
ISO
RGD
PMID:20435931
RGD:5490544
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
G
CD40LG
CD40 ligand
treatment
ISO
protein:increased expression:plasma (rat)
RGD
PMID:7689748 PMID:22611405 PMID:27218142
RGD:11344958 RGD:11352298 RGD:11352696
NCBI chr X:111,778,666...111,788,901
Ensembl chr X:111,778,493...111,789,709
G
CD44
CD44 molecule
ISO
protein:increased expression:joint, macrophage, lymphocyte
RGD
PMID:8639178
RGD:2289388
NCBI chr 2:25,788,699...25,884,209
Ensembl chr 2:25,788,703...25,884,153
G
CD46
CD46 molecule, complement regulatory protein
ISO
RGD
PMID:21852528
RGD:6483461
NCBI chr 9:135,025,439...135,078,910
G
CD59
CD59 molecule
ISO
RGD
PMID:14519760
RGD:1600483
NCBI chr 2:27,186,587...27,207,303
G
CD69
CD69 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12882836
NCBI chr 5:62,078,134...62,084,961
Ensembl chr 5:62,077,988...62,085,900
G
CD80
CD80 molecule
ISO
RGD
PMID:22004797
RGD:6902903
NCBI chr13:140,693,312...140,730,541
Ensembl chr13:140,693,382...140,728,976
G
CDC42
cell division cycle 42
ISO
protein:increased activation:bone marrow, macrophage
RGD
PMID:21266780
RGD:5688271
NCBI chr 6:80,035,034...80,089,243
Ensembl chr 6:80,035,123...80,089,233
G
CDKN2A
cyclin dependent kinase inhibitor 2A
treatment
ISO
RGD
PMID:10395320
RGD:8552686
NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
G
CFH
complement factor H
ISO
RGD
PMID:19828624
RGD:5684557
G
COL2A1
collagen type II alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16200597 PMID:21188452 PMID:23326410 PMID:24709313 PMID:25194622 PMID:25481498 PMID:26070417 PMID:29908986 PMID:29935983 PMID:36181686 More...
NCBI chr 5:78,350,131...78,380,893
Ensembl chr 5:78,350,137...78,380,718
G
CP
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19205849 PMID:19330884
RGD:2314686
NCBI chr13:89,396,713...89,463,540
Ensembl chr13:89,396,708...89,463,476
G
CPOX
coproporphyrinogen oxidase
ISO
protein:decreased activity:liver (rat)
RGD
PMID:9173682
RGD:1600958
NCBI chr13:160,332,436...160,345,862
Ensembl chr13:160,332,436...160,348,232
G
CRHR1
corticotropin releasing hormone receptor 1
ISO
RGD
PMID:17550594
RGD:1626231
NCBI chr12:17,251,361...17,306,308
Ensembl chr12:17,252,020...17,306,285
G
CRP
C-reactive protein, pentraxin-related
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19330884
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
G
CSF1
colony stimulating factor 1
ISO
protein:increased expression:dorsal root ganglion
RGD
PMID:32510872
RGD:127338469
NCBI chr 4:110,178,466...110,198,232
Ensembl chr 4:110,178,475...110,197,900
G
CSF1R
colony stimulating factor 1 receptor
treatment
ISO
RGD
PMID:18434589
RGD:151665814
NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
G
CSF3
colony stimulating factor 3
treatment
ISO
RGD
PMID:12742377
RGD:11039465
NCBI chr12:22,333,445...22,335,949
Ensembl chr12:22,333,449...22,338,753
G
CSK
C-terminal Src kinase
ISO
RGD
PMID:10411542
RGD:5134371
NCBI chr 7:58,736,473...58,755,034
Ensembl chr 7:58,736,531...58,755,260
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
treatment
ISO
RGD
PMID:7543497 PMID:22354915
RGD:7204500 RGD:7204519
NCBI chr15:107,283,081...107,288,041
Ensembl chr15:107,282,927...107,289,103
G
CTSB
cathepsin B
ISO
mRNA:increased expression:knee joint, synovium (rat)
RGD
PMID:17195213
RGD:2315521
NCBI chr14:15,014,139...15,035,081
Ensembl chr14:15,011,711...15,033,877
G
CTSK
cathepsin K
ISO
mRNA:increased expression:synovium, bone marrow
RGD
PMID:15353610
RGD:1601025
NCBI chr 4:98,389,459...98,404,969
Ensembl chr 4:98,391,428...98,404,961
G
CTSS
cathepsin S
ISO
RGD
PMID:21439785
RGD:5686915
NCBI chr 4:98,415,273...98,442,952
Ensembl chr 4:98,417,883...98,442,950
G
CX3CL1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:11465708
RGD:4892002
NCBI chr 6:19,312,351...19,324,439
G
CX3CR1
C-X3-C motif chemokine receptor 1
ISO
protein:increased expression:spinal cord
RGD
PMID:11465708 PMID:17123734
RGD:4891969 RGD:4892002
NCBI chr13:23,944,386...23,957,567
Ensembl chr13:23,944,369...23,957,486
G
DDR2
discoidin domain receptor tyrosine kinase 2
ameliorates
ISO
RGD
PMID:24819400
RGD:150519886
NCBI chr 4:87,749,738...87,911,818
Ensembl chr 4:87,756,168...87,911,296
G
DHODH
dihydroorotate dehydrogenase (quinone)
ISO
RGD
PMID:15182735
RGD:2316231
NCBI chr 6:14,942,898...14,956,000
Ensembl chr 6:14,942,933...14,955,997
G
DNASE2
deoxyribonuclease 2, lysosomal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974942
NCBI chr 2:66,150,071...66,152,857
Ensembl chr 2:66,149,862...66,152,855
G
DNMT1
DNA methyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25194984
NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,566...69,029,844
G
DRD1
dopamine receptor D1
treatment
ISO
mRNA:increased expression:corpus striatum (rat)
RGD
PMID:23762129
RGD:7248592
NCBI chr16:49,189,555...49,193,722
Ensembl chr16:49,189,602...49,191,976
G
DRD2
dopamine receptor D2
treatment
ISO
mRNA:increased expression:corpus striatum (rat)
RGD
PMID:23762129
RGD:7248592
NCBI chr 9:41,068,618...41,135,262
Ensembl chr 9:41,068,779...41,133,599
G
EDN1
endothelin 1
ISO
mRNA:increased expression:inguinal lymph node (mouse)
RGD
PMID:22249931
RGD:8661695
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
G
EGFR
epidermal growth factor receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7589090
NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
G
ESR1
estrogen receptor 1
treatment
ISO
associated with Osteoporosis
RGD
PMID:20112355
RGD:10045851
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
G
ESR2
estrogen receptor 2
ISO
RGD
PMID:16269464
RGD:5508854
NCBI chr 1:193,823,666...193,907,330
Ensembl chr 1:193,829,560...193,906,565
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:21436072
RGD:5147764
NCBI chr 2:15,793,257...15,819,151
Ensembl chr 2:15,791,455...15,819,137
G
F2R
coagulation factor II thrombin receptor
severity
ISO
RGD
PMID:19674841
RGD:7387269
NCBI chr 2:85,642,794...85,659,133
Ensembl chr 2:85,641,474...85,656,636
G
F2RL1
F2R like trypsin receptor 1
ISO
RGD
PMID:12511586
RGD:735010
NCBI chr 2:85,732,082...85,747,552
Ensembl chr 2:85,732,189...85,750,858
G
FASLG
Fas ligand
treatment
ISO
RGD
PMID:22354915
RGD:7204500
NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
G
FCGR1A
Fc fragment of IgG, high affinity Ia, receptor (CD64)
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:dorsal root ganglion
CTD RGD
PMID:12875993 PMID:16670289 PMID:32510872
RGD:127338469 RGD:9685708
NCBI chr 4:99,233,632...99,242,531
Ensembl chr 4:99,233,611...99,242,586
G
FCGR2B
Fc fragment of IgG, low affinity IIb, receptor (CD32)
ISO
RGD
PMID:23341540
RGD:11344930
NCBI chr 4:88,873,762...88,892,964
G
FGF8
fibroblast growth factor 8
ISO
RGD
PMID:18699993
RGD:2314157
NCBI chr14:112,808,215...112,814,225
Ensembl chr14:112,808,162...112,814,248
G
FGFR1
fibroblast growth factor receptor 1
ISO
RGD
PMID:22833219
RGD:10402072
NCBI chr15:48,053,895...48,106,634
Ensembl chr15:48,053,340...48,106,724
G
FLT1
fms related receptor tyrosine kinase 1
ISO
RGD
PMID:19180491
RGD:6483591
NCBI chr11:5,620,698...5,797,095
Ensembl chr11:5,621,212...5,795,264
G
FLT3
fms related receptor tyrosine kinase 3
ISO
RGD
PMID:10857786
RGD:61066
NCBI chr11:5,370,475...5,455,439
Ensembl chr11:5,370,496...5,455,358
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
treatment
ISO
RGD
PMID:24186846
RGD:405650594
NCBI chr 7:98,449,508...98,451,971
Ensembl chr 7:98,449,349...98,455,554
G
FOXP3
forkhead box P3
treatment
ISO
mRNA,protein:decreased expression:lung
RGD
PMID:23643080 PMID:29264841
RGD:38549364 RGD:38599003
NCBI chr X:43,303,777...43,328,164
Ensembl chr X:43,303,785...43,322,968
G
GJA1
gap junction protein alpha 1
ISO
RGD
PMID:23165424
RGD:7207259
NCBI chr 1:40,988,818...41,002,129
Ensembl chr 1:40,988,528...41,002,156
G
GLI1
GLI family zinc finger 1
treatment
ISO
RGD
PMID:25821409
RGD:12879456
NCBI chr 5:22,736,325...22,747,421
Ensembl chr 5:22,739,900...22,747,421
G
GPI
glucose-6-phosphate isomerase
ISO
RGD
PMID:23911657
RGD:11051957
NCBI chr 6:44,038,374...44,069,331
Ensembl chr 6:44,038,357...44,069,328
G
GRK2
G protein-coupled receptor kinase 2
disease_progression treatment
ISO
protein:altered expression:T cell (rat) protein:increased expression:aorta (rat)
RGD
PMID:28349925 PMID:28631356 PMID:28653218
RGD:13513975 RGD:13513976 RGD:13513979
NCBI chr 2:5,209,435...5,227,543
Ensembl chr 2:5,209,439...5,227,758
G
GRN
granulin precursor
ISO
RGD
PMID:21393509
RGD:5509782
NCBI chr12:18,893,772...18,900,444
Ensembl chr12:18,893,770...18,900,446
G
GSK3B
glycogen synthase kinase 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16713974
NCBI chr13:140,136,109...140,370,197
Ensembl chr13:140,136,158...140,369,569
G
GUSB
glucuronidase beta
treatment
ISO
RGD
PMID:827200
RGD:42724460
NCBI chr 3:16,672,071...16,686,520
Ensembl chr 3:16,671,389...16,689,203
G
HAVCR2
hepatitis A virus cellular receptor 2
ISO
mRNA,protein:altered expression:bone:
RGD
PMID:25264706
RGD:9686117
NCBI chr16:66,138,157...66,160,568
Ensembl chr16:66,139,535...66,160,538
G
HDAC6
histone deacetylase 6
treatment
ISO
RGD
PMID:23541634
RGD:9681550
NCBI chr X:42,917,911...42,941,894
Ensembl chr X:42,917,964...42,941,887
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:21679445
RGD:8693318
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
G
HMGB1
high mobility group box 1
ISO
protein:altered localization:cytoplasm, extracellular matrix
RGD
PMID:12384917
RGD:728698
NCBI chr11:7,195,556...7,321,071
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:17119970
RGD:5508468
NCBI chr 2:84,380,245...84,401,117
Ensembl chr 2:84,380,224...84,402,957
G
HP
haptoglobin
ISO
mRNA, protein:increased expression:tendon, ankle protein:increased expression:serum
RGD
PMID:12801280 PMID:15899029
RGD:1626370 RGD:1626375
NCBI chr 6:14,980,382...14,985,245
G
HSPD1
heat shock protein family D (Hsp60) member 1
ISO
RGD
PMID:10882416 PMID:15529360
RGD:12910542 RGD:1624244
NCBI chr15:101,360,355...101,373,498
Ensembl chr15:101,360,094...101,373,526
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7774621 PMID:12412757 PMID:19203382 PMID:22450443
RGD:10755750 RGD:2311498
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IGF1
insulin like growth factor 1
ISO
protein:decreased expression:plasma
RGD
PMID:19246225
RGD:2306697
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
G
IGFBP3
insulin like growth factor binding protein 3
ISO
mRNA, protein:increased expression:kidney, serum
RGD
PMID:14642797
RGD:10402760
NCBI chr18:50,002,921...50,009,425
Ensembl chr18:50,003,022...50,010,690
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO
RGD
PMID:19652024 PMID:21087862
RGD:7495772 RGD:7495778
NCBI chr17:11,289,607...11,348,557
Ensembl chr17:11,289,690...11,348,549
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
treatment
ISO
RGD
PMID:16684367
RGD:12791276
NCBI chr X:125,035,575...125,056,445
Ensembl chr X:125,036,508...125,056,453
G
IL10
interleukin 10
treatment
ISO
protein:decreased expression:serum: CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:15270736 PMID:19169271 PMID:19193354 PMID:20974942 PMID:22052031 PMID:22450443 PMID:23140046 More...
RGD:1626677 RGD:2311059 RGD:7193038 RGD:7364838 RGD:8662976
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL13
interleukin 13
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:10444273 PMID:11860705 PMID:17665443
RGD:4889497 RGD:8549606
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
G
IL15
interleukin 15
ISO
RGD
PMID:20188418
RGD:5000761
NCBI chr 8:85,666,963...85,740,980
Ensembl chr 8:85,667,321...85,678,461
G
IL17A
interleukin 17A
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
RGD CTD
PMID:20925596 PMID:20974942 PMID:21194185 PMID:23377547
RGD:4781444 RGD:9068936 RGD:9130803
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
G
IL18
interleukin 18
disease_progression
ISO
RGD
PMID:15147345 PMID:19096963
RGD:4889415 RGD:4889503
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
G
IL1A
interleukin 1 alpha
ISO
protein:increased expression:serum:
RGD
PMID:19169271 PMID:20379758
RGD:6907373 RGD:8662976
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,119
G
IL1RL1
interleukin 1 receptor like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20472598
NCBI chr 3:51,868,549...51,902,454
Ensembl chr 3:51,846,792...51,951,383
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
mRNA:increased expression:popliteal lymph node (rat) human gene in a rat model mouse model treated with human protein rat model treated with human protein
RGD
PMID:10921508 PMID:12727108 PMID:15270736 PMID:22267332 PMID:23006786
RGD:1626677 RGD:6907376 RGD:8549801 RGD:8551741 RGD:8551745
G
IL2
interleukin 2
treatment
ISO
protein:increased expression:serum:
RGD
PMID:2492102 PMID:19169271
RGD:10047055 RGD:8662976
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
IL20
interleukin 20
ISO
RGD
PMID:20722035
RGD:5147393
NCBI chr 9:67,498,788...67,502,110
Ensembl chr 9:67,498,813...67,502,096
G
IL2RA
interleukin 2 receptor subunit alpha
ISO
RGD
PMID:17928458
RGD:2325988
NCBI chr10:64,948,149...65,001,320
Ensembl chr10:64,948,563...65,001,142
G
IL33
interleukin 33
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20472598
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
G
IL4
interleukin 4
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:10444273 PMID:16869003 PMID:23140046 PMID:23972727
RGD:10402790 RGD:2317300 RGD:7193038
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
G
IL6
interleukin 6
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8607900 PMID:10381487 PMID:20131233 PMID:20974942 PMID:22450443 PMID:23503893 PMID:24028507 More...
RGD:10755447 RGD:11049551 RGD:11049553 RGD:11060267
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
IL6ST
interleukin 6 cytokine family signal transducer
ISO
RGD
PMID:20626857
RGD:5509945
NCBI chr16:35,101,304...35,151,832
Ensembl chr16:35,101,306...35,192,220
G
ITGA4
integrin subunit alpha 4
treatment
ISO
RGD
PMID:12969328
RGD:9698440
NCBI chr15:86,942,054...87,028,428
Ensembl chr15:86,947,240...87,030,364
G
ITGB2
integrin subunit beta 2
ISO
RGD
PMID:8881759
RGD:6482229
NCBI chr13:207,514,281...207,544,108
Ensembl chr13:207,512,950...207,544,107
G
ITGB3
integrin subunit beta 3
ISO
protein:increased expression:endothelial cell
RGD
PMID:16869003
RGD:2317300
NCBI chr12:16,694,466...16,752,228
Ensembl chr12:16,693,514...16,752,292
G
JAG1
jagged canonical Notch ligand 1
ISO
RGD
PMID:19265135
RGD:6482234
NCBI chr17:19,591,248...19,629,659
Ensembl chr17:19,591,259...19,629,641
G
JAK1
Janus kinase 1
treatment
ISO
RGD
PMID:29452839
RGD:19165139
NCBI chr 6:147,320,288...147,567,188
Ensembl chr 6:147,429,056...147,567,182
G
JAK2
Janus kinase 2
treatment
ISO
RGD
PMID:22339472 PMID:22800927 PMID:23711144
RGD:10403066 RGD:10403074 RGD:10403081
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
JAK3
Janus kinase 3
treatment
ISO
RGD
PMID:18234077 PMID:21434883 PMID:25762693
RGD:11533938 RGD:11533942 RGD:11533944
NCBI chr 2:59,905,901...59,926,504
Ensembl chr 2:59,905,919...59,926,495
G
KCNN4
potassium calcium-activated channel subfamily N member 4
ameliorates
ISO
RGD
PMID:25131209
RGD:150521609
NCBI chr 6:50,580,016...50,593,518
Ensembl chr 6:50,580,022...50,593,544
G
KLKB1
kallikrein B1
ISO
RGD
PMID:9783057 PMID:22739815
RGD:7297047 RGD:7327138
NCBI chr15:47,071,581...47,100,272
Ensembl chr15:47,071,556...47,103,622
G
KYAT1
kynurenine aminotransferase 1
ISO
RGD
PMID:16984225
RGD:2306289
NCBI chr 1:269,172,628...269,209,553
Ensembl chr 1:269,172,628...269,209,478
G
LEP
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15142272
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
G
LGALS3
galectin 3
ISO
RGD
PMID:16507131
RGD:1625684
NCBI chr 1:184,478,639...184,496,155
Ensembl chr 1:184,478,710...184,497,951
G
LOC110256000
membrane primary amine oxidase-like
ISO
RGD
PMID:16947396
RGD:2313925
NCBI chr12:19,996,324...20,007,006
G
LOC110258578
interleukin-1 beta-like
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
RGD CTD
PMID:19330884 PMID:20131233 PMID:20974942 PMID:21557995 PMID:22450443 PMID:23140046 PMID:24028507 PMID:29408684 More...
RGD:10755447 RGD:13792834 RGD:7175317 RGD:7193038
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
ISO
RGD
PMID:16331767
RGD:10412332
NCBI chr 1:27,380,143...27,600,500
Ensembl chr 1:27,380,142...27,600,493
G
MIF
macrophage migration inhibitory factor
ISO
RGD
PMID:10765927
RGD:1642012
NCBI chr14:49,840,303...49,841,063
Ensembl chr14:49,840,305...49,841,068
G
MIR152
microRNA mir-152
ISO
CTD Direct Evidence: marker/mechanism miRNA:decreased exression:synovial membrane of synovial joint
CTD RGD
PMID:25194984
RGD:21066343
NCBI chr12:24,292,249...24,292,328
Ensembl chr12:24,292,251...24,292,336
G
MIR23B
microRNA mir-23b
treatment
ISO
mRNA:decreased expression:joint (mouse)
RGD
PMID:22660635
RGD:155663483
NCBI chr10:27,080,197...27,080,276
Ensembl chr10:27,080,197...27,080,276
G
MMP1
matrix metallopeptidase 1
ISO
RGD
PMID:21108488 PMID:21288455 PMID:24011916
RGD:7207362 RGD:7207365 RGD:8549748
NCBI chr 9:33,411,738...33,420,205
Ensembl chr 9:33,411,065...33,420,076
G
MMP13
matrix metallopeptidase 13
treatment
ISO
RGD
PMID:11435459 PMID:24244039
RGD:1582329 RGD:8694124
NCBI chr 9:33,549,003...33,616,700
Ensembl chr 9:33,549,008...33,561,162
G
MMP3
matrix metallopeptidase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974942
NCBI chr 9:33,446,969...33,453,995
Ensembl chr 9:33,446,836...33,454,000
G
MMP9
matrix metallopeptidase 9
ISO
protein:increased expression:cartilage, serum, synovial fluid
RGD
PMID:17463159
RGD:1642035
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
MPO
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22450443
NCBI chr12:34,557,031...34,570,091
Ensembl chr12:34,556,408...34,567,904
G
MT-ATP8
mitochondrially encoded ATP synthase membrane subunit 8
susceptibility
ISO
DNA:transversion: :m.7778G>T (mouse)
RGD
PMID:19759059
RGD:5490297
NCBI chr MT:8,959...9,162
Ensembl chr MT:8,959...9,162
G
MTOR
mechanistic target of rapamycin kinase
treatment
ISO
RGD
PMID:22391142
RGD:10041007
NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
G
MYD88
MYD88 innate immune signal transduction adaptor
ISO
RGD
PMID:20131263
RGD:8552884
NCBI chr13:22,976,951...22,979,568
Ensembl chr13:22,966,137...22,983,109
G
MYOD1
myogenic differentiation 1
treatment
ISO
RGD
PMID:23781298
RGD:9686078
NCBI chr 2:41,422,522...41,424,236
Ensembl chr 2:41,415,775...41,424,435
G
MYOG
myogenin
treatment
ISO
RGD
PMID:23781298
RGD:9686078
NCBI chr 9:113,783,233...113,785,312
Ensembl chr 9:113,782,284...113,787,340
G
NCF1
neutrophil cytosolic factor 1
severity
ISO
DNA:missense mutations:cds:p.M106V, p.M153T (rat)
RGD
PMID:12461526
RGD:628543
NCBI chr 3:11,820,367...11,834,394
Ensembl chr 3:11,820,266...11,839,354
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
RGD
PMID:20131263 PMID:21424514
RGD:5508728 RGD:8552884
NCBI chr 6:34,132,127...34,167,446
Ensembl chr 6:34,130,938...34,177,534
G
NOS2
nitric oxide synthase 2
ISO
protein:increased expression:ankle joint (mouse)
RGD
PMID:12826065 PMID:21880869
RGD:1358527 RGD:5509060
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
G
NOS3
nitric oxide synthase 3
treatment
ISO
RGD
PMID:29337196
RGD:13504725
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
G
NPSR1
neuropeptide S receptor 1
treatment
ISO
RGD
PMID:24884567
RGD:9831205
NCBI chr18:38,942,499...39,212,791
Ensembl chr18:38,942,487...39,085,754
G
NQO1
NAD(P)H quinone dehydrogenase 1
severity
ISO
RGD
PMID:16905546
RGD:11073695
NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590
G
NR1H2
nuclear receptor subfamily 1 group H member 2
ISO
RGD
PMID:21859686
RGD:6480864
NCBI chr 6:55,238,536...55,245,457
Ensembl chr 6:55,239,500...55,245,456
G
NR1H3
nuclear receptor subfamily 1 group H member 3
ISO
RGD
PMID:21859686
RGD:6480864
NCBI chr 2:15,315,283...15,336,785
Ensembl chr 2:15,315,282...15,334,820
G
NRAS
NRAS proto-oncogene, GTPase
ISO
RGD
PMID:18706093
RGD:2300006
NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
G
NTS
neurotensin
ISO
RGD
PMID:8518953
RGD:9743903
NCBI chr 5:96,261,299...96,272,947
Ensembl chr 5:96,260,560...96,272,976
G
ORM1
orosomucoid 1
ISO
protein:increased expression:liver
RGD
PMID:16166348
RGD:2316639
NCBI chr 1:254,939,154...254,943,065
G
P2RY12
purinergic receptor P2Y12
ISO
RGD
PMID:22028806
RGD:6480518
NCBI chr13:91,522,754...91,572,195
Ensembl chr13:91,521,817...91,572,005
G
PAM
peptidylglycine alpha-amidating monooxygenase
ISO
RGD
PMID:17138865
RGD:6483527
NCBI chr 2:108,255,923...108,536,192
Ensembl chr 2:108,255,930...108,536,880
G
PARP1
poly(ADP-ribose) polymerase 1
severity
ISO
RGD
PMID:16356201
RGD:5684009
NCBI chr10:14,203,157...14,241,164
Ensembl chr10:14,203,160...14,241,196
G
PDYN
prodynorphin
treatment
ISO
RGD
PMID:25102697
RGD:401851905
NCBI chr17:33,505,075...33,521,534
Ensembl chr17:33,505,079...33,521,532
G
PECAM1
platelet and endothelial cell adhesion molecule 1
severity
ISO
protein:increased expression:knee joint, blood vessels (mouse)
RGD
PMID:14613294 PMID:21982514 PMID:22548760
RGD:6484738 RGD:6771177 RGD:6771222
NCBI chr12:14,667,643...14,723,296
Ensembl chr12:14,649,044...14,723,293
G
PGF
placental growth factor
ISO
RGD
PMID:19180491
RGD:6483591
NCBI chr 7:98,149,510...98,162,784
Ensembl chr 7:98,148,994...98,162,741
G
PIK3CD
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
ISO
RGD
PMID:18412166
RGD:6482696
NCBI chr 6:70,026,254...70,086,950
Ensembl chr 6:70,026,373...70,084,742
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
RGD
PMID:18412166 PMID:20374644
RGD:6482684 RGD:6482696
NCBI chr 9:106,698,200...106,748,217
Ensembl chr 9:106,698,207...106,745,099
G
PLAU
plasminogen activator, urokinase
ISO
RGD
PMID:20973954
RGD:6483801
NCBI chr14:76,629,313...76,635,173
Ensembl chr14:76,629,299...76,635,172
G
POMC
proopiomelanocortin
treatment
ISO
RGD
PMID:25102697
RGD:401851905
NCBI chr 3:113,661,712...113,668,558
Ensembl chr 3:113,661,004...113,670,418
G
PRDM1
PR/SET domain 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36181686
NCBI chr 1:72,309,096...72,335,474
Ensembl chr 1:72,311,880...72,335,466
G
PTCH1
patched 1
treatment
ISO
RGD
PMID:25821409
RGD:12879456
NCBI chr10:26,627,165...26,703,225
Ensembl chr10:26,627,425...26,703,223
G
PTGER4
prostaglandin E receptor 4
disease_progression treatment
ISO
mRNA:increased expression:tarsal joint, synovium (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11207665 PMID:18287210 PMID:20423341
RGD:10003041 RGD:10003052 RGD:10043377
NCBI chr16:25,670,832...25,686,556
Ensembl chr16:25,670,862...25,686,552
G
PTGES
prostaglandin E synthase
ISO
mRNA, protein:increased expression:paw
RGD
PMID:12707354
RGD:2300108
NCBI chr 1:269,911,785...269,924,481
Ensembl chr 1:269,911,789...269,924,462
G
PTGES3
prostaglandin E synthase 3
ISO
mRNA:increased expression:paw (rat)
RGD
PMID:12707354
RGD:2300108
NCBI chr 5:22,000,335...22,022,830
Ensembl chr 5:22,000,341...22,021,660
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
mRNA, protein:increased expression:synovium
RGD
PMID:22289897
RGD:5687744
NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:autopod joint mRNA, protein:increased expression:synovium
RGD
PMID:18758904 PMID:21765105 PMID:22289897
RGD:2300221 RGD:5508310 RGD:5687744
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
ISO
protein:increased expression:metatarsophalangeal joint, mononuclear cell (rat)
RGD
PMID:24998229
RGD:11532752
NCBI chr 4:106,692,102...106,758,101
Ensembl chr 4:106,686,604...106,758,099
G
RAG2
recombination activating 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20974942
NCBI chr 2:24,547,605...24,553,944
Ensembl chr 2:24,547,644...24,558,403
G
S100A8
S100 calcium binding protein A8
ISO
RGD
PMID:8343166
RGD:633930
NCBI chr 4:96,209,670...96,210,603
Ensembl chr 4:96,209,659...96,210,602
G
S100A9
S100 calcium binding protein A9
ISO
RGD
PMID:8343166
RGD:633930
NCBI chr 4:96,236,114...96,238,989
G
SERPINC1
serpin family C member 1
ISO
protein:decreased expression:plasma
RGD
PMID:22781611
RGD:11035273
NCBI chr 9:116,181,988...116,193,100
Ensembl chr 9:116,181,670...116,193,201
G
SFRP4
secreted frizzled related protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25194984
NCBI chr 9:108,404,314...108,414,335
Ensembl chr 9:108,404,040...108,414,307
G
SHH
sonic hedgehog signaling molecule
treatment
ISO
RGD
PMID:25821409
RGD:12879456
NCBI chr18:2,546,202...2,555,484
Ensembl chr18:2,545,994...2,555,484
G
SLC11A1
solute carrier family 11 member 1
severity
ISO
RGD
PMID:17122779
RGD:5684943
NCBI chr15:120,434,100...120,446,396
Ensembl chr15:120,433,952...120,446,396
G
SLPI
secretory leukocyte peptidase inhibitor
treatment
ISO
protein:decreased expression:articular cartilage of joint
RGD
PMID:9744360 PMID:10449524
RGD:634208 RGD:9999431
NCBI chr17:47,595,804...47,598,364
Ensembl chr17:47,595,803...47,598,387
G
SMO
smoothened, frizzled class receptor
treatment
ISO
RGD
PMID:25821409
RGD:12879456
NCBI chr18:19,450,730...19,478,796
Ensembl chr18:19,450,743...19,478,898
G
SOCS3
suppressor of cytokine signaling 3
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:16507131
RGD:1625684
NCBI chr12:3,643,832...3,647,015
Ensembl chr12:3,643,929...3,647,009
G
SPN
sialophorin
ISO
associated with Staphylococcal Infections
RGD
PMID:7927732
RGD:2303983
NCBI chr 3:17,978,731...17,982,222
Ensembl chr 3:17,978,801...17,982,864
G
STAT1
signal transducer and activator of transcription 1
ISO
protein:increased tyrosine phosphorylation:macrophage, synovial cell CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:14674010 PMID:15188379
RGD:1582346
NCBI chr15:95,593,201...95,646,324
Ensembl chr15:95,593,211...95,646,260
G
STAT3
signal transducer and activator of transcription 3
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15188379 PMID:21937456 PMID:23711144
RGD:10403081
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
TAC1
tachykinin precursor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9259450
NCBI chr 9:77,197,403...77,206,529
Ensembl chr 9:77,197,536...77,206,523
G
TGFB1
transforming growth factor beta 1
ISO
RGD
PMID:29763498
RGD:15036801
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
G
TGFBR2
transforming growth factor beta receptor 2
ISO
protein:increased expression:synovium
RGD
PMID:9010265
RGD:1601623
NCBI chr13:16,784,370...16,875,828
Ensembl chr13:16,784,490...16,878,160
G
THBD
thrombomodulin
ISO
RGD
PMID:16879225
RGD:5685015
NCBI chr17:30,219,870...30,223,499
Ensembl chr17:30,217,303...30,224,099
G
TIMP4
TIMP metallopeptidase inhibitor 4
ISO
RGD
PMID:12483743
RGD:2290463
NCBI chr13:68,179,803...68,191,199
Ensembl chr13:68,179,806...68,190,942
G
TJP1
tight junction protein 1
ISO
RGD
PMID:18848892
RGD:2325138
NCBI chr 1:144,930,387...145,195,857
Ensembl chr 1:144,930,370...145,195,836
G
TLR2
toll like receptor 2
ISO
RGD
PMID:20131263 PMID:21725847
RGD:7241099 RGD:8552884
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
G
TLR3
toll like receptor 3
ISO
mRNA, protein:increased expression:spleen (rat)
RGD
PMID:20500834
RGD:5128706
NCBI chr15:46,966,262...46,977,774
Ensembl chr15:46,969,006...46,979,291
G
TNF
tumor necrosis factor
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum:
CTD RGD
PMID:7589090 PMID:9598899 PMID:19169271 PMID:19203382 PMID:19330884 PMID:19765281 PMID:20131233 PMID:20974942 PMID:21452922 PMID:21690068 PMID:22450443 PMID:23052485 PMID:23140046 PMID:24028507 PMID:24394943 PMID:29408684 More...
RGD:10450611 RGD:10755447 RGD:13792834 RGD:7193038 RGD:7245941 RGD:8661761 RGD:8662976
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
TNFRSF11B
TNF receptor superfamily member 11b
treatment
ISO
CTD Direct Evidence: therapeutic Sinomenine CHEBI:9163 mRNA:decreased expression:bone
CTD RGD
PMID:16696922 PMID:23333834 PMID:24066131
RGD:1624171 RGD:42721982
NCBI chr 4:19,850,212...19,879,132
Ensembl chr 4:19,850,350...19,879,125
G
TNFRSF1A
TNF receptor superfamily member 1A
treatment
ISO
RGD
PMID:20370892 PMID:21690068 PMID:23052485
RGD:7245941 RGD:8661729 RGD:8661761
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
G
TNFRSF1B
TNF receptor superfamily member 1B
treatment
ISO
human protein in rat model
RGD
PMID:21463515 PMID:21690068 PMID:23052485
RGD:5131255 RGD:7245941 RGD:8661761
NCBI chr 6:72,195,420...72,231,146
Ensembl chr 6:72,195,435...72,231,147
G
TRPV2
transient receptor potential cation channel subfamily V member 2
treatment
ISO
RGD
PMID:25869297
RGD:9999444
NCBI chr12:59,132,529...59,152,633
Ensembl chr12:59,135,329...59,152,228
G
TXNDC5
thioredoxin domain containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326410
NCBI chr 7:5,210,192...5,236,857
Ensembl chr 7:5,210,064...5,236,812
G
VEGFA
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9598899 PMID:26221077
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
VIM
vimentin
ISO
RGD
PMID:7516431
RGD:6480480
NCBI chr10:43,516,441...43,526,172
Ensembl chr10:43,517,307...43,526,170
G
VIP
vasoactive intestinal peptide
ISO
RGD
PMID:19055696 PMID:21998117
RGD:5685376 RGD:5685612
NCBI chr 1:13,611,786...13,620,250
Ensembl chr 1:13,611,311...13,620,269
G
XDH
xanthine dehydrogenase
ISO
protein:increased expression:brain, mitochondrion
RGD
PMID:25870945
RGD:13208957
NCBI chr 3:107,987,060...108,052,043
Ensembl chr 3:107,987,126...108,053,169
G
XYLT1
xylosyltransferase 1
ISO
mRNA:decreased expression:articular cartilage
RGD
PMID:19001053
RGD:2313142
NCBI chr 3:27,158,438...27,492,629
Ensembl chr 3:27,158,878...27,492,762
G
A2M
alpha-2-macroglobulin
treatment
ISO
RGD
PMID:1710603
RGD:10046021
NCBI chr 5:62,406,928...62,483,690
Ensembl chr 5:62,440,810...62,483,678
G
ADAM17
ADAM metallopeptidase domain 17
ISO
RGD
PMID:15878627
RGD:1559178
NCBI chr 3:126,795,513...126,853,995
Ensembl chr 3:126,795,426...126,853,995
G
ADAM8
ADAM metallopeptidase domain 8
ISO
RGD
PMID:9670863
RGD:2325244
NCBI chr14:141,221,177...141,233,728
Ensembl chr14:141,221,198...141,232,306
G
AIF1
allograft inflammatory factor 1
ISO
protein:altered expression:spinal cord (rat)
RGD
PMID:19246105
RGD:2313022
NCBI chr 7:23,711,752...23,731,191
Ensembl chr 7:23,726,787...23,731,671
G
AKAP12
A-kinase anchoring protein 12
ISO
mRNA,protein:increased expression:spinal cord
RGD
PMID:20155814
RGD:14348972
NCBI chr 1:14,904,109...15,017,016
Ensembl chr 1:14,908,115...15,016,997
G
AMIGO2
adhesion molecule with Ig like domain 2
severity
ISO
RGD
PMID:28119027
RGD:14392778
NCBI chr 5:77,642,144...77,645,748
Ensembl chr 5:77,642,195...77,645,753
G
ANXA1
annexin A1
ISO
protein:increased expression:brain, astrocyte, macrophage
RGD
PMID:9472682
RGD:2306942
NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279
G
APOE
apolipoprotein E
ISO
RGD
PMID:28578430
RGD:13703134
NCBI chr 6:51,373,113...51,375,333
Ensembl chr 6:51,372,292...51,375,330
G
AQP4
aquaporin 4
disease_progression severity
ISO
RGD
PMID:19660138 PMID:21056916 PMID:21157915 PMID:23707078
RGD:5148015 RGD:5490116 RGD:5490117 RGD:8696030
NCBI chr 6:111,407,632...111,422,169
Ensembl chr 6:111,407,639...111,422,109
G
B2M
beta-2-microglobulin
ISO
RGD
PMID:15837577
RGD:6482690
NCBI chr 1:126,837,721...126,844,043
Ensembl chr 1:126,835,143...126,981,582
G
B4GALT6
beta-1,4-galactosyltransferase 6
ISO
mRNA:increased expression:astrocyte
RGD
PMID:25216636
RGD:14390079
NCBI chr 6:115,525,515...115,593,265
Ensembl chr 6:115,524,636...115,593,270
G
BDNF
brain derived neurotrophic factor
ISO
RGD
PMID:23212569
RGD:10059360
NCBI chr 2:32,623,668...32,679,293
Ensembl chr 2:32,624,048...32,679,765
G
C3
complement C3
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:22320401
RGD:7175513
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
G
C6
complement C6
severity
ISO
RGD
PMID:11970970
RGD:625607
NCBI chr16:26,023,646...26,089,518
Ensembl chr16:26,020,628...26,084,652
G
CACNA1B
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:11353727
RGD:1580151
G
CALCB
calcitonin-related polypeptide beta
no_association
ISO
RGD
PMID:19563774
RGD:5684360
NCBI chr 2:44,043,135...44,048,651
G
CASP3
caspase 3
ISO
protein:increased activity, increased expression:spinal cord
RGD
PMID:18521931
RGD:2311436
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CASP8
caspase 8
ISO
protein:increased activity, increased expression:spinal cord
RGD
PMID:18521931
RGD:2311436
NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
G
CASP9
caspase 9
ISO
protein:increased expression:spinal cord
RGD
PMID:18521931
RGD:2311436
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
G
CAV3
caveolin 3
onset
ISO
Protein:increased expression:spinal cord, astrocyte
RGD
PMID:15925413
RGD:1582168
NCBI chr13:65,117,868...65,130,886
Ensembl chr13:65,117,795...65,131,273
G
CBLB
Cbl proto-oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chr13:153,480,525...153,700,115
Ensembl chr13:153,395,978...153,700,056
G
CCL1
C-C motif chemokine ligand 1
ISO
mRNA:decreased expression:lymph node
RGD
PMID:19865101
RGD:4145472
NCBI chr12:40,728,014...40,731,411
Ensembl chr12:40,728,014...40,731,411
G
CCL11
chemokine (C-C motif) ligand 11
ISO
mRNA:increased expression:lymph node
RGD
PMID:19865101
RGD:4145472
NCBI chr12:40,779,906...40,782,862
Ensembl chr12:40,779,173...40,782,893
G
CCL2
chemokine (C-C motif) ligand 2
ISO
mRNA:decreased expression:lymph node mRNA:increased expression:spinal cord mRNA:increased expression:optic chiasma (rat)
RGD
PMID:11241588 PMID:17666800 PMID:19865101
RGD:2307114 RGD:4145472 RGD:8548888
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
CCL3L1
chemokine (C-C motif) ligand 3-like 1
ISO
mRNA:increased expression:spinal cord
RGD
PMID:17666800
RGD:2307114
NCBI chr12:39,491,999...39,493,345
Ensembl chr12:39,491,914...39,493,774
G
CCL5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:spinal cord protein:increased expression:brain (mouse)
RGD
PMID:15833367 PMID:17666800
RGD:2307114 RGD:4890027
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
G
CCR1
C-C motif chemokine receptor 1
ISO
RGD
PMID:14512166 PMID:14655765
RGD:5688165 RGD:5688167
NCBI chr13:29,227,218...29,233,862
Ensembl chr13:29,227,222...29,233,960
G
CCR2
C-C motif chemokine receptor 2
ISO
mRNA:increased expression:spinal cord
RGD
PMID:9655467
RGD:632391
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,285,012...29,376,343
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:15034073
RGD:6893394
NCBI chr13:29,251,950...29,286,470
Ensembl chr13:29,285,012...29,376,343
G
CCR5
C-C motif chemokine receptor 5
ISO
mRNA:increased expression:spinal cord, macrophage, microglia (rat)
RGD
PMID:17484785
RGD:4890436
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
G
CD28
CD28 molecule
ISO
RGD
PMID:16061730
RGD:2307203
NCBI chr15:107,128,103...107,155,431
Ensembl chr15:107,128,203...107,162,935
G
CD4
CD4 molecule
treatment
ISO
protein:decreased expression:T lymphocyte:
RGD
PMID:3097071 PMID:9138014
RGD:10058963 RGD:10058968
NCBI chr 5:63,892,129...63,918,547
Ensembl chr 5:63,892,137...63,918,519
G
CD80
CD80 molecule
ISO
RGD
PMID:9379015
RGD:6902906
NCBI chr13:140,693,312...140,730,541
Ensembl chr13:140,693,382...140,728,976
G
CD86
CD86 molecule
resistance disease_progression
ISO
protein:increased expression:spinal cord, blood vessel (rat)
RGD
PMID:10477557 PMID:20451260
RGD:4892207 RGD:4892227
NCBI chr13:138,427,573...138,504,307
Ensembl chr13:138,427,533...138,504,310
G
CIITA
class II major histocompatibility complex transactivator
ISO
RGD
PMID:15821736
RGD:1358146
NCBI chr 3:32,171,706...32,230,775
Ensembl chr 3:32,172,214...32,230,780
G
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:7541143 PMID:10650887 PMID:21107918
RGD:6483335 RGD:6483351 RGD:6483353
NCBI chr12:20,758,081...20,765,655
Ensembl chr12:20,758,083...20,765,553
G
COMT
catechol-O-methyltransferase
treatment
ISO
RGD
PMID:25242632
RGD:13450949
NCBI chr14:51,384,729...51,403,997
Ensembl chr14:51,385,738...51,403,998
G
CPB2
carboxypeptidase B2
ISO
RGD
PMID:22768796
RGD:7243111
NCBI chr11:21,234,447...21,298,250
Ensembl chr11:21,234,447...21,298,241
G
CSPG4
chondroitin sulfate proteoglycan 4
ISO
protein:increased expression:spinal cord
RGD
PMID:20162860 PMID:21679768
RGD:5686852 RGD:5686863
NCBI chr 7:57,949,182...57,988,602
Ensembl chr 7:57,949,455...57,988,335
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
ISO
RGD
PMID:9379015
RGD:6902906
NCBI chr15:107,283,081...107,288,041
Ensembl chr15:107,282,927...107,289,103
G
CTSC
cathepsin C
ISO
RGD
PMID:843913
RGD:1599653
NCBI chr 9:21,726,628...21,761,796
Ensembl chr 9:21,722,036...21,761,516
G
CTSS
cathepsin S
ISO
RGD
PMID:21439785
RGD:5686915
NCBI chr 4:98,415,273...98,442,952
Ensembl chr 4:98,417,883...98,442,950
G
CX3CL1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:16053521
RGD:4891973
NCBI chr 6:19,312,351...19,324,439
G
CX3CR1
C-X3-C motif chemokine receptor 1
ISO
RGD
PMID:16053521 PMID:24706865
RGD:4891973 RGD:9491767
NCBI chr13:23,944,386...23,957,567
Ensembl chr13:23,944,369...23,957,486
G
CXCR2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:19616545
RGD:7257694
NCBI chr15:120,219,657...120,230,203
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:21038468
RGD:5135506
NCBI chr X:57,592,032...57,595,706
Ensembl chr X:57,592,038...57,595,692
G
DAB2
DAB adaptor protein 2
disease_progression
ISO
RGD
PMID:21890121
RGD:7243155
NCBI chr16:24,590,638...24,776,937
Ensembl chr16:24,590,645...24,646,122
G
DLK1
delta like non-canonical Notch ligand 1
ISO
RGD
PMID:24676147
RGD:150520045
NCBI chr 7:121,565,844...121,577,493
Ensembl chr 7:121,565,854...121,576,654
G
DLL1
delta like canonical Notch ligand 1
ISO
RGD
PMID:17947672
RGD:6482235
NCBI chr 1:198,815...211,346
Ensembl chr 1:199,358...211,346
G
DLL4
delta like canonical Notch ligand 4
ameliorates
ISO
RGD
PMID:21813770
RGD:155663662
NCBI chr 1:130,376,720...130,386,411
Ensembl chr 1:130,376,721...130,386,411
G
DUSP10
dual specificity phosphatase 10
ISO
RGD
PMID:15306813
RGD:7775013
NCBI chr10:10,866,446...10,905,852
Ensembl chr10:10,866,448...10,905,857
G
ENTPD1
ectonucleoside triphosphate diphosphohydrolase 1
disease_progression
ISO
RGD
PMID:19524108
RGD:9685491
NCBI chr14:107,263,546...107,390,923
Ensembl chr14:107,263,449...107,389,010
G
EPO
erythropoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18382691
NCBI chr 3:8,620,508...8,622,936
Ensembl chr 3:8,620,508...8,622,936
G
ERN1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr12:14,881,913...14,963,290
Ensembl chr12:14,881,923...14,963,284
G
ESR2
estrogen receptor 2
ISO
RGD
PMID:21182085 PMID:21565615
RGD:5508732 RGD:5508735
NCBI chr 1:193,823,666...193,907,330
Ensembl chr 1:193,829,560...193,906,565
G
FASLG
Fas ligand
treatment
ISO
RGD
PMID:10944459
RGD:12903984
NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
G
FGF2
fibroblast growth factor 2
ISO
mRNA:increased expression:spinal cord
RGD
PMID:8929896 PMID:9814819
RGD:8655647 RGD:9831448
NCBI chr 8:101,278,877...101,344,084
Ensembl chr 8:101,278,885...101,343,916
G
FLT1
fms related receptor tyrosine kinase 1
treatment
ISO
RGD
PMID:18721816
RGD:10402153
NCBI chr11:5,620,698...5,797,095
Ensembl chr11:5,621,212...5,795,264
G
FOXO3
forkhead box O3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27742544
NCBI chr 1:74,626,673...74,760,323
Ensembl chr 1:74,628,218...74,760,325
G
GHRH
growth hormone releasing hormone
resistance
ISO
RGD
PMID:21846799
RGD:5687168
NCBI chr17:40,386,725...40,398,312
Ensembl chr17:40,387,344...40,397,857
G
GHRL
ghrelin and obestatin prepropeptide
treatment
ISO
RGD
PMID:19620309
RGD:12905041
NCBI chr13:66,442,106...66,453,576
Ensembl chr13:66,445,992...66,452,917
G
GJC2
gap junction protein gamma 2
ISO
protein:decreased expression:white matter of spinal cord, gap junction (mouse)
RGD
PMID:22461072
RGD:13208593
NCBI chr 2:51,257,623...51,267,969
Ensembl chr 2:51,258,207...51,267,962
G
GLI1
GLI family zinc finger 1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr 5:22,736,325...22,747,421
Ensembl chr 5:22,739,900...22,747,421
G
GLUD1
glutamate dehydrogenase 1
ISO
mRNA, protein:decreased expression:spinal cord
RGD
PMID:9145307
RGD:6484657
NCBI chr14:87,968,850...88,005,375
Ensembl chr14:87,968,850...88,005,520
G
GPX3
glutathione peroxidase 3
ISO
RGD
PMID:22320401
RGD:7175513
NCBI chr16:71,980,467...71,989,011
Ensembl chr16:71,980,475...71,989,026
G
HAVCR2
hepatitis A virus cellular receptor 2
ISO
mRNA:increased expression:spinal cord:
RGD
PMID:11823861 PMID:15913792
RGD:9686086 RGD:9686113
NCBI chr16:66,138,157...66,160,568
Ensembl chr16:66,139,535...66,160,538
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:14691063 PMID:17085013
RGD:5508469 RGD:5508476
NCBI chr 2:84,380,245...84,401,117
Ensembl chr 2:84,380,224...84,402,957
G
IFNB1
interferon beta 1
exacerbates treatment ameliorates
ISO
RGD
PMID:8955226 PMID:9578846 PMID:18997868 PMID:19380780
RGD:401854237 RGD:401854246 RGD:401854247 RGD:5147399
NCBI chr 1:201,850,935...201,851,495
Ensembl chr 1:201,850,935...201,851,495
G
IFNG
interferon gamma
treatment disease_progression
ISO
RGD
PMID:15661899 PMID:22896638
RGD:10755692 RGD:7987912
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IGF1
insulin like growth factor 1
treatment
ISO
human protein in a rat model
RGD
PMID:7541143
RGD:6483353
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:23872438
RGD:7364993
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL10RA
interleukin 10 receptor subunit alpha
ISO
RGD
PMID:12620647
RGD:2316323
NCBI chr 9:45,310,527...45,324,557
Ensembl chr 9:45,310,534...45,325,168
G
IL12A
interleukin 12A
ISO
RGD
PMID:12471147
RGD:724447
NCBI chr13:99,733,394...99,741,078
Ensembl chr13:99,733,394...99,741,078
G
IL12B
interleukin 12B
ISO
mRNA, protein:increased expression:lymph node
RGD
PMID:19233473
RGD:4831840
NCBI chr16:64,143,268...64,158,929
Ensembl chr16:64,143,268...64,158,929
G
IL13
interleukin 13
severity
ISO
RGD
PMID:7523520 PMID:18250480
RGD:5684366 RGD:5684367
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
G
IL16
interleukin 16
ISO
RGD
PMID:17641011
RGD:5024940
NCBI chr 7:49,973,937...50,102,346
Ensembl chr 7:49,973,938...50,102,346
G
IL17A
interleukin 17A
treatment
ISO
mRNA, protein:increased expression:lymph node
RGD
PMID:16200068 PMID:16785554 PMID:19233473 PMID:20003332
RGD:4831840 RGD:4888522 RGD:4889113 RGD:9212317
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
G
IL18
interleukin 18
ISO
mRNA:increased expression:spinal cord
RGD
PMID:9834127 PMID:9846824
RGD:4889542 RGD:4889543
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
G
IL18R1
interleukin 18 receptor 1
ISO
mRNA:increased expression:lymph node
RGD
PMID:19269041
RGD:2311529
NCBI chr 3:51,803,383...51,844,758
Ensembl chr 3:51,803,175...51,844,684
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:7593560
RGD:8551836
G
IL21
interleukin 21
ISO
RGD
PMID:18997868
RGD:5147399
NCBI chr 8:101,532,742...101,540,712
Ensembl chr 8:101,532,531...101,541,713
G
IL21R
interleukin 21 receptor
no_association disease_progression
ISO
RGD
PMID:18353312 PMID:18546146
RGD:6892939 RGD:6892940
NCBI chr 3:19,447,488...19,489,201
Ensembl chr 3:19,443,359...19,489,152
G
IL22
interleukin 22
ISO
RGD
PMID:19269041
RGD:2311529
NCBI chr 5:32,599,522...32,604,507
Ensembl chr 5:32,599,471...32,604,513
G
IL27
interleukin 27
ISO
protein:decreased expression:blood serum (mouse)
RGD
PMID:33403844
RGD:126790527
NCBI chr 3:18,421,962...18,427,916
Ensembl chr 3:18,421,981...18,427,915
G
IL2RA
interleukin 2 receptor subunit alpha
ISO
RGD
PMID:19269041
RGD:2311529
NCBI chr10:64,948,149...65,001,320
Ensembl chr10:64,948,563...65,001,142
G
IL4
interleukin 4
treatment
ISO
RGD
PMID:1383385 PMID:18239607
RGD:7829778 RGD:8142395
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
G
IL6
interleukin 6
ISO
protein:increased expression:oligodendrocytes (rat)
RGD
PMID:9358769 PMID:23322593
RGD:12791289 RGD:2307412
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
ITGA4
integrin subunit alpha 4
treatment susceptibility
ISO
rat bone marrow cells in a mouse model
RGD
PMID:12626659 PMID:18722022
RGD:9698418 RGD:9698436
NCBI chr15:86,942,054...87,028,428
Ensembl chr15:86,947,240...87,030,364
G
JAG1
jagged canonical Notch ligand 1
ISO
RGD
PMID:17947672
RGD:6482235
NCBI chr17:19,591,248...19,629,659
Ensembl chr17:19,591,259...19,629,641
G
JAK2
Janus kinase 2
ISO
RGD
PMID:22066025
RGD:6483041
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
JAK3
Janus kinase 3
treatment
ISO
RGD
PMID:25012120
RGD:11533939
NCBI chr 2:59,905,901...59,926,504
Ensembl chr 2:59,905,919...59,926,495
G
KDR
kinase insert domain receptor
ISO
RGD
PMID:19233483
RGD:5684404
NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
ISO
RGD
PMID:25972476
RGD:12910744
NCBI chr 8:41,402,334...41,492,306
Ensembl chr 8:41,402,043...41,493,734
G
LRP1
LDL receptor related protein 1
ISO
protein:increased expression:cerebellum, spinal cord
RGD
PMID:19299462
RGD:13800552
NCBI chr 5:22,435,636...22,519,276
G
LTA
lymphotoxin alpha
ISO
mRNA:increased expression:spinal cord mRNA:increased expression:brain
RGD
PMID:7593556 PMID:9184655
RGD:1625038 RGD:4143220
NCBI chr 7:23,696,387...23,698,280
Ensembl chr 7:23,696,040...23,698,299
G
MAPT
microtubule associated protein tau
treatment
ISO
RGD
PMID:15494405
RGD:1358431
NCBI chr12:17,098,259...17,211,483
Ensembl chr12:17,095,587...17,211,373
G
MBP
myelin basic protein
ISO
CTD Direct Evidence: marker/mechanism human sequence peptide in a rat model; associated with Herpesviridae infections
CTD RGD
PMID:11501064 PMID:12811845 PMID:15159442 PMID:16285900 PMID:17884951 PMID:24070732 More...
RGD:30296670 RGD:7349334
NCBI chr 1:147,649,516...147,685,289
Ensembl chr 1:147,590,865...147,685,290
G
MDK
midkine
ISO
RGD
PMID:9814819
RGD:9831448
NCBI chr 2:16,130,787...16,133,791
Ensembl chr 2:16,130,788...16,133,510
G
MIR23B
microRNA mir-23b
treatment
ISO
mRNA:decreased expression:spinal cord (mouse)
RGD
PMID:22660635
RGD:155663483
NCBI chr10:27,080,197...27,080,276
Ensembl chr10:27,080,197...27,080,276
G
MMP2
matrix metallopeptidase 2
ISO
RGD
PMID:19922364
RGD:2325703
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
G
MMP7
matrix metallopeptidase 7
ISO
RGD
PMID:9549496
RGD:8547909
NCBI chr 9:33,214,590...33,225,080
Ensembl chr 9:33,214,594...33,225,080
G
MMP9
matrix metallopeptidase 9
treatment
ISO
protein:increased expression:multiple tissues
RGD
PMID:9549496 PMID:20810258 PMID:22800566 PMID:24797785
RGD:13204762 RGD:13204801 RGD:8547909 RGD:8547936
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
MOBP
myelin associated oligodendrocyte basic protein
ISO
RGD
PMID:10623862
RGD:27226694
NCBI chr13:24,138,078...24,186,838
G
MOG
myelin oligodendrocyte glycoprotein
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10384097 PMID:12799014 PMID:12904460 PMID:14624757 PMID:16931536 PMID:17654737 PMID:17728465 PMID:18566399 PMID:18667803 PMID:21068375 PMID:21317386 PMID:21341682 PMID:23360710 PMID:23547115 PMID:23639249 PMID:30661753 More...
RGD:9685372 RGD:9685373 RGD:9685375
NCBI chr 7:22,595,565...22,606,137
Ensembl chr 7:22,595,510...22,610,817
G
MT-2B
metallothionein-2A
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:19619133
RGD:6484112
NCBI chr 6:18,645,125...18,646,034
Ensembl chr 6:18,645,153...18,646,033
G
MT3
metallothionein 3
ISO
mRNA:increased expression:brain (mouse)
RGD
PMID:19619133
RGD:6484112
NCBI chr 6:18,634,735...18,636,134
Ensembl chr 6:18,634,261...18,636,131
G
NCAM1
neural cell adhesion molecule 1
ISO
protein:decreased expression:hippocampus
RGD
PMID:17064783
RGD:40924670
NCBI chr 9:40,628,602...40,960,605
Ensembl chr 9:40,628,631...40,960,591
G
NEFL
neurofilament light chain
ISO
protein:increased expression:cerebrospinal fluid, spinal cord
RGD
PMID:16182933
RGD:2299007
NCBI chr14:8,991,321...8,996,900
Ensembl chr14:8,991,331...8,997,112
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19910389
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
G
NGF
nerve growth factor
ISO
protein, mRNA:increased expression:thalamus and cortex, CNS
RGD
PMID:8866783
RGD:5508386
NCBI chr 4:105,256,691...105,307,843
Ensembl chr 4:105,256,749...105,307,837
G
NGFR
nerve growth factor receptor
severity
ISO
mRNA:increased expression:central nervous system
RGD
PMID:8866783 PMID:16519950
RGD:5508312 RGD:5508386
NCBI chr12:25,699,410...25,720,355
Ensembl chr12:25,699,427...25,720,356
G
NOS2
nitric oxide synthase 2
ISO
RGD
PMID:21857957
RGD:5509069
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
G
NR1H2
nuclear receptor subfamily 1 group H member 2
ISO
RGD
PMID:21266776
RGD:6480877
NCBI chr 6:55,238,536...55,245,457
Ensembl chr 6:55,239,500...55,245,456
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
RGD
PMID:17322387
RGD:4892331
NCBI chr 2:144,822,937...144,956,451
Ensembl chr 2:144,822,939...144,956,451
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
mRNA:increased expression:brain subventricular zone:
RGD
PMID:15589512
RGD:5684777
NCBI chr 4:93,219,509...93,237,944
Ensembl chr 4:93,219,516...93,255,981
G
OLIG1
oligodendrocyte transcription factor 1
treatment
ISO
RGD
PMID:24941845
RGD:40902822
NCBI chr13:196,644,065...196,646,406
Ensembl chr13:196,644,059...196,646,403
G
OLIG2
oligodendrocyte transcription factor 2
treatment
ISO
RGD
PMID:24941845 PMID:29682587
RGD:40902822 RGD:40902863
NCBI chr13:196,596,838...196,602,197
Ensembl chr13:196,599,822...196,600,793
G
PDCD1
programmed cell death 1
susceptibility
ISO
RGD
PMID:24648472
RGD:40818258
NCBI chr15:140,337,353...140,347,493
Ensembl chr15:140,336,258...140,347,478
G
PDGFB
platelet derived growth factor subunit B
treatment
ISO
RGD
PMID:16042218
RGD:11080975
Ensembl chr 5:8,986,462...9,007,435
G
PDGFRA
platelet derived growth factor receptor alpha
treatment
ISO
RGD
PMID:16042218
RGD:11080975
NCBI chr 8:40,966,568...41,021,440
Ensembl chr 8:40,967,493...41,021,441
G
PDGFRB
platelet derived growth factor receptor beta
treatment
ISO
RGD
PMID:16042218
RGD:11080975
NCBI chr 2:151,155,753...151,192,818
Ensembl chr 2:151,155,756...151,192,647
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
RGD
PMID:20303183
RGD:6482686
NCBI chr 9:106,698,200...106,748,217
Ensembl chr 9:106,698,207...106,745,099
G
PLP1
proteolipid protein 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21068375 PMID:24941845
RGD:40902822
NCBI chr X:84,676,627...84,683,517
Ensembl chr X:84,666,733...84,685,058
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17261635
NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,741...3,364,239
G
PRF1
perforin 1
ISO
RGD
PMID:20708278
RGD:6482806
NCBI chr14:73,515,306...73,520,256
Ensembl chr14:73,512,769...73,520,202
G
PRKAA1
protein kinase AMP-activated catalytic subunit alpha 1
severity
ISO
RGD
PMID:19486896
RGD:6484540
NCBI chr16:25,745,902...25,783,524
Ensembl chr16:25,745,324...25,783,707
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:microglia, macrophage, protein:increased expression:cerebral cortex, cerebellum, spinal cord
RGD
PMID:10229132 PMID:21667309
RGD:5688149 RGD:5688250
NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:endothelial cell protein:increased expression:cerebral cortex, cerebellum, spinal cord
RGD
PMID:10229132 PMID:21667309
RGD:5688149 RGD:5688250
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
PTN
pleiotrophin
ISO
mRNA:increased expression:spinal cord (rat)
RGD
PMID:9814819
RGD:9831448
NCBI chr18:12,219,708...12,309,045
Ensembl chr18:12,219,787...12,309,044
G
QKI
QKI, KH domain containing RNA binding
ISO
RGD
PMID:22740327
RGD:10045997
NCBI chr 1:4,732,575...4,883,386
Ensembl chr 1:4,735,514...4,883,392
G
RANGRF
RAN guanine nucleotide release factor
ISO
RGD
PMID:8557821
RGD:6771380
NCBI chr12:53,484,584...53,486,716
Ensembl chr12:53,485,265...53,486,713
G
RHOA
ras homolog family member A
severity
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chr13:31,918,484...31,991,207
Ensembl chr13:31,918,834...31,986,607
G
SERPINE1
serpin family E member 1
ISO
mRNA,protein:increased expression,increased activity:spinal cord, astrocyte:
RGD
PMID:11733372
RGD:13208549
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
G
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:15892298 PMID:18991353
RGD:12801423 RGD:12801440
NCBI chr18:2,546,202...2,555,484
Ensembl chr18:2,545,994...2,555,484
G
SIGMAR1
sigma non-opioid intracellular receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr10:32,160,767...32,163,540
Ensembl chr10:32,160,822...32,164,718
G
SIRT1
sirtuin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23547115
NCBI chr14:71,091,167...71,126,351
Ensembl chr14:71,091,167...71,123,297
G
SLA-DRA
MHC class II DR-alpha
ISO
RGD
PMID:8676084
RGD:5490166
NCBI chr 7:24,825,037...24,830,650
Ensembl chr 7:24,825,054...24,835,158
G
SLPI
secretory leukocyte peptidase inhibitor
treatment
ISO
RGD
PMID:22436018
RGD:9999395
NCBI chr17:47,595,804...47,598,364
Ensembl chr17:47,595,803...47,598,387
G
SNCB
synuclein beta
ISO
RGD
PMID:12496452
RGD:730073
NCBI chr 2:81,287,764...81,302,859
Ensembl chr 2:81,287,759...81,302,861
G
SRSF9
serine and arginine rich splicing factor 9
treatment
ISO
RGD
PMID:20616573
RGD:11040805
NCBI chr14:40,425,412...40,433,950
Ensembl chr14:40,419,093...40,434,047
G
STAT1
signal transducer and activator of transcription 1
ISO
RGD
PMID:22066025
RGD:6483041
NCBI chr15:95,593,201...95,646,324
Ensembl chr15:95,593,211...95,646,260
G
STAT3
signal transducer and activator of transcription 3
ISO
RGD
PMID:17878325 PMID:22066025
RGD:6483041 RGD:6892946
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
STAT4
signal transducer and activator of transcription 4
ISO
RGD
PMID:11240014
RGD:7207888
NCBI chr15:95,656,206...95,764,099
Ensembl chr15:95,656,077...95,763,472
G
TGFB1
transforming growth factor beta 1
ISO
mRNA, protein:increased expression:central nervous system
RGD
PMID:17204936
RGD:2302088
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
G
TGFB2
transforming growth factor beta 2
ISO
mRNA, protein:decreased expression:central nervous system
RGD
PMID:17204936
RGD:2302088
NCBI chr10:8,306,136...8,435,307
Ensembl chr10:8,305,539...8,390,341
G
TIMP3
TIMP metallopeptidase inhibitor 3
ISO
protein:increased expression:spinal cord
RGD
PMID:15878627
RGD:1559178
NCBI chr 5:12,185,816...12,242,599
Ensembl chr 5:12,185,818...12,242,581
G
TLR2
toll like receptor 2
ISO
protein:increased expression:spinal cord
RGD
PMID:18644848
RGD:2312575
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
G
TLR4
toll like receptor 4
ISO
protein:increased expression:spinal cord
RGD
PMID:18644848
RGD:2312575
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
TNF
tumor necrosis factor
treatment
ISO
RGD
PMID:11421579
RGD:12904661
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
VCAM1
vascular cell adhesion molecule 1
ISO
RGD
PMID:12196270
RGD:1580348
NCBI chr 4:117,496,914...117,511,211
Ensembl chr 4:117,496,920...117,511,222
G
VDR
vitamin D receptor
treatment
ISO
RGD
PMID:21287548 PMID:21318047
RGD:13210791 RGD:8158064
NCBI chr 5:78,205,807...78,266,505
Ensembl chr 5:78,205,810...78,266,475
G
VEGFA
vascular endothelial growth factor A
ISO
mRNA:decreased expression:Cerebrospinal Fluid: mRNA,protein:decreased expression:spinal cord:
RGD
PMID:12387457 PMID:17083617
RGD:634258 RGD:7421596
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
VIP
vasoactive intestinal peptide
ISO
RGD
PMID:20978211
RGD:5685386
NCBI chr 1:13,611,786...13,620,250
Ensembl chr 1:13,611,311...13,620,269
G
XBP1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr14:46,011,239...46,016,526
Ensembl chr14:46,008,377...46,016,526
G
ARPC5
actin related protein 2/3 complex subunit 5
treatment
ISO
RGD
PMID:17997938
RGD:11049469
NCBI chr 9:124,839,062...124,847,906
Ensembl chr 9:124,837,765...124,848,105
G
C3
complement C3
ISO
RGD
PMID:147324 PMID:17962462
RGD:11040804 RGD:7401263
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
G
C6
complement C6
susceptibility
ISO
RGD
PMID:17034580
RGD:1600670
NCBI chr16:26,023,646...26,089,518
Ensembl chr16:26,020,628...26,084,652
G
CD40LG
CD40 ligand
treatment
ISO
RGD
PMID:11359850
RGD:8547800
NCBI chr X:111,778,666...111,788,901
Ensembl chr X:111,778,493...111,789,709
G
CFB
complement factor B
treatment
ISO
RGD
PMID:25355917
RGD:11041161
NCBI chr 7:24,034,077...24,040,523
Ensembl chr 7:24,033,740...24,041,179
G
CTSL
cathepsin L
ISO
mRNA:increased expression:quadriceps (rat)
RGD
PMID:16365386
RGD:2315588
NCBI chr10:27,668,523...27,674,705
Ensembl chr10:27,668,264...27,674,618
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
RGD
PMID:15843529 PMID:19232748
RGD:1598501 RGD:2311364
NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
RGD
PMID:15843529
RGD:1598501
NCBI chr 8:71,665,541...71,670,236
Ensembl chr 8:71,663,501...71,670,271
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:15843529 PMID:19232748
RGD:1598501 RGD:2311364
NCBI chr X:57,592,032...57,595,706
Ensembl chr X:57,592,038...57,595,692
G
IL15
interleukin 15
ISO
protein:increased expression:skeletal muscle
RGD
PMID:11585642
RGD:1626617
NCBI chr 8:85,666,963...85,740,980
Ensembl chr 8:85,667,321...85,678,461
G
IL23R
interleukin 23 receptor
ISO
mRNA:increased expression:lymph node
RGD
PMID:21193288
RGD:5108250
NCBI chr 6:145,337,765...145,401,909
Ensembl chr 6:145,335,741...145,401,510
G
IL2RA
interleukin 2 receptor subunit alpha
ISO
RGD
PMID:18250419
RGD:2325986
NCBI chr10:64,948,149...65,001,320
Ensembl chr10:64,948,563...65,001,142
G
IL4R
interleukin 4 receptor
ISO
protein:increased expression:skeletal muscle
RGD
PMID:19395316
RGD:4889981
NCBI chr 3:19,526,343...19,576,792
Ensembl chr 3:19,523,564...19,576,544
G
MUSK
muscle associated receptor tyrosine kinase
ISO
RGD
PMID:17081697
RGD:2317084
NCBI chr 1:251,650,151...251,758,538
Ensembl chr 1:251,650,710...251,756,608
G
MYOG
myogenin
ISO
RGD
PMID:1312030
RGD:9686077
NCBI chr 9:113,783,233...113,785,312
Ensembl chr 9:113,782,284...113,787,340
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
RGD
PMID:23674516
RGD:8695925
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
G
AGER
advanced glycosylation end-product specific receptor
ISO
protein:increased expression:heart
RGD
PMID:24599045
RGD:8696002
NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,120...24,221,162
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:23833961 PMID:28903333
RGD:13702869 RGD:13702874
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:23833961
RGD:13702874
NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
G
CASP9
caspase 9
treatment
ISO
RGD
PMID:23833961
RGD:13702874
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
G
CAV1
caveolin 1
ISO
RGD
PMID:17060028
RGD:1625364
NCBI chr18:29,648,120...29,682,451
Ensembl chr18:29,649,992...29,682,465
G
CAV2
caveolin 2
ISO
RGD
PMID:17060028
RGD:1625364
NCBI chr18:29,699,012...29,707,277
Ensembl chr18:29,699,020...29,707,277
G
CCL2
chemokine (C-C motif) ligand 2
disease_progression
ISO
mRNA, protein:increased expression:heart, serum (rat)
RGD
PMID:11472393
RGD:8549580
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
CD28
CD28 molecule
treatment severity
ISO
RGD
PMID:8759765 PMID:19907173
RGD:13702882 RGD:13702883
NCBI chr15:107,128,103...107,155,431
Ensembl chr15:107,128,203...107,162,935
G
CD40
CD40 molecule
treatment
ISO
RGD
PMID:25297507
RGD:13702884
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
G
FGL2
fibrinogen like 2
severity
ISO
RGD
PMID:28892130
RGD:38549573
NCBI chr 9:102,869,044...102,875,564
Ensembl chr 9:102,868,802...102,875,576
G
FOXP3
forkhead box P3
severity treatment
ISO
RGD
PMID:19907173 PMID:28892130
RGD:13702882 RGD:38549573
NCBI chr X:43,303,777...43,328,164
Ensembl chr X:43,303,785...43,322,968
G
GRK2
G protein-coupled receptor kinase 2
treatment
ISO
RGD
PMID:30024944
RGD:13792695
NCBI chr 2:5,209,435...5,227,543
Ensembl chr 2:5,209,439...5,227,758
G
HAMP
hepcidin antimicrobial peptide
ISO
mRNA:increased expression:heart
RGD
PMID:19615879
RGD:11041636
NCBI chr 6:44,785,863...44,787,303
Ensembl chr 6:44,784,160...44,787,305
G
HMGB1
high mobility group box 1
ISO
protein:increased expression:heart, serum
RGD
PMID:24599045
RGD:8696002
NCBI chr11:7,195,556...7,321,071
G
HSPA5
heat shock protein family A (Hsp70) member 5
treatment
ISO
RGD
PMID:21927577
RGD:5685668
NCBI chr 1:265,930,044...265,934,959
Ensembl chr 1:265,930,045...265,934,894
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:11701617
RGD:13702911
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:19907173
RGD:13702882
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL13
interleukin 13
treatment
ISO
RGD
PMID:15902684
RGD:8549607
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
mouse gene in a rat model
RGD
PMID:15795329
RGD:8551728
G
IL6
interleukin 6
treatment
ISO
RGD
PMID:26339812
RGD:11062109
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
KCNA5
potassium voltage-gated channel subfamily A member 5
ISO
RGD
PMID:15306225
RGD:7242784
NCBI chr 5:65,439,336...65,442,207
Ensembl chr 5:65,439,336...65,442,207
G
LOC100736765
myosin-6
ISO
RGD
PMID:10199887
RGD:12792956
NCBI chr 7:75,677,666...75,704,486
Ensembl chr 7:75,676,791...75,704,644
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:15167281
RGD:8553039
NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944
G
RORC
RAR related orphan receptor C
severity
ISO
RGD
PMID:28892130
RGD:38549573
NCBI chr 4:97,374,672...97,399,017
Ensembl chr 4:97,375,136...97,400,209
G
RPS6
ribosomal protein S6
ISO
RGD
PMID:22014063
RGD:11041642
NCBI chr 1:203,444,360...203,447,643
Ensembl chr 1:203,444,450...203,451,468
G
SIRT1
sirtuin 1
treatment
ISO
RGD
PMID:17322642
RGD:9586020
NCBI chr14:71,091,167...71,126,351
Ensembl chr14:71,091,167...71,123,297
G
ADAM8
ADAM metallopeptidase domain 8
ISO
RGD
PMID:9670863
RGD:2325244
NCBI chr14:141,221,177...141,233,728
Ensembl chr14:141,221,198...141,232,306
G
AIF1
allograft inflammatory factor 1
ISO
protein:increased expression:spinal cord (rat)
RGD
PMID:15710454
RGD:2313042
NCBI chr 7:23,711,752...23,731,191
Ensembl chr 7:23,726,787...23,731,671
G
ANXA1
annexin A1
ISO
protein:increased expression:sciatic nerve
RGD
PMID:10603033
RGD:2306914
NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279
G
APP
amyloid beta precursor protein
treatment
ISO
RGD
PMID:28446186
RGD:13782060
NCBI chr13:189,434,854...189,716,120
Ensembl chr13:189,435,094...189,716,056
G
CAV1
caveolin 1
ISO
protein:increased phosphorylation:sciatic nerve
RGD
PMID:17234162
RGD:2289125
NCBI chr18:29,648,120...29,682,451
Ensembl chr18:29,649,992...29,682,465
G
CCR1
C-C motif chemokine receptor 1
ISO
protein:increased expression:sciatic nerve, macrophage, T cell
RGD
PMID:20500551
RGD:5688140
NCBI chr13:29,227,218...29,233,862
Ensembl chr13:29,227,222...29,233,960
G
CD14
CD14 molecule
severity
ISO
RGD
PMID:19162137
RGD:2312712
NCBI chr 2:142,348,036...142,349,686
Ensembl chr 2:142,346,360...142,349,581
G
CD28
CD28 molecule
ISO
RGD
PMID:12864982
RGD:2307204
NCBI chr15:107,128,103...107,155,431
Ensembl chr15:107,128,203...107,162,935
G
CD40
CD40 molecule
ISO
RGD
PMID:17188497
RGD:5491181
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
G
CD40LG
CD40 ligand
ISO
RGD
PMID:17188497
RGD:5491181
NCBI chr X:111,778,666...111,788,901
Ensembl chr X:111,778,493...111,789,709
G
CD59
CD59 molecule
ISO
protein:increased expression:Schwann cell (rat)
RGD
PMID:10450801
RGD:1600494
NCBI chr 2:27,186,587...27,207,303
G
CX3CL1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:18448252
RGD:4891968
NCBI chr 6:19,312,351...19,324,439
G
CX3CR1
C-X3-C motif chemokine receptor 1
ISO
RGD
PMID:18448252
RGD:4891968
NCBI chr13:23,944,386...23,957,567
Ensembl chr13:23,944,369...23,957,486
G
DCC
DCC netrin 1 receptor
ISO
RGD
PMID:16337279
RGD:2314374
NCBI chr 1:101,518,629...103,087,021
Ensembl chr 1:101,846,100...103,083,096
G
DHODH
dihydroorotate dehydrogenase (quinone)
treatment
ISO
RGD
PMID:11522581
RGD:11040446
NCBI chr 6:14,942,898...14,956,000
Ensembl chr 6:14,942,933...14,955,997
G
EPAS1
endothelial PAS domain protein 1
ISO
RGD
PMID:23603807
RGD:10395381
NCBI chr 3:94,167,759...94,253,662
Ensembl chr 3:94,165,816...94,254,079
G
EPO
erythropoietin
ISO
RGD
PMID:20361946
RGD:10400894
NCBI chr 3:8,620,508...8,622,936
Ensembl chr 3:8,620,508...8,622,936
G
FOXP3
forkhead box P3
ISO
protein:decreased expression:sciatic nerve
RGD
PMID:30464413
RGD:38549576
NCBI chr X:43,303,777...43,328,164
Ensembl chr X:43,303,785...43,322,968
G
HAVCR2
hepatitis A virus cellular receptor 2
disease_progression
ISO
mRNA,protein:increased expression:sciatic nerve:
RGD
PMID:21784136
RGD:9686114
NCBI chr16:66,138,157...66,160,568
Ensembl chr16:66,139,535...66,160,538
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ISO
RGD
PMID:23603807
RGD:10395381
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
disease_progression
ISO
RGD
PMID:17286627
RGD:5508466
NCBI chr 2:84,380,245...84,401,117
Ensembl chr 2:84,380,224...84,402,957
G
IFNB1
interferon beta 1
ameliorates
ISO
RGD
PMID:10494101
RGD:401854240
NCBI chr 1:201,850,935...201,851,495
Ensembl chr 1:201,850,935...201,851,495
G
IL17A
interleukin 17A
ISO
mRNA, protein:increased expression:sciatic nerve, inguinal lymph node
RGD
PMID:10785455 PMID:19207263
RGD:4831923 RGD:4888513
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
G
IL5
interleukin 5
treatment
ISO
RGD
PMID:22310911
RGD:11522768
NCBI chr 2:134,832,143...134,846,141
Ensembl chr 2:134,832,147...134,835,212
G
LOC110258578
interleukin-1 beta-like
treatment
ISO
RGD
PMID:18400050
RGD:7401218
G
MMP7
matrix metallopeptidase 7
ISO
RGD
PMID:9546322
RGD:9685357
NCBI chr 9:33,214,590...33,225,080
Ensembl chr 9:33,214,594...33,225,080
G
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:9546322
RGD:9685357
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
NOS2
nitric oxide synthase 2
ISO
protein:increased expression:nerve root, leukocyte, Schwann cell (rat)
RGD
PMID:15144861
RGD:1580265
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:
RGD
PMID:12916703
RGD:5688236
NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:
RGD
PMID:12916703
RGD:5688236
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
RHOA
ras homolog family member A
ISO
protein:increased expression:spinal ganglion, macrophage, T cell
RGD
PMID:17367505
RGD:1642966
NCBI chr13:31,918,484...31,991,207
Ensembl chr13:31,918,834...31,986,607
G
SPP1
secreted phosphoprotein 1
ISO
RGD
PMID:15531104
RGD:1581323
NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
G
TLR2
toll like receptor 2
severity
ISO
RGD
PMID:19162137
RGD:2312712
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
G
TLR4
toll like receptor 4
ISO
mRNA:increased expression:multiple tissues
RGD
PMID:18434754
RGD:2312677
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
TLR9
toll like receptor 9
ISO
mRNA:increased expression:multiple tissues
RGD
PMID:18434754
RGD:2312677
NCBI chr13:34,353,444...34,370,990
Ensembl chr13:34,349,609...34,357,673
G
TNF
tumor necrosis factor
treatment
ISO
RGD
PMID:18400050
RGD:7401218
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
TREM1
triggering receptor expressed on myeloid cells 1
ameliorates
ISO
mRNA:increased expression:sciatic nerve,peripheral blood mononuclar cell
RGD
PMID:28260057
RGD:127284841
NCBI chr 7:36,510,253...36,531,796
Ensembl chr 7:36,510,253...36,531,796
G
CCL2
chemokine (C-C motif) ligand 2
ISO
protein:increased expression:testis (rat)
RGD
PMID:14638441
RGD:1358455
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
HNRNPH1
heterogeneous nuclear ribonucleoprotein H1
ISO
RGD
PMID:16092147
RGD:1624236
NCBI chr 2:78,961,456...78,971,799
Ensembl chr 2:78,963,309...78,969,949
G
HSPD1
heat shock protein family D (Hsp60) member 1
ISO
RGD
PMID:16092147
RGD:1624236
NCBI chr15:101,360,355...101,373,498
Ensembl chr15:101,360,094...101,373,526
G
INHA
inhibin subunit alpha
ISO
protein:decreased expression:serum:
RGD
PMID:11431143
RGD:8694089
NCBI chr15:121,581,847...121,586,020
Ensembl chr15:121,580,803...121,586,006
G
SERPINA1
serpin family A member 1
ISO
protein:increased expression:serum
RGD
PMID:16092147
RGD:1624236
NCBI chr 7:115,604,282...115,616,915
Ensembl chr 7:115,583,043...115,614,645
G
CCL2
chemokine (C-C motif) ligand 2
ISO
mRNA:increased expression:iris, ciliary body, popliteal lymph nodes (rat)
RGD
PMID:15109911
RGD:8549495
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
CCR2
C-C motif chemokine receptor 2
no_association
ISO
RGD
PMID:19357362 PMID:24736166
RGD:8657357 RGD:8657383
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,285,012...29,376,343
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
ISO
RGD
PMID:11481266 PMID:14528321
RGD:7204514 RGD:7421509
NCBI chr15:107,283,081...107,288,041
Ensembl chr15:107,282,927...107,289,103
G
CX3CL1
C-X3-C motif chemokine ligand 1
ISO
mRNA, protein:increased expression:iris, ciliary body, aqueous humor
RGD
PMID:16030495
RGD:9479740
NCBI chr 6:19,312,351...19,324,439
G
CX3CR1
C-X3-C motif chemokine receptor 1
ISO
RGD
PMID:16030495 PMID:19689733
RGD:9479740 RGD:9491397
NCBI chr13:23,944,386...23,957,567
Ensembl chr13:23,944,369...23,957,486
G
DLL4
delta like canonical Notch ligand 4
disease_progression
ISO
RGD
PMID:31209505
RGD:155791448
NCBI chr 1:130,376,720...130,386,411
Ensembl chr 1:130,376,721...130,386,411
G
FAS
Fas cell surface death receptor
susceptibility
ISO
RGD
PMID:11067900
RGD:8662852
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:8100190
RGD:8158117
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
IL10
interleukin 10
disease_progression treatment
ISO
RGD
PMID:16043105 PMID:18390724 PMID:18495789 PMID:31209505
RGD:155791448 RGD:7365044 RGD:7365052 RGD:7365069
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL17A
interleukin 17A
treatment
ISO
mRNA:increased expression:lymph node (rat)
RGD
PMID:21686325 PMID:23626769 PMID:24117055
RGD:9074484 RGD:9158567 RGD:9173789
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
G
IL1RN
interleukin 1 receptor antagonist
ISO
human protein in mouse model
RGD
PMID:16009838
RGD:8549788
G
MMP1
matrix metallopeptidase 1
onset
ISO
mRNA, protein:increased expression:eye (rat)
RGD
PMID:19755419
RGD:7207388
NCBI chr 9:33,411,738...33,420,205
Ensembl chr 9:33,411,065...33,420,076
G
NOTCH1
notch receptor 1
disease_progression
ISO
RGD
PMID:31209505
RGD:155791448
G
RPE65
retinoid isomerohydrolase RPE65
ISO
human peptides in a rat model
RGD
PMID:16109648
RGD:9585652
NCBI chr 6:144,206,078...144,229,471
Ensembl chr 6:144,206,078...144,229,467
G
SOCS1
suppressor of cytokine signaling 1
ameliorates
ISO
RGD
PMID:24993154
RGD:151232288
NCBI chr 3:31,879,143...31,883,041
Ensembl chr 3:31,881,225...31,884,967
G
STAT3
signal transducer and activator of transcription 3
treatment
ISO
RGD
PMID:22238646
RGD:8694304
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
TLR4
toll like receptor 4
ISO
RGD
PMID:20207969
RGD:7794846
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
ACE2
angiotensin converting enzyme 2
treatment
ISO
human gene in a mouse model
RGD
PMID:25228068
RGD:40818264
NCBI chr X:12,099,849...12,152,204
Ensembl chr X:12,093,242...12,151,286
G
C3
complement C3
ISO
RGD
PMID:16143328
RGD:7401262
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
G
CCL2
chemokine (C-C motif) ligand 2
ISO
mRNA:increased expression:eye:
RGD
PMID:12605265
RGD:8661671
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
CCR2
C-C motif chemokine receptor 2
ISO
mRNA:increased expression:eye:
RGD
PMID:12605265
RGD:8661671
NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,285,012...29,376,343
G
CD40LG
CD40 ligand
treatment
ISO
RGD
PMID:15972638
RGD:8547777
NCBI chr X:111,778,666...111,788,901
Ensembl chr X:111,778,493...111,789,709
G
CFB
complement factor B
treatment
ISO
RGD
PMID:20806290 PMID:21216963
RGD:7411717 RGD:7411732
NCBI chr 7:24,034,077...24,040,523
Ensembl chr 7:24,033,740...24,041,179
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:7909311
RGD:8547706
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
IFNG
interferon gamma
ISO
mRNA,protein:increased expression:eye:
RGD
PMID:1572694
RGD:8142388
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:11359436 PMID:15240742 PMID:21296818 PMID:22629453
RGD:7364830 RGD:7364849 RGD:7365075 RGD:7365084
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL2
interleukin 2
disease_progression
ISO
mRNA:increased expression:uvea:
RGD
PMID:7803357 PMID:7929845
RGD:8662946 RGD:8662951
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
IL4
interleukin 4
disease_progression
ISO
mRNA:increased expression:uvea:
RGD
PMID:7803357
RGD:8662946
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
G
STAT3
signal transducer and activator of transcription 3
ISO
RGD
PMID:18424728
RGD:8694299
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
RGD
PMID:19635911
RGD:8661744
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
G
ACE
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
treatment
ISO
RGD
PMID:17342403 PMID:24239644
RGD:40400720 RGD:40400748
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
G
ACER3
alkaline ceramidase 3
severity
ISO
mRNA,protein:decreased expression, decreased activity:colon:
RGD
PMID:26938296
RGD:35673322
NCBI chr 9:10,985,078...11,167,386
Ensembl chr 9:10,967,857...11,162,502
G
ADAM17
ADAM metallopeptidase domain 17
treatment
ISO
RGD
PMID:11884025
RGD:632022
NCBI chr 3:126,795,513...126,853,995
Ensembl chr 3:126,795,426...126,853,995
G
ADRB3
adrenoceptor beta 3
no_association
ISO
mRNA:unaltered expression:colon (rat)
RGD
PMID:11803250
RGD:5684894
NCBI chr15:48,468,803...48,478,370
Ensembl chr15:48,475,144...48,479,562
G
AGER
advanced glycosylation end-product specific receptor
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,120...24,221,162
G
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:29572553
RGD:152995414
G
ATM
ATM serine/threonine kinase
exacerbates
ISO
RGD
PMID:20179206
RGD:126781749
NCBI chr 9:36,620,656...36,759,555
Ensembl chr 9:36,620,658...36,759,552
G
ATP5F1A
ATP synthase F1 subunit alpha
treatment
ISO
RGD
PMID:25689466
RGD:13703055
NCBI chr 1:95,738,789...95,750,835
Ensembl chr 1:95,733,090...95,750,841
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
BIRC3
baculoviral IAP repeat containing 3
exacerbates
ISO
RGD
PMID:26037070
RGD:11537970
NCBI chr 9:33,003,570...33,020,252
Ensembl chr 9:33,003,276...33,020,242
G
CD68
CD68 molecule
treatment
ISO
RGD
PMID:25004394
RGD:40925931
NCBI chr12:52,874,754...52,877,256
Ensembl chr12:52,874,785...52,877,695
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:142,803,697...142,937,124
Ensembl chr 1:142,803,701...142,937,123
G
CSF1R
colony stimulating factor 1 receptor
ameliorates
ISO
RGD
PMID:23451116
RGD:150524300
NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
G
CSF3
colony stimulating factor 3
treatment
ISO
RGD
PMID:16689657
RGD:11039462
NCBI chr12:22,333,445...22,335,949
Ensembl chr12:22,333,449...22,338,753
G
CXCL8
C-X-C motif chemokine ligand 8
treatment
ISO
RGD
PMID:29655167
RGD:39939058
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
G
EREG
epiregulin
ISO
protein:increased expression:colonic mucosa (mouse)
RGD
PMID:20498653
RGD:39457688
NCBI chr 8:70,351,316...70,372,530
Ensembl chr 8:70,351,311...70,372,569
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
treatment
ISO
RGD
PMID:31160593
RGD:126779602
NCBI chr 9:109,384,976...109,450,943
Ensembl chr 9:109,385,015...109,450,941
G
FAS
Fas cell surface death receptor
treatment
ISO
RGD
PMID:22368862
RGD:10054108
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FGF10
fibroblast growth factor 10
treatment
ISO
human protein in mouse model human gene product in mouse model human protein in mouse model with bacterial delivery system
RGD
PMID:10381813 PMID:11952999 PMID:19736360 PMID:23676805
RGD:126928132 RGD:126928133 RGD:127284855 RGD:127284874
NCBI chr16:28,695,465...28,779,953
Ensembl chr16:28,695,470...28,777,509
G
FGF7
fibroblast growth factor 7
treatment
ISO
human protein in mouse model
RGD
PMID:10219846
RGD:126928136
NCBI chr 1:122,215,878...122,278,705
Ensembl chr 1:122,215,882...122,277,750
G
FOXP3
forkhead box P3
treatment
ISO
mRNA:increased expression:mucosa: protein:increased expression:colon:
RGD
PMID:17229795 PMID:26925602 PMID:27498708 PMID:28733028
RGD:14975101 RGD:38455994 RGD:38455995 RGD:38549362
NCBI chr X:43,303,777...43,328,164
Ensembl chr X:43,303,785...43,322,968
G
HAMP
hepcidin antimicrobial peptide
ISO
protein:increased expression:colon
RGD
PMID:24764672
RGD:11041628
NCBI chr 6:44,785,863...44,787,303
Ensembl chr 6:44,784,160...44,787,305
G
HMGB1
high mobility group box 1
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr11:7,195,556...7,321,071
G
HSF1
heat shock transcription factor 1
ISO
protein:increased acetylation:colon (rat)
RGD
PMID:25608526
RGD:10402402
NCBI chr 4:463,531...486,483
Ensembl chr 4:463,393...486,473
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:10092309 PMID:29572553
RGD:11522714 RGD:152995414
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
IFNG
interferon gamma
ISO
protein:increased expression:plasma:
RGD
PMID:15030379 PMID:27498708
RGD:10755756 RGD:14975101
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IFNGR1
interferon gamma receptor 1
ameliorates
ISO
RGD
PMID:25918247
RGD:124715468
NCBI chr 1:27,037,151...27,061,095
Ensembl chr 1:27,037,165...27,061,093
G
IL10
interleukin 10
treatment
ISO
associated with Helicobacter Infections
RGD
PMID:16982822 PMID:25727887 PMID:27815529 PMID:29572553
RGD:11049170 RGD:11049485 RGD:14975260 RGD:152995414
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:8978354
RGD:8551835
G
IL2
interleukin 2
ISO
RGD
PMID:16630696
RGD:8662978
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
IL23A
interleukin 23 subunit alpha
severity
ISO
mRNA:increased expression:colon (mouse)
RGD
PMID:24028683
RGD:39458035
NCBI chr 5:21,732,416...21,733,981
Ensembl chr 5:21,732,165...21,734,267
G
IL25
interleukin 25
treatment
ISO
RGD
PMID:19118508
RGD:39456129
NCBI chr 7:75,710,453...75,717,688
Ensembl chr 7:75,709,995...75,714,355
G
IL33
interleukin 33
severity treatment
ISO
RGD
PMID:25112700 PMID:28423665
RGD:39938951 RGD:39939041
NCBI chr 1:215,899,830...215,941,944
Ensembl chr 1:215,899,436...215,941,840
G
IL6
interleukin 6
treatment
ISO
RGD
PMID:16133010 PMID:16630696 PMID:27096537
RGD:11062139 RGD:11062146 RGD:8662978
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
IRF9
interferon regulatory factor 9
ameliorates
ISO
RGD
PMID:25918247
RGD:124715468
NCBI chr 7:75,133,800...75,139,641
Ensembl chr 7:75,126,622...75,139,640
G
ITGA2
integrin subunit alpha 2
treatment
ISO
RGD
PMID:16534417
RGD:11530069
NCBI chr16:32,336,240...32,440,311
Ensembl chr16:32,336,292...32,437,103
G
ITGA4
integrin subunit alpha 4
ISO
protein:increased expression:colon (rat)
RGD
PMID:12183646
RGD:729408
NCBI chr15:86,942,054...87,028,428
Ensembl chr15:86,947,240...87,030,364
G
JAK2
Janus kinase 2
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
KCNMA1
potassium calcium-activated channel subfamily M alpha 1
ISO
mRNA, protein:increased expression:colon
RGD
PMID:23986198
RGD:10412026
NCBI chr14:79,345,382...80,106,337
Ensembl chr14:79,352,005...80,106,295
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
G
KL
klotho
ISO
mRNA:decreased expression:kidney:
RGD
PMID:20004202
RGD:10403055
NCBI chr11:9,427,236...9,479,251
Ensembl chr11:9,427,037...9,479,228
G
LOC110258578
interleukin-1 beta-like
treatment
ISO
RGD
PMID:31175857
RGD:14975282
G
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
RGD
PMID:27028006
RGD:13800882
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
RGD
PMID:29037916
RGD:13800567
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MIF
macrophage migration inhibitory factor
severity
ISO
RGD
PMID:15807847
RGD:36947390
NCBI chr14:49,840,303...49,841,063
Ensembl chr14:49,840,305...49,841,068
G
MIR155
microRNA mir-155
treatment
ISO
associated with Helicobacter Infections
RGD
PMID:21880981 PMID:28246471 PMID:28461115 PMID:28752563 PMID:30253332 PMID:30927737 More...
RGD:21079443 RGD:21079463 RGD:21079473 RGD:21081536 RGD:24922208 RGD:25314295
NCBI chr13:189,138,822...189,138,902
Ensembl chr13:189,138,822...189,138,902
G
MIR21
microRNA mir-21
ameliorates
ISO
RGD
PMID:23826144
RGD:41404691
NCBI chr12:36,065,267...36,065,358
Ensembl chr12:36,065,267...36,065,358
G
MMP2
matrix metallopeptidase 2
treatment
ISO
RGD
PMID:23323009
RGD:13207328
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
G
MMP9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:23323009
RGD:13207328
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
MPO
myeloperoxidase
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr12:34,557,031...34,570,091
Ensembl chr12:34,556,408...34,567,904
G
MYD88
MYD88 innate immune signal transduction adaptor
exacerbates
ISO
RGD
PMID:25362351
RGD:150521530
NCBI chr13:22,976,951...22,979,568
Ensembl chr13:22,966,137...22,983,109
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:22350949
RGD:10412739
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
G
NFKBIA
NFKB inhibitor alpha
treatment
ISO
RGD
PMID:21642017
RGD:10413866
NCBI chr 7:64,508,119...64,510,754
Ensembl chr 7:64,507,822...64,511,277
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
protein:increased expression:colonic mucosa:
RGD
PMID:22997830
RGD:13204727
NCBI chr 6:34,132,127...34,167,446
Ensembl chr 6:34,130,938...34,177,534
G
NPY
neuropeptide Y
treatment
ISO
RGD
PMID:20533056
RGD:10448943
NCBI chr18:47,985,796...47,993,726
Ensembl chr18:47,985,725...47,992,667
G
PDGFRA
platelet derived growth factor receptor alpha
treatment
ISO
RGD
PMID:24115822
RGD:11080973
NCBI chr 8:40,966,568...41,021,440
Ensembl chr 8:40,967,493...41,021,441
G
PDGFRB
platelet derived growth factor receptor beta
treatment
ISO
RGD
PMID:24115822
RGD:11080973
NCBI chr 2:151,155,753...151,192,818
Ensembl chr 2:151,155,756...151,192,647
G
PHEX
phosphate regulating endopeptidase X-linked
ISO
mRNA:decreased expression:bone:
RGD
PMID:16890604
RGD:11556253
NCBI chr X:18,199,396...18,420,985
Ensembl chr X:18,203,174...18,418,004
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
susceptibility
ISO
RGD
PMID:20347874
RGD:38599183
NCBI chr 9:106,698,200...106,748,217
Ensembl chr 9:106,698,207...106,745,099
G
PTGER4
prostaglandin E receptor 4
treatment
ISO
RGD
PMID:12100473
RGD:727388
NCBI chr16:25,670,832...25,686,556
Ensembl chr16:25,670,862...25,686,552
G
RELA
RELA proto-oncogene, NF-kB subunit
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
G
RNASEL
ribonuclease L
severity
ISO
RGD
PMID:23567782
RGD:40902808
NCBI chr 9:123,895,045...123,910,386
Ensembl chr 9:123,893,294...123,910,398
G
SLC11A1
solute carrier family 11 member 1
ISO
RGD
PMID:19116231
RGD:5684934
NCBI chr15:120,434,100...120,446,396
Ensembl chr15:120,433,952...120,446,396
G
SMAD4
SMAD family member 4
susceptibility
ISO
RGD
PMID:23090737
RGD:12880038
NCBI chr 1:100,521,843...100,633,501
Ensembl chr 1:100,589,850...100,628,029
G
SOCS3
suppressor of cytokine signaling 3
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr12:3,643,832...3,647,015
Ensembl chr12:3,643,929...3,647,009
G
TNF
tumor necrosis factor
treatment
ISO
RGD
PMID:21296062 PMID:29572553
RGD:152995414 RGD:8661763
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
TNFRSF1A
TNF receptor superfamily member 1A
treatment
ISO
RGD
PMID:21296062
RGD:8661763
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
G
VEGFA
vascular endothelial growth factor A
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
AACS
acetoacetyl-CoA synthetase
ISO
protein:decreased activity:liver
RGD
PMID:12034369
RGD:2301022
NCBI chr14:28,109,845...28,169,261
Ensembl chr14:28,109,869...28,169,253
G
ABAT
4-aminobutyrate aminotransferase
ISO
RGD
PMID:9846053
RGD:1598518
NCBI chr 3:33,913,068...33,960,804
Ensembl chr 3:33,908,970...34,015,474
G
ABCB1
ATP-binding cassette, sub-family B (MDR/TAP), member 1
treatment disease_progression
ISO
protein: decreased expression mRNA:increased expression:ileum, intestinal mucosa (rat) mRNA:increased expression:brain
RGD
PMID:17074306 PMID:17664251 PMID:21685928 PMID:26460146
RGD:11041112 RGD:1598559 RGD:2312730 RGD:8657121
NCBI chr 9:93,049,955...93,146,469
G
ABCB4
ATP binding cassette subfamily B member 4
ISO
RGD
PMID:12055592
RGD:1598588
NCBI chr 9:93,171,371...93,262,124
G
ABCC2
ATP binding cassette subfamily C member 2
ISO
mRNA: increased expression: brain mRNA:decreased expression:liver protein: increased expression
RGD
PMID:17664251 PMID:19356064 PMID:20487213
RGD:11541075 RGD:2312728 RGD:2312730
NCBI chr14:110,955,698...111,038,898
Ensembl chr14:110,955,633...111,037,537
G
ABCC3
ATP binding cassette subfamily C member 3
ISO
mRNA:increased expression:liver
RGD
PMID:20487213
RGD:11541075
NCBI chr12:26,920,764...26,978,389
Ensembl chr12:26,920,821...26,978,363
G
ABCC9
ATP binding cassette subfamily C member 9
ISO
mRNA, protein:decreased expression:heart
RGD
PMID:22257425
RGD:12792003
NCBI chr 5:51,536,531...51,673,583
Ensembl chr 5:51,536,526...51,691,595
G
ABCG2A
ATP binding cassette subfamily G member 2A
ISO
protein:decreased expression:cerebral cortex
RGD
PMID:17915193
RGD:2315584
NCBI chr 8:130,853,414...130,945,388
Ensembl chr 8:130,889,684...130,945,393
G
ABCG5
ATP binding cassette subfamily G member 5
ISO
RGD
PMID:14618236
RGD:1558629
NCBI chr 3:96,616,304...96,656,893
Ensembl chr 3:96,616,246...96,656,889
G
ABCG8
ATP binding cassette subfamily G member 8
ISO
RGD
PMID:14618236
RGD:1558629
NCBI chr 3:96,596,975...96,616,224
Ensembl chr 3:96,596,531...96,616,229
G
ACAA1
acetyl-CoA acyltransferase 1
ISO
mRNA:increased expression:heart
RGD
PMID:17632588
RGD:2313044
NCBI chr13:22,964,844...23,020,138
Ensembl chr13:22,964,875...23,020,143
G
ACADVL
acyl-CoA dehydrogenase very long chain
ISO
protein:decreased expression:brain
RGD
PMID:25260493
RGD:10047114
NCBI chr12:52,573,521...52,581,755
Ensembl chr12:52,576,402...52,581,748
G
ACE
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
ISO
protein:increased expression:kidney CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18679036 PMID:22191573
RGD:2313799
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
G
ACE2
angiotensin converting enzyme 2
ISO
protein:altered expression:kidney
RGD
PMID:18679036
RGD:2313799
NCBI chr X:12,099,849...12,152,204
Ensembl chr X:12,093,242...12,151,286
G
ACHE
acetylcholinesterase
treatment
ISO
protein:increased expression:blood
RGD
PMID:1385785 PMID:19296211 PMID:19303406 PMID:19347982
RGD:150517552 RGD:2312430 RGD:2312432 RGD:2312437
NCBI chr 3:8,732,451...8,738,274
Ensembl chr 3:8,732,441...8,738,605
G
ACMSD
aminocarboxymuconate semialdehyde decarboxylase
treatment
ISO
RGD
PMID:12042425 PMID:19169727
RGD:13831125 RGD:13831126
NCBI chr15:17,121,950...17,164,005
Ensembl chr15:17,106,724...17,163,899
G
ACOX1
acyl-CoA oxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr12:5,450,913...5,479,550
Ensembl chr12:5,439,361...5,479,546
G
ACP5
acid phosphatase 5, tartrate resistant
ISO
protein:increased activity:femoral bone (rat)
RGD
PMID:19699734
RGD:2315882
NCBI chr 2:70,206,159...70,209,855
Ensembl chr 2:70,206,162...70,208,229
G
ACSL1
acyl-CoA synthetase long chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9452481
NCBI chr15:45,866,858...45,936,327
Ensembl chr15:45,866,857...45,963,729
G
ACSL3
acyl-CoA synthetase long chain family member 3
ISO
RGD
PMID:21136146
RGD:13831298
NCBI chr15:124,741,986...124,816,955
Ensembl chr15:124,765,854...124,816,960
G
ACSL6
acyl-CoA synthetase long chain family member 6
ISO
mRNA:decreased expression:heart
RGD
PMID:16428347
RGD:1599808
NCBI chr 2:134,210,915...134,278,860
Ensembl chr 2:134,210,917...134,278,820
G
ADA
adenosine deaminase
ISO
protein:increased expression:platelet
RGD
PMID:9784839 PMID:19166862
RGD:2313538 RGD:2313540
NCBI chr17:47,044,492...47,072,232
Ensembl chr17:47,044,497...47,072,245
G
ADCYAP1
adenylate cyclase activating polypeptide 1
ISO
protein:increased expression:pancreas, hypothalamus
RGD
PMID:9864055
RGD:2325314
NCBI chr 6:105,414,628...105,422,294
Ensembl chr 6:105,414,631...105,422,294
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
mRNA, protein:decreased expression:adipose tissue, serum protein:increased expression:retina
RGD
PMID:16201273 PMID:23174569
RGD:1599146 RGD:8694416
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
G
ADIPOR2
adiponectin receptor 2
no_association
ISO
Reduced Adipor2 mRNA in livers of diabetic mice
RGD
PMID:17884446 PMID:18222103 PMID:19220660
RGD:2312478 RGD:2312488 RGD:2312495
NCBI chr 5:68,755,789...68,807,247
Ensembl chr 5:68,755,811...68,807,235
G
ADK
adenosine kinase
ISO
protein:decreased expression:spleen, lymphocyte
RGD
PMID:12729803
RGD:2313360
NCBI chr14:76,836,072...77,320,586
Ensembl chr14:76,836,095...77,322,416
G
ADM
adrenomedullin
ISO
protein:increased expression:pigmented epithelial cell, retina
RGD
PMID:16955796
RGD:1625296
NCBI chr 2:49,229,223...49,231,521
Ensembl chr 2:49,229,223...49,231,866
G
ADORA1
adenosine A1 receptor
treatment
ISO
associated with hypertension protein:decreased expression:hippocampus
RGD
PMID:9597368 PMID:11593763 PMID:16256246 PMID:19276628
RGD:1625365 RGD:2313804 RGD:2313805 RGD:2313808
NCBI chr 9:113,835,279...113,875,899
Ensembl chr 9:113,835,921...113,872,365
G
ADORA2A
adenosine A2a receptor
ISO
protein:increased expression:hippocampus
RGD
PMID:16256246
RGD:2313805
NCBI chr14:49,467,186...49,485,845
Ensembl chr14:49,468,877...49,485,850
G
ADRA1A
adrenoceptor alpha 1A
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17054657 PMID:19133277
RGD:1625775
NCBI chr14:10,623,391...10,733,378
Ensembl chr14:10,626,293...10,733,068
G
ADRB1
adrenoceptor beta 1
ISO
protein:decreased expression:left ventricle muscular part
RGD
PMID:21054861
RGD:5129115
NCBI chr14:124,400,330...124,401,739
Ensembl chr14:124,400,330...124,401,739
G
ADRB3
adrenoceptor beta 3
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:left ventricle muscular part
CTD RGD
PMID:17622774 PMID:21054861
RGD:5129115
NCBI chr15:48,468,803...48,478,370
Ensembl chr15:48,475,144...48,479,562
G
ADSL
adenylosuccinate lyase
ISO
protein:increased activity:heart (rat)
RGD
PMID:3360219
RGD:1598762
NCBI chr 5:8,027,799...8,045,480
Ensembl chr 5:8,025,508...8,047,603
G
ADSS1
adenylosuccinate synthase 1
ISO
protein:increased activity:heart (rat)
RGD
PMID:3360219
RGD:1598762
G
AGER
advanced glycosylation end-product specific receptor
treatment
ISO
mRNA:increased expression:renal cortex (mouse) protein:increased expression:lacrimal gland
RGD
PMID:16283249 PMID:20801062 PMID:21458563 PMID:22476978
RGD:1625335 RGD:7243964 RGD:7244188 RGD:7245558
NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,120...24,221,162
G
AGT
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15831366 PMID:17177138 PMID:18829990
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
G
AGTR2
angiotensin II receptor type 2
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:12172324
RGD:6903861
NCBI chr X:95,267,709...95,272,237
Ensembl chr X:95,269,300...95,270,388
G
AIFM1
apoptosis inducing factor mitochondria associated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23499715
NCBI chr X:106,676,596...106,708,290
Ensembl chr X:106,670,520...106,708,317
G
AIRE
autoimmune regulator
susceptibility
ISO
RGD
PMID:18399912
RGD:2306853
NCBI chr13:207,148,401...207,158,355
Ensembl chr13:207,148,401...207,158,532
G
AKR1B1
aldo-keto reductase family 1 member B
ISO
mRNA:increased expression:kidney (rat)
RGD
PMID:8204669
RGD:8548781
NCBI chr18:14,593,516...14,752,316
Ensembl chr18:14,684,036...14,752,310
G
AKT1
AKT serine/threonine kinase 1
ISO
protein:decreased serine phosphorylation:cornea protein:increased serine phosphorylation:cortex of kidney
RGD
PMID:18599524 PMID:21330660
RGD:5131482 RGD:8657153
G
ALAD
aminolevulinate dehydratase
susceptibility treatment
ISO
protein:decreased activity:blood, liver protein:decreased activity:liver, erythrocyte (rat) protein:decreased activity:liver, kidney (rat)
RGD
PMID:7728901 PMID:10224671 PMID:18668330 PMID:19043199 PMID:21864646 PMID:24947461 More...
RGD:12904683 RGD:12904692 RGD:12904702 RGD:12904704 RGD:15039405 RGD:4144150
NCBI chr 1:254,015,426...254,027,584
Ensembl chr 1:254,012,850...254,027,508
G
ALAS1
aminolevulinate, delta-, synthase 1 pseudogene
ISO
protein:decreased activity:liver (rat)
RGD
PMID:6688350
RGD:4144808
NCBI chr13:34,333,263...34,347,435
Ensembl chr13:34,333,113...34,347,589
G
ALDOB
aldolase, fructose-bisphosphate B
ISO
mRNA:reduced expression:liver, small intestine (rat)
RGD
PMID:2984252
RGD:2313437
NCBI chr 1:243,127,870...243,141,504
Ensembl chr 1:243,110,585...243,141,418
G
ANGPT1
angiopoietin 1
ISO
protein:increased expression:retina
RGD
PMID:15047628 PMID:17294737
RGD:1626163 RGD:2313817
NCBI chr 4:29,925,203...30,233,434
Ensembl chr 4:29,933,135...30,233,960
G
ANGPT2
angiopoietin 2
ISO
protein:increased expression:retina
RGD
PMID:15047628
RGD:2313817
NCBI chr15:37,544,177...37,600,925
Ensembl chr15:37,544,707...37,599,041
G
ANGPTL3
angiopoietin like 3
ISO
protein:increased expression:liver
RGD
PMID:15094378
RGD:2314234
NCBI chr 6:149,836,417...149,845,854
Ensembl chr 6:149,832,542...149,845,831
G
ANXA1
annexin A1
ISO
protein:increased glycation:respiratory system blood vessel endothelium
RGD
PMID:11423489
RGD:2306888
NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279
G
ANXA2
annexin A2
ISO
protein:increased glycation:respiratory system blood vessel endothelium
RGD
PMID:11423489
RGD:2306888
NCBI chr 1:111,588,721...111,635,064
Ensembl chr 1:111,588,306...111,635,059
G
AOC1
amine oxidase copper containing 1
ISO
RGD
PMID:1632778
RGD:2312809
NCBI chr18:6,309,583...6,321,016
Ensembl chr18:6,309,594...6,320,974
G
APOA1
apolipoprotein A1
treatment
ISO
RGD
PMID:17488882
RGD:7241577
NCBI chr 9:44,216,481...44,218,360
Ensembl chr 9:44,216,392...44,218,713
G
APOB
apolipoprotein B
ISO
RGD
PMID:17292734
RGD:1642185
NCBI chr 3:117,250,096...117,316,200
Ensembl chr 3:117,250,096...117,316,200
G
APOE
apolipoprotein E
ISO
protein:decreased expression:plasma (rat)
RGD
PMID:16947119
RGD:1599198
NCBI chr 6:51,373,113...51,375,333
Ensembl chr 6:51,372,292...51,375,330
G
APOM
apolipoprotein M
ISO
protein:decreased secretion:plasma
RGD
PMID:16516154
RGD:2314249
NCBI chr 7:23,768,974...23,773,324
Ensembl chr 7:23,768,984...23,773,324
G
APRT
adenine phosphoribosyltransferase
ISO
protein:decreased activity:mammary gland (rat)
RGD
PMID:2451510
RGD:1599204
NCBI chr 6:890,272...893,278
Ensembl chr 6:890,831...893,276
G
AQP1
aquaporin 1 (Colton blood group)
ISO
protein:increased expression:retina
RGD
PMID:19596320
RGD:2316078
NCBI chr18:42,063,482...42,076,741
Ensembl chr18:42,063,485...42,076,746
G
AQP2
aquaporin 2
ISO
protein:decreased expression:kidney collecting duct protein:increased expression:Kidney Medulla
RGD
PMID:11380083 PMID:15705184
RGD:2314326 RGD:2314347
NCBI chr 5:15,862,739...15,868,565
Ensembl chr 5:15,863,486...15,868,565
G
AQP4
aquaporin 4
ISO
mRNA,protein:increased expression:retina:
RGD
PMID:22449442
RGD:8695996
NCBI chr 6:111,407,632...111,422,169
Ensembl chr 6:111,407,639...111,422,109
G
AR
androgen receptor
ISO
protein:decreased expression:pancreatic B cell mRNA, protein:decreased expression:epididymis, prostate gland, testis
RGD
PMID:16398356 PMID:18543106
RGD:2306772 RGD:2306774
NCBI chr X:53,609,113...53,806,778
Ensembl chr X:53,609,176...53,800,677
G
ARG1
arginase 1
ISO
protein:increased expression:aorta, liver (rat)
RGD
PMID:17967788
RGD:4142848
NCBI chr 1:32,006,035...32,028,983
Ensembl chr 1:32,006,046...32,028,988
G
ARG2
arginase 2
ISO
protein:increased activity:kidney (rat)
RGD
PMID:12841630
RGD:4143269
NCBI chr 7:91,343,987...91,385,911
Ensembl chr 7:91,343,988...91,385,909
G
ARNTL
aryl hydrocarbon receptor nuclear translocator like
ISO
RGD
PMID:18624957
RGD:2301030
NCBI chr 2:45,895,637...46,025,174
Ensembl chr 2:45,895,289...45,988,570
G
ASPA
aspartoacylase
ISO
protein:increased expression:duodenum, brain
RGD
PMID:16707098
RGD:1601247
NCBI chr12:49,612,845...49,630,303
Ensembl chr12:49,610,519...49,641,864
G
ASS1
argininosuccinate synthase 1
ISO
mRNA, protein:increased expression:aorta (rat)
RGD
PMID:11384198
RGD:1599310
NCBI chr 1:270,531,434...270,586,364
Ensembl chr 1:270,531,589...270,586,364
G
ATF3
activating transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 9:130,772,259...130,829,678
Ensembl chr 9:130,772,262...130,785,506
G
ATG7
autophagy related 7
treatment
ISO
protein:decreased expression:myocardium
RGD
PMID:24874076 PMID:24993523
RGD:11557993 RGD:11557996
NCBI chr13:67,301,756...67,699,141
Ensembl chr13:67,417,938...67,707,654
G
ATP2A1
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
ISO
RGD
PMID:28483572
RGD:12910731
NCBI chr 3:18,545,064...18,568,312
Ensembl chr 3:18,545,071...18,568,310
G
ATP2A2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
ISO
protein:increased carbonylation:heart CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16123366 PMID:20122173 PMID:21300842 PMID:28483572
RGD:12910731 RGD:13782130 RGD:6904139
NCBI chr14:31,674,659...31,744,981
Ensembl chr14:31,674,757...31,744,969
G
ATP2A3
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16123366 PMID:20122173
RGD:13782130
NCBI chr12:49,980,488...50,014,006
Ensembl chr12:49,980,497...50,025,171
G
ATP4B
ATPase H+/K+ transporting subunit beta
ISO
RGD
PMID:20237950
RGD:14696743
NCBI chr11:78,780,013...78,785,143
Ensembl chr11:78,780,013...78,785,116
G
ATP5F1A
ATP synthase F1 subunit alpha
ISO
protein:decreased expression:cerebral cortex, mitochondrion (rat)
RGD
PMID:28526935
RGD:13703047
NCBI chr 1:95,738,789...95,750,835
Ensembl chr 1:95,733,090...95,750,841
G
ATP5F1B
ATP synthase F1 subunit beta
ISO
associated with polycystic ovary syndrome;mRNA, protein:decreased expression:pancreas (rat)
RGD
PMID:28397049
RGD:13703107
NCBI chr 5:21,984,750...21,992,393
Ensembl chr 5:21,984,580...21,992,407
G
ATP5PD
ATP synthase peripheral stalk subunit d
ISO
protein:decreased expression:retina (rat)
RGD
PMID:17465459
RGD:5147874
NCBI chr12:6,241,467...6,247,344
G
ATP5PF
ATP synthase peripheral stalk subunit F6
treatment
ISO
RGD
PMID:28731155
RGD:13800891
NCBI chr13:189,281,429...189,290,234
Ensembl chr13:189,278,945...189,290,229
G
AVP
vasopressin
ISO
mRNA:increased expression:hypothalamus
RGD
PMID:18420743
RGD:2301919
NCBI chr17:32,581,234...32,583,145
Ensembl chr17:32,581,234...32,583,185
G
BAD
BCL2 associated agonist of cell death
ISO
protein:decreased serine phosphorylation:cornea protein:increased expression, decreased phosphorylation, altered activity:testis
RGD
PMID:17870134 PMID:21330660
RGD:2292685 RGD:5131482
NCBI chr 2:7,831,192...7,842,864
Ensembl chr 2:7,830,920...7,842,863
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:retina
CTD RGD
PMID:18991018 PMID:23090186 PMID:23267840
RGD:10054099 RGD:2311240
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140
G
BCHE
butyrylcholinesterase
ISO
protein:decreased expression:retina
RGD
PMID:11478742 PMID:12379509 PMID:16187484
RGD:1599458 RGD:2306781 RGD:2306783
NCBI chr13:104,946,732...105,007,568
G
BCKDHA
branched chain keto acid dehydrogenase E1 subunit alpha
ISO
protein:increased expression:liver
RGD
PMID:9460082
RGD:1599467
NCBI chr 6:49,381,995...49,398,745
Ensembl chr 6:49,381,967...49,398,743
G
BCKDHB
branched chain keto acid dehydrogenase E1 subunit beta
ISO
Protein:increased expression:liver;
RGD
PMID:9460082
RGD:1599467
NCBI chr 1:85,755,819...86,017,661
Ensembl chr 1:85,755,743...86,017,650
G
BCL2
BCL2 apoptosis regulator
ISO
mRNA:decreased expression:embryo CTD Direct Evidence: marker/mechanism protein:increased expression:retina
RGD CTD
PMID:15649569 PMID:16959961 PMID:18991018 PMID:23090186
RGD:1599491 RGD:2311240
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
BCL2L1
BCL2 like 1
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression, altered activity:testis
CTD RGD
PMID:16959961 PMID:17870134
RGD:2292685
NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694
G
BDH1
3-hydroxybutyrate dehydrogenase 1
ISO
protein:decreased activity:heart, mitochondrion (rat)
RGD
PMID:3548709
RGD:2326100
NCBI chr13:132,602,372...132,647,271
Ensembl chr13:132,605,489...132,645,937
G
BDKRB1
bradykinin receptor B1
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:heart
RGD CTD
PMID:12489796 PMID:12522068 PMID:20092893 PMID:21430409
RGD:704379 RGD:704380 RGD:7241569
NCBI chr 7:117,491,350...117,492,410
Ensembl chr 7:117,491,350...117,492,410
G
BDKRB2
bradykinin receptor B2
ISO
protein:increased expression:hindbrain, spinal cord mRNA:increased expression:heart
RGD
PMID:12489796 PMID:16138314
RGD:4890452 RGD:704379
NCBI chr 7:117,438,622...117,472,005
Ensembl chr 7:117,438,713...117,472,005
G
BDNF
brain derived neurotrophic factor
treatment
ISO
RGD
PMID:24857910
RGD:10059399
NCBI chr 2:32,623,668...32,679,293
Ensembl chr 2:32,624,048...32,679,765
G
BECN1
beclin 1
treatment
ISO
RGD
PMID:24993523
RGD:11557996
NCBI chr12:20,041,914...20,054,249
Ensembl chr12:20,041,956...20,054,373
G
BMPR2
bone morphogenetic protein receptor type 2
ISO
protein:increased expression:lung
RGD
PMID:21521772
RGD:5135278
NCBI chr15:105,971,577...106,132,496
Ensembl chr15:105,970,428...106,135,730
G
BTC
betacellulin
ISO
RGD
PMID:14988244 PMID:18388935 PMID:19819964
RGD:1357906 RGD:2306965 RGD:2313774
NCBI chr 8:70,645,721...70,697,538
Ensembl chr 8:70,649,317...70,697,420
G
CACNG4
calcium voltage-gated channel auxiliary subunit gamma 4
ISO
mRNA:decreased expression:sinoatrial node:
RGD
PMID:27096430
RGD:13524560
NCBI chr12:13,391,080...13,454,542
Ensembl chr12:13,391,079...13,452,174
G
CAD
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
ISO
protein:decreased activity:mammary gland (rat)
RGD
PMID:1476792
RGD:5132591
NCBI chr 3:111,887,017...111,914,511
Ensembl chr 3:111,887,020...111,914,492
G
CALCB
calcitonin-related polypeptide beta
ISO
protein:decreased expression:dorsal root ganglion, neuron protein:increased expression:penis erectile tissue, seminal vesicle
RGD
PMID:17151309 PMID:19152794
RGD:2314033 RGD:2314035
NCBI chr 2:44,043,135...44,048,651
G
CALD1
caldesmon 1
ISO
RGD
PMID:10644879
RGD:2314036
NCBI chr18:14,267,955...14,486,641
Ensembl chr18:14,267,959...14,486,726
G
CAPN10
calpain 10
ISO
mRNA, protein:decreased expression:kidney cortex
RGD
PMID:22568896
RGD:7247732
NCBI chr15:139,557,643...139,568,764
Ensembl chr15:139,557,469...139,568,767
G
CARHSP1
calcium regulated heat stable protein 1
treatment
ISO
RGD
PMID:19997081
RGD:39128203
NCBI chr 3:33,834,347...33,847,941
Ensembl chr 3:33,838,488...33,847,938
G
CASP1
caspase 1, apoptosis-related cysteine peptidase
ISO
mRNA:increased expression:retina
RGD
PMID:18398369
RGD:2315888
NCBI chr 9:35,188,066...35,199,364
Ensembl chr 9:35,186,420...35,200,328
G
CASP3
caspase 3
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased activity:hypothalamus
CTD RGD
PMID:19094082 PMID:20654064 PMID:28843149
RGD:13782300 RGD:2311447
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CASP6
caspase 6
ISO
protein:increased activity:heart left ventricle
RGD
PMID:15662549
RGD:2301316
NCBI chr 8:112,519,450...112,534,315
Ensembl chr 8:112,520,629...112,537,045
G
CASP8
caspase 8
treatment
ISO
protein:increased activity, increased expression:pituitary gland, prolactin secreting cell protein:increased expression, increased activity:pituitary gland
RGD
PMID:15976052 PMID:17563067 PMID:19540304 PMID:28843149
RGD:13782300 RGD:2311319 RGD:2311427 RGD:2311429
NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
G
CASP9
caspase 9
ISO
protein:increased activity, increased expression:pituitary gland
RGD
PMID:15976052
RGD:2311319
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
G
CASQ1
calsequestrin 1
ISO
protein:increased activity:skeletal muscle tissue
RGD
PMID:11976916
RGD:2314137
NCBI chr 4:90,276,752...90,288,990
Ensembl chr 4:90,276,757...90,288,250
G
CASR
calcium sensing receptor
ISO
protein:increased expression:pancreas, liver, kidney (rat)
RGD
PMID:22844268
RGD:7205442
NCBI chr13:138,279,785...138,364,934
Ensembl chr13:138,280,364...138,364,252
G
CAT
catalase
ISO
CTD Direct Evidence: marker/mechanism|therapeutic associated with alcohol use disorder; protein:decreased activity;testis, epididymis (rat)
CTD RGD
PMID:12123627 PMID:15855331 PMID:20376213 PMID:20709041 PMID:25541261
RGD:405255664 RGD:5130772
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
G
CAV1
caveolin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18266981 PMID:25086377
RGD:10045572
NCBI chr18:29,648,120...29,682,451
Ensembl chr18:29,649,992...29,682,465
G
CAV3
caveolin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18266981
NCBI chr13:65,117,868...65,130,886
Ensembl chr13:65,117,795...65,131,273
G
CCK
cholecystokinin
ISO
RGD
PMID:15536283
RGD:2313638
NCBI chr13:25,940,674...25,945,879
Ensembl chr13:25,937,645...25,945,793
G
CCKBR
cholecystokinin B receptor
ISO
mRNA, protein:decreased expression:pancreas
RGD
PMID:15161757
RGD:1358452
NCBI chr 9:3,409,222...3,419,513
G
CCL2
chemokine (C-C motif) ligand 2
treatment
ISO
protein:increased expression:gingiva protein:increased expression:plasma
RGD
PMID:16891764 PMID:17876613 PMID:18976114
RGD:2306984 RGD:2306992 RGD:8549535
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
CCL20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21340626
NCBI chr15:129,172,743...129,176,069
G
CCN1
cellular communication network factor 1
ISO
mRNA:increased expression:retina (mouse)
RGD
PMID:22160564
RGD:329845551
NCBI chr 4:130,392,404...130,395,179
Ensembl chr 4:130,392,407...130,395,150
G
CCN2
cellular communication network factor 2
ISO
mRNA, protein:increased expression:heart, myocardium (rat) mRNA:increased expression:heart left ventricle (rat)
RGD
PMID:19625611 PMID:19820199
RGD:2314021 RGD:2314487
NCBI chr 1:31,674,398...31,677,697
Ensembl chr 1:31,674,394...31,677,691
G
CCNA2
cyclin A2
ISO
RGD
PMID:20031167
RGD:2316310
NCBI chr 8:102,260,346...102,266,274
Ensembl chr 8:102,260,215...102,266,309
G
CCNB1
cyclin B1
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:20031167
RGD:2316310
NCBI chr16:47,338,239...47,348,385
Ensembl chr16:47,338,110...47,348,377
G
CCND3
cyclin D3
ISO
protein:increased expression:kidney, glomerulus
RGD
PMID:19276076
RGD:2316018
NCBI chr 7:37,087,336...37,182,462
Ensembl chr 7:37,082,097...37,181,366
G
CCNT1
cyclin T1
ISO
mRNA,protein:decreased expression:liver:
RGD
PMID:20828602
RGD:9698426
NCBI chr 5:14,768,423...14,808,424
Ensembl chr 5:14,768,426...14,806,813
G
CCR5
C-C motif chemokine receptor 5
ISO
protein:increased expression:retina
RGD
PMID:21575160
RGD:11533943
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
G
CD28
CD28 molecule
ISO
RGD
PMID:11160314
RGD:2307200
NCBI chr15:107,128,103...107,155,431
Ensembl chr15:107,128,203...107,162,935
G
CD36
CD36 molecule
treatment
ISO
mRNA:increased expression:multiple organs
RGD
PMID:16838191 PMID:23691525
RGD:11041145 RGD:2307214
NCBI chr 9:99,685,748...99,782,296
Ensembl chr 9:99,605,181...99,782,105
G
CD3E
CD3 epsilon subunit of T-cell receptor complex
ISO
RGD
PMID:16628253
RGD:2314179
NCBI chr 9:45,619,730...45,633,972
Ensembl chr 9:45,619,482...45,633,968
G
CD40LG
CD40 ligand
treatment
ISO
protein:increased expression:platelet (rat)
RGD
PMID:19237211 PMID:21831422
RGD:11352661 RGD:2312338
NCBI chr X:111,778,666...111,788,901
Ensembl chr X:111,778,493...111,789,709
G
CD68
CD68 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20388520
NCBI chr12:52,874,754...52,877,256
Ensembl chr12:52,874,785...52,877,695
G
CD80
CD80 molecule
ISO
RGD
PMID:11160314
RGD:2307200
NCBI chr13:140,693,312...140,730,541
Ensembl chr13:140,693,382...140,728,976
G
CD86
CD86 molecule
ISO
RGD
PMID:8993020
RGD:2313930
NCBI chr13:138,427,573...138,504,307
Ensembl chr13:138,427,533...138,504,310
G
CDK9
cyclin dependent kinase 9
ISO
mRNA,protein:decreased expression:liver:
RGD
PMID:20828602
RGD:9698426
NCBI chr 1:268,277,083...268,280,493
Ensembl chr 1:268,276,841...268,281,052
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
protein:increased expression:testes:
RGD
PMID:24828139
RGD:8662307
NCBI chr 7:32,354,776...32,363,771
Ensembl chr 7:32,359,455...32,363,761
G
CEL
carboxyl ester lipase
ISO
protein:decreased expression:pancreas,
RGD
PMID:8446851
RGD:2313971
NCBI chr 1:272,763,203...272,770,259
Ensembl chr 1:272,763,003...272,770,255
G
CFD
complement factor D
ISO
protein:decreased expression:serum
RGD
PMID:8372111
RGD:1624344
NCBI chr 2:77,509,792...77,511,988
Ensembl chr 2:77,509,795...77,511,974
G
CFTR
CF transmembrane conductance regulator
severity
ISO
RGD
PMID:16804061
RGD:2314614
NCBI chr18:28,627,717...28,818,209
Ensembl chr18:28,627,728...28,817,950
G
CHAT
choline O-acetyltransferase
ISO
protein:decreased expression:telencephalon
RGD
PMID:26282349
RGD:402463971
NCBI chr14:90,117,464...90,167,611
Ensembl chr14:90,117,464...90,167,611
G
CHRM2
cholinergic receptor muscarinic 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18603373
NCBI chr18:12,455,139...12,600,314
Ensembl chr18:12,455,145...12,600,186
G
CLPS
colipase
ISO
RGD
PMID:19577003
RGD:2314624
NCBI chr 7:31,618,920...31,621,132
Ensembl chr 7:31,618,920...31,621,132
G
CLU
clusterin
ISO
protein:increased expression:retina protein:increased expression:pancreatic islet
RGD
PMID:12763621 PMID:23351716
RGD:9068392 RGD:9068411
NCBI chr14:11,336,585...11,352,569
Ensembl chr14:11,336,595...11,349,764
G
CNR1
cannabinoid receptor 1
ISO
protein:increased expression:hypothalamus, striatum
RGD
PMID:18401837
RGD:2314633
NCBI chr 1:56,466,022...56,493,275
Ensembl chr 1:56,467,835...56,492,602
G
COMT
catechol-O-methyltransferase
ISO
protein:decreased expression:liver
RGD
PMID:12010186
RGD:2289789
NCBI chr14:51,384,729...51,403,997
Ensembl chr14:51,385,738...51,403,998
G
CP
ceruloplasmin
ISO
Protein:increased expression:plasma
RGD
PMID:16947119
RGD:1599198
NCBI chr13:89,396,713...89,463,540
Ensembl chr13:89,396,708...89,463,476
G
CPS1
carbamoyl-phosphate synthase 1
ISO
protein:increased activity:liver (rat)
RGD
PMID:2882780
RGD:4144110
NCBI chr15:113,210,038...113,339,086
Ensembl chr15:113,150,157...113,339,078
G
CPT1A
carnitine palmitoyltransferase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 2:4,250,642...4,293,914
Ensembl chr 2:4,233,099...4,293,911
G
CPT1B
carnitine palmitoyltransferase 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr 5:155,552...163,536
Ensembl chr 5:155,643...163,531
G
CRH
corticotropin releasing hormone
ISO
mRNA:increased expression:paraventricular hypothalamic nucleus (rat)
RGD
PMID:9652969
RGD:5508166
NCBI chr 4:68,481,696...68,486,122
Ensembl chr 4:68,484,053...68,486,121
G
CRP
C-reactive protein, pentraxin-related
ISO
RGD
PMID:21736771 PMID:21736794
RGD:6482316 RGD:6907422
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
G
CRTC2
CREB regulated transcription coactivator 2
ISO
RGD
PMID:23595987
RGD:9685169
NCBI chr 4:95,734,228...95,745,630
Ensembl chr 4:95,734,299...95,745,629
G
CS
citrate synthase
ISO
protein:increased expression:hippocampus protein decreased expression:heart, soleus
RGD
PMID:12077722 PMID:21088877
RGD:329337352 RGD:329337354
NCBI chr 5:21,669,778...21,700,737
Ensembl chr 5:21,666,585...21,700,711
G
CSF1
colony stimulating factor 1
ISO
mRNA,protein:increased expression:retina (rat)
RGD
PMID:19219684
RGD:151665779
NCBI chr 4:110,178,466...110,198,232
Ensembl chr 4:110,178,475...110,197,900
G
CSF1R
colony stimulating factor 1 receptor
ISO
mRNA,protein:increased expression:retina (rat)
RGD
PMID:19219684
RGD:151665779
NCBI chr 2:151,102,138...151,130,311
Ensembl chr 2:151,102,147...151,147,633
G
CTSB
cathepsin B
ISO
protein:decreased activity:glomerulus (rat)
RGD
PMID:10393385
RGD:2315531
NCBI chr14:15,014,139...15,035,081
Ensembl chr14:15,011,711...15,033,877
G
CTSC
cathepsin C
ISO
RGD
PMID:148980
RGD:1599652
NCBI chr 9:21,726,628...21,761,796
Ensembl chr 9:21,722,036...21,761,516
G
CTSL
cathepsin L
ISO
mRNA:increased expression:gastrocnemius muscle (rat)
RGD
PMID:14718385
RGD:1641826
NCBI chr10:27,668,523...27,674,705
Ensembl chr10:27,668,264...27,674,618
G
CX3CL1
C-X3-C motif chemokine ligand 1
ISO
mRNA:increased expression:kidney CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15153757 PMID:20388520
RGD:4891992
NCBI chr 6:19,312,351...19,324,439
G
CX3CR1
C-X3-C motif chemokine receptor 1
ISO
mRNA:increased expression:kidney
RGD
PMID:15153757
RGD:4891992
NCBI chr13:23,944,386...23,957,567
Ensembl chr13:23,944,369...23,957,486
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
mRNA:increased expression:pancreatic islet
RGD
PMID:17372021
RGD:2311360
NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
G
CXCL12
C-X-C motif chemokine ligand 12
ISO
protein:increased expression:retina
RGD
PMID:17878289 PMID:18201529
RGD:2306555 RGD:2306557
NCBI chr14:91,516,383...91,543,857
Ensembl chr14:91,516,431...91,552,752
G
CYBA
cytochrome b-245 alpha chain
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:pancreas: mRNA, protein:increased expression:aorta
CTD RGD
PMID:11812764 PMID:12967931 PMID:20226688 PMID:23905384
RGD:11040693 RGD:2317852
NCBI chr 6:1,015,212...1,021,422
Ensembl chr 6:1,015,162...1,021,420
G
CYP11A1
cytochrome P450 family 11 subfamily A member 1
ISO
mRNA:decreased expression:sciatic nerve (rat)
RGD
PMID:20826654
RGD:4145530
NCBI chr 7:59,172,829...59,188,479
Ensembl chr 7:59,175,758...59,188,478
G
CYP19A2
cytochrome P450 19A2
ISO
protein:decreased expression:ovary, testis (rat)
RGD
PMID:20428845
RGD:4890359
NCBI chr 1:120,652,172...120,695,899
Ensembl chr 1:120,367,667...120,695,899
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
protein:increased expression:liver, microsome (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10711628 PMID:22342832
RGD:2307074
NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
G
CYP27B1
cytochrome P450 family 27 subfamily B member 1
ISO
RGD
PMID:3295473
RGD:2307313
NCBI chr 5:23,053,129...23,058,865
Ensembl chr 5:23,053,892...23,058,470
G
CYP2B6B
cytochrome P450 family 2 subfamily B member 6B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22342832
NCBI chr 6:49,158,175...49,173,872
Ensembl chr 6:49,110,812...49,178,334
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO
mRNA, protein:increased expression:kidney, liver
RGD
PMID:12700423 PMID:19406192
RGD:2313683 RGD:2313685
NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817
G
DBH
dopamine beta-hydroxylase
ISO
mRNA, protein:increased expression:adrenal gland (rat)
RGD
PMID:16396986
RGD:5130724
NCBI chr 1:273,204,407...273,225,562
Ensembl chr 1:273,204,175...273,225,552
G
DCN
decorin
ISO
RGD
PMID:15713786
RGD:2311414
NCBI chr 5:91,678,601...91,713,925
Ensembl chr 5:91,682,658...91,714,235
G
DEFB1
defensin beta 1
ISO
RGD
PMID:16740310
RGD:2312491
G
DHODH
dihydroorotate dehydrogenase (quinone)
ISO
protein:decreased activity:mammary gland (rat)
RGD
PMID:1476792 PMID:1723607
RGD:11040445 RGD:5132591
NCBI chr 6:14,942,898...14,956,000
Ensembl chr 6:14,942,933...14,955,997
G
DPP4
dipeptidyl peptidase 4
ISO
RGD
PMID:19765579
RGD:2313699
NCBI chr15:68,661,764...68,742,961
Ensembl chr15:68,660,521...68,743,663
G
DRD1
dopamine receptor D1
treatment
ISO
protein:decreased activity:striatum (rat)
RGD
PMID:1386820 PMID:20513244
RGD:2311600 RGD:7248621
NCBI chr16:49,189,555...49,193,722
Ensembl chr16:49,189,602...49,191,976
G
DRD2
dopamine receptor D2
ISO
protein:altered activity:hypothalamus, pancreatic islet, brainstem (rat)
RGD
PMID:17174299
RGD:1624999
NCBI chr 9:41,068,618...41,135,262
Ensembl chr 9:41,068,779...41,133,599
G
DUSP1
dual specificity phosphatase 1
ISO
mRNA, protein:decreased expression:ventricle myocardium mRNA:increased expression:retina
RGD
PMID:17063547 PMID:17647144
RGD:2298672 RGD:7771540
NCBI chr16:51,457,924...51,461,095
Ensembl chr16:51,458,020...51,461,086
G
ECE1
endothelin converting enzyme 1
ISO
mRNA:increased expression:thoracic aorta
RGD
PMID:23600389
RGD:7243858
NCBI chr 6:79,408,322...79,465,827
Ensembl chr 6:79,408,326...79,466,152
G
EDN1
endothelin 1
treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:heart, kidney, retina (rat)
CTD RGD
PMID:12458661 PMID:12967931 PMID:18351623 PMID:18516100
RGD:2312288 RGD:2313282
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
G
EDNRA
endothelin receptor type A
ISO
RGD
PMID:20690982
RGD:4892336
NCBI chr 8:81,210,750...81,279,053
Ensembl chr 8:81,209,327...81,276,853
G
EEF2
eukaryotic translation elongation factor 2
treatment
ISO
protein:decreased expression:cardiac muscle:
RGD
PMID:7513958
RGD:10401649
NCBI chr 2:74,746,541...74,756,687
Ensembl chr 2:74,747,080...74,756,680
G
EGFR
epidermal growth factor receptor
ISO
protein:decreased tyrosine phosphorylation:cornea
RGD
PMID:21330660
RGD:5131482
NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
G
ELN
elastin
ISO
mRNA:increased expression:bladder:
RGD
PMID:18279932
RGD:9585725
NCBI chr 3:11,214,194...11,245,891
Ensembl chr 3:11,214,205...11,244,897
G
ENO2
enolase 2
ISO
protein:increased expression:brain
RGD
PMID:15780189
RGD:2293753
NCBI chr 5:63,799,927...63,809,067
Ensembl chr 5:63,799,930...63,809,410
G
ENPP2
ectonucleotide pyrophosphatase/phosphodiesterase 2
ISO
protein:decreased expression:retina:
RGD
PMID:22864860
RGD:9685437
NCBI chr 4:19,319,815...19,433,492
Ensembl chr 4:19,319,810...19,433,488
G
ENTPD1
ectonucleoside triphosphate diphosphohydrolase 1
ISO
protein:enzyme activity:platelet protein,mRNA:increased expression:glial cell, retina:
RGD
PMID:17119848 PMID:18687327
RGD:9685473 RGD:9685486
NCBI chr14:107,263,546...107,390,923
Ensembl chr14:107,263,449...107,389,010
G
EP300
E1A binding protein p300
treatment
ISO
mRNA:increased expression:heart (rat)
RGD
PMID:18351623 PMID:18413674 PMID:18657544 PMID:22228707
RGD:2312263 RGD:2312287 RGD:2312288 RGD:7296926
NCBI chr 5:7,311,165...7,394,515
Ensembl chr 5:7,311,171...7,393,760
G
EPO
erythropoietin
ISO
mRNA:increased expression:Schwann cell:
RGD
PMID:24673486
RGD:11041670
NCBI chr 3:8,620,508...8,622,936
Ensembl chr 3:8,620,508...8,622,936
G
EPOR
erythropoietin receptor
ISO
mRNA:increased expression:Schwann cell:
RGD
PMID:24673486
RGD:11041670
NCBI chr 2:70,063,601...70,068,821
Ensembl chr 2:70,063,519...70,068,821
G
ERCC1
ERCC excision repair 1, endonuclease non-catalytic subunit
treatment
ISO
RGD
PMID:22228707
RGD:7296926
NCBI chr 6:51,783,537...51,808,898
Ensembl chr 6:51,783,478...51,798,984
G
ERCC4
ERCC excision repair 4, endonuclease catalytic subunit
treatment
ISO
RGD
PMID:22228707
RGD:7296926
NCBI chr 3:29,266,234...29,306,109
Ensembl chr 3:29,269,989...29,306,151
G
ESR1
estrogen receptor 1
ISO
protein:decreased expression:vagina,nucleus protein:decreased expression:penis
RGD
PMID:15596216 PMID:16734901
RGD:2306775 RGD:2314014
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
G
ESRRA
estrogen related receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23090186
NCBI chr 2:7,803,504...7,812,868
Ensembl chr 2:7,803,510...7,813,098
G
ETS1
ETS proto-oncogene 1, transcription factor
ISO
protein:increased expression:retina
RGD
PMID:17622743
RGD:2313849
NCBI chr 9:55,377,264...55,512,180
Ensembl chr 9:55,377,266...55,512,115
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
ISO
protein:increased expression:kidney
RGD
PMID:23508046
RGD:9587808
NCBI chr 9:109,384,976...109,450,943
Ensembl chr 9:109,385,015...109,450,941
G
F11R
F11 receptor
ISO
RGD
PMID:18506084
RGD:7488940
NCBI chr 4:89,425,101...89,447,889
Ensembl chr 4:89,425,018...89,449,599
G
F2
coagulation factor II, thrombin
ISO
protein:increased expression:kidney
RGD
PMID:15990447
RGD:2313862
NCBI chr 2:15,793,257...15,819,151
Ensembl chr 2:15,791,455...15,819,137
G
F3
coagulation factor III, tissue factor
ISO
protein:increased activity:kidney
RGD
PMID:15990447
RGD:2313862
NCBI chr 4:122,827,018...122,837,673
Ensembl chr 4:122,826,644...122,837,666
G
F7
coagulation factor VII
ISO
protein:decreased activity:plasma (rat)
RGD
PMID:11474472 PMID:16779662
RGD:2312313 RGD:2312396
NCBI chr11:78,512,389...78,518,668
Ensembl chr11:78,512,137...78,518,668
G
FABP3
fatty acid binding protein 3
ISO
mRNA, protein:decreased expression:aorta
RGD
PMID:7744030
RGD:2307330
NCBI chr 6:87,943,003...87,950,708
Ensembl chr 6:87,942,790...87,951,610
G
FABP4
fatty acid binding protein 4
ISO
protein:decreased expresssion:fat cell
RGD
PMID:9059981
RGD:1625411
NCBI chr 4:55,096,400...55,101,209
Ensembl chr 4:55,096,404...55,101,896
G
FADS1
fatty acid desaturase 1
ISO
RGD
PMID:16099631
RGD:1625413
NCBI chr 2:9,735,425...9,747,405
Ensembl chr 2:9,735,322...9,750,506
G
FAS
Fas cell surface death receptor
onset
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:heart ventricle
CTD RGD
PMID:16123366 PMID:19820199 PMID:20004692
RGD:2314021 RGD:2315698
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FASLG
Fas ligand
ISO
protein:increased expression:heart ventricle
RGD
PMID:19820199
RGD:2314021
NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
G
FBN1
fibrillin 1
ISO
protein:increased expression:renal glomerulus (rat)
RGD
PMID:16380460
RGD:7365080
NCBI chr 1:123,102,011...123,359,649
Ensembl chr 1:123,102,009...123,359,649
G
FGA
fibrinogen alpha chain
ISO
protein:increased expression:plasma (rat)
RGD
PMID:23086277
RGD:9684989
NCBI chr 8:74,574,870...74,584,202
Ensembl chr 8:74,574,882...74,584,202
G
FGF2
fibroblast growth factor 2
ISO
protein:increased expression:vitreous humor
RGD
PMID:10792180 PMID:12663474
RGD:2315880 RGD:8655613
NCBI chr 8:101,278,877...101,344,084
Ensembl chr 8:101,278,885...101,343,916
G
FGF21
fibroblast growth factor 21
treatment
ISO
protein:decreased expression:serum: CTD Direct Evidence: therapeutic
RGD CTD
PMID:23262585 PMID:23499715 PMID:25359298
RGD:10401916 RGD:10401921
NCBI chr 6:54,082,653...54,084,532
Ensembl chr 6:54,080,739...54,084,601
G
FLT1
fms related receptor tyrosine kinase 1
ISO
mRNA:decreased expression:heart mRNA:decreased expression:skeletal muscle
RGD
PMID:16741021 PMID:16816123
RGD:2313724 RGD:2313725
NCBI chr11:5,620,698...5,797,095
Ensembl chr11:5,621,212...5,795,264
G
FN1
fibronectin 1
treatment
ISO
protein:increased expression:kidney
RGD
PMID:22228707 PMID:22937115
RGD:7206838 RGD:7296926
NCBI chr15:117,658,158...117,737,145
Ensembl chr15:117,658,099...117,731,014
G
FOXA2
forkhead box A2
ISO
mRNA:increased expression:kidney cortex
RGD
PMID:19433262
RGD:2312358
NCBI chr17:29,997,397...30,001,704
Ensembl chr17:29,997,401...30,001,707
G
FOXA3
forkhead box A3
ISO
mRNA:increased expression:liver
RGD
PMID:11018767
RGD:2315085
NCBI chr 6:52,181,095...52,188,777
Ensembl chr 6:52,181,114...52,188,774
G
FOXO3
forkhead box O3
ISO
CTD Direct Evidence: marker/mechanism protein:increased phosphorylation, increased expression:glomerulus, cytoplasm: mRNA:decreased expression:liver:
CTD RGD
PMID:12683947 PMID:17082237 PMID:23090186 PMID:23792339
RGD:10402196 RGD:10402199
NCBI chr 1:74,626,673...74,760,323
Ensembl chr 1:74,628,218...74,760,325
G
FOXP3
forkhead box P3
treatment
ISO
mRNA,protein:increased expression: peripheral blood, spleen, lymphoid node
RGD
PMID:18328191 PMID:32341701
RGD:38599142 RGD:38599143
NCBI chr X:43,303,777...43,328,164
Ensembl chr X:43,303,785...43,322,968
G
FUCA1
alpha-L-fucosidase 1
ISO
RGD
PMID:3924473
RGD:2315947
NCBI chr 6:81,638,213...81,655,993
Ensembl chr 6:81,637,994...81,656,068
G
FURIN
furin, paired basic amino acid cleaving enzyme
disease_progression
ISO
protein:decreased expression:kidney
RGD
PMID:16541018
RGD:1582625
NCBI chr 7:53,455,634...53,472,791
Ensembl chr 7:53,460,017...53,472,787
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
treatment
ISO
protein:increased activity:liver, kidney
RGD
PMID:16176150 PMID:27366200
RGD:14695533 RGD:2315960
NCBI chr12:19,965,885...19,975,783
Ensembl chr12:19,965,330...19,975,857
G
G6PD
glucose-6-phosphate dehydrogenase
treatment
ISO
protein:increased expression:lens protein:decreased expression:liver
RGD
PMID:16718375 PMID:19374864 PMID:25116122
RGD:10449121 RGD:2307337 RGD:2307345
NCBI chr X:125,029,147...125,041,040
Ensembl chr X:125,029,150...125,041,040
G
GABBR1
gamma-aminobutyric acid type B receptor subunit 1
ISO
RGD
PMID:2849069
RGD:2315971
NCBI chr 7:22,547,938...22,577,639
Ensembl chr 7:22,540,381...22,578,619
G
GAL
galanin and GMAP prepropeptide
ISO
protein:decreased expression:pancreatic islet
RGD
PMID:7505518 PMID:11489087
RGD:2313740 RGD:2313742
NCBI chr 2:4,351,113...4,357,167
Ensembl chr 2:4,351,113...4,356,647
G
GALP
galanin like peptide
ISO
mRNA:increased expression:arcuate nucleus, pars posterior
RGD
PMID:15256810 PMID:16046316
RGD:2313737 RGD:2313739
NCBI chr 6:60,485,612...60,493,591
Ensembl chr 6:60,485,649...60,493,584
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
treatment
ISO
RGD
PMID:27655796
RGD:13792671
NCBI chr 5:64,129,678...64,135,194
Ensembl chr 5:64,129,679...64,133,991
G
GATA4
GATA binding protein 4
ISO
protein:increased serine phosphorylation:heart
RGD
PMID:22293779
RGD:7207042
NCBI chr14:14,858,470...14,938,156
Ensembl chr14:14,884,662...14,939,941
G
GC
GC vitamin D binding protein
ISO
protein:decreased expression:serum
RGD
PMID:3838933
RGD:2315540
NCBI chr 8:68,326,293...68,360,262
Ensembl chr 8:68,326,299...68,360,262
G
GCG
glucagon
treatment
ISO
RGD
PMID:18996945
RGD:10402370
NCBI chr15:68,800,557...68,810,268
Ensembl chr15:68,800,560...68,810,242
G
GCH1
GTP cyclohydrolase 1
treatment
ISO
protein:increased degradation:heart associated with type 1 diabetes mellitus
RGD
PMID:18061195 PMID:18596126 PMID:27295516
RGD:2314434 RGD:329961323 RGD:401700392
NCBI chr 1:184,201,232...184,264,060
Ensembl chr 1:184,199,679...184,257,315
G
GCNT1
glucosaminyl (N-acetyl) transferase 1
ISO
mRNA:increased expression:heart
RGD
PMID:7560067
RGD:632804
NCBI chr 1:229,429,020...229,602,834
Ensembl chr 1:229,429,066...229,468,268
G
GFPT1
glutamine--fructose-6-phosphate transaminase 1
ISO
protein:decreased expression:epididymal fat pad, liver, skeletal muscle
RGD
PMID:7589852
RGD:2313355
NCBI chr 3:73,028,750...73,086,191
Ensembl chr 3:73,028,804...73,085,319
G
GHR
growth hormone receptor
ISO
RGD
PMID:7964296 PMID:12529387
RGD:11567222 RGD:2307365
NCBI chr16:27,126,300...27,422,618
Ensembl chr16:27,126,734...27,421,449
G
GHRH
growth hormone releasing hormone
treatment
ISO
RGD
PMID:22393012
RGD:10401241
NCBI chr17:40,386,725...40,398,312
Ensembl chr17:40,387,344...40,397,857
G
GHRHR
growth hormone releasing hormone receptor
ISO
RGD
PMID:18285528
RGD:10401258
NCBI chr18:42,030,505...42,046,178
Ensembl chr18:42,030,510...42,046,184
G
GHRL
ghrelin and obestatin prepropeptide
disease_progression
ISO
protein:increased expression:plasma
RGD
PMID:18657539 PMID:23965296
RGD:12905048 RGD:2313750
NCBI chr13:66,442,106...66,453,576
Ensembl chr13:66,445,992...66,452,917
G
GHSR
growth hormone secretagogue receptor
ISO
mRNA:increased expression:Arcuate nucleus :
RGD
PMID:23965296
RGD:12905048
NCBI chr13:110,981,465...111,006,149
Ensembl chr13:110,983,298...111,038,324
G
GIP
gastric inhibitory polypeptide
ISO
mRNA:increased expression:retina (rat)
RGD
PMID:12789546
RGD:2312548
NCBI chr12:25,160,783...25,167,952
Ensembl chr12:25,160,789...25,167,940
G
GIPR
gastric inhibitory polypeptide receptor
ISO
mRNA:increased expression:retina (rat)
RGD
PMID:12789546
RGD:2312548
NCBI chr 6:52,022,667...52,033,959
Ensembl chr 6:52,022,681...52,033,954
G
GJA1
gap junction protein alpha 1
treatment
ISO
protein:decreased expression:retina, blood vessel protein:altered expression:retina: protein:increased expression:dermis
RGD
PMID:20130277 PMID:20609064 PMID:22110070 PMID:22455314
RGD:7207269 RGD:7207415 RGD:7364887 RGD:8662383
NCBI chr 1:40,988,818...41,002,129
Ensembl chr 1:40,988,528...41,002,156
G
GJA5
gap junction protein alpha 5
treatment
ISO
RGD
PMID:20609064
RGD:7207415
NCBI chr 4:99,854,129...99,871,288
Ensembl chr 4:99,854,392...99,871,286
G
GJB2
gap junction protein beta 2
ISO
mRNA,protein:decreased expression:retina:
RGD
PMID:22110070
RGD:7364887
NCBI chr11:774,090...781,252
Ensembl chr11:775,166...775,846
G
GJB6
gap junction protein beta 6
ISO
RGD
PMID:21567444
RGD:7364783
NCBI chr11:793,276...800,109
Ensembl chr11:793,280...800,046
G
GJD3
gap junction protein delta 3
ISO
protein:decreased expression:retina:
RGD
PMID:23385797
RGD:7364769
NCBI chr12:22,040,312...22,044,238
G
GLP1R
glucagon like peptide 1 receptor
ISO
RGD
PMID:10580413
RGD:1624356
NCBI chr 7:34,497,779...34,534,356
Ensembl chr 7:34,497,759...34,534,627
G
GLRX
glutaredoxin
ISO
protein:increase activity:retina:
RGD
PMID:17324929
RGD:9686046
NCBI chr 2:102,425,580...102,437,851
Ensembl chr 2:102,425,580...102,437,858
G
GLUL
glutamate-ammonia ligase
treatment
ISO
mRNA, protein:decreased expression: retina protein:decreased expression:retina
RGD
PMID:21770802 PMID:23284834 PMID:23595285 PMID:25335981 PMID:26677078
RGD:401794412 RGD:401794418 RGD:401794421 RGD:401794423 RGD:401794586
NCBI chr 9:123,751,551...123,762,575
Ensembl chr 9:123,748,380...123,762,545
G
GMPS
guanine monophosphate synthase
ISO
protein:increased activity:liver (rat)
RGD
PMID:3043317
RGD:5135485
NCBI chr13:95,742,342...95,820,903
Ensembl chr13:95,738,659...95,819,759
G
GNAT1
G protein subunit alpha transducin 1
ISO
protein:decreased expression:retina
RGD
PMID:15939031
RGD:1600001
NCBI chr13:32,671,377...32,678,394
Ensembl chr13:32,671,432...32,678,391
G
GNAT3
G protein subunit alpha transducin 3
ISO
mRNA, protein;increased expression:taste bud
RGD
PMID:18824257
RGD:2302147
NCBI chr 9:99,848,406...99,910,236
Ensembl chr 9:99,859,691...99,911,158
G
GP91-PHOX
NADPH oxidase heavy chain subunit
ISO
mRNA:increased expression:aorta mRNA:increased expression:cerebral cortex;associated with reperfusion injury CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11157681 PMID:15148062 PMID:19478208
RGD:1599683 RGD:1599691
NCBI chr X:33,654,656...33,678,346
Ensembl chr X:33,643,648...33,680,580
G
GPAM
glycerol-3-phosphate acyltransferase, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9452481
NCBI chr14:122,538,600...122,582,390
Ensembl chr14:122,538,603...122,579,148
G
GPD2
glycerol-3-phosphate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr15:63,592,723...63,728,636
Ensembl chr15:63,619,762...63,728,633
G
GPX1
glutathione peroxidase 1
treatment
ISO
protein:increased expression:liver protein:increased expression:glomerulus CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15039483 PMID:16123366 PMID:18387670 PMID:19229592 PMID:25744399
RGD:11353782 RGD:2306161 RGD:2306606 RGD:2306607
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433
G
GPX3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:12753302 PMID:16651743 PMID:23407453 PMID:32546886
RGD:2312629 RGD:2312631 RGD:401827857 RGD:401827917
NCBI chr16:71,980,467...71,989,011
Ensembl chr16:71,980,475...71,989,026
G
GRIN1
glutamate ionotropic receptor NMDA type subunit 1
treatment
ISO
RGD
PMID:23595285
RGD:401794586
G
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
ISO
mRNA, protein:increased expression:cerebellum (rat)
RGD
PMID:20056114
RGD:4107025
NCBI chr 5:58,477,862...58,948,735
Ensembl chr 5:58,480,528...58,927,558
G
GRK1
G protein-coupled receptor kinase 1
ISO
protein:increased expression:retina
RGD
PMID:15939031
RGD:1600001
NCBI chr11:78,793,670...78,803,291
Ensembl chr11:78,793,777...78,804,262
G
GSK3A
glycogen synthase kinase 3 alpha
treatment
ISO
RGD
PMID:8526919
RGD:10401824
NCBI chr 6:49,690,319...49,700,735
Ensembl chr 6:49,690,370...49,701,189
G
GSR
glutathione-disulfide reductase
treatment
ISO
protein:decreased activity:plasma: CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20187988 PMID:20620209 PMID:25050809
RGD:10401889 RGD:7257587
NCBI chr15:54,382,564...54,433,989
Ensembl chr15:54,382,567...54,433,984
G
GSTA4
glutathione S-transferase alpha 4
ISO
protein:increased expression:pancreas, kidney, liver (rat)
RGD
PMID:14693714
RGD:5687773
NCBI chr 7:46,635,903...46,656,491
Ensembl chr 7:46,635,902...46,656,450
G
GUK1
guanylate kinase 1
ISO
protein:decreased expression:retina (rat)
RGD
PMID:17465459
RGD:5147874
NCBI chr 2:51,247,665...51,257,481
Ensembl chr 2:51,241,952...51,257,485
G
H6PD
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
ISO
RGD
PMID:20923496
RGD:6784507
NCBI chr 6:69,666,348...69,700,303
Ensembl chr 6:69,666,601...69,700,298
G
HADH
hydroxyacyl-CoA dehydrogenase
ISO
RGD
PMID:7050060
RGD:2302232
NCBI chr 8:113,952,561...114,005,510
Ensembl chr 8:113,950,034...114,005,511
G
HADHA
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
protein:decreased expression:brain
RGD
PMID:25260493
RGD:10047114
NCBI chr 3:112,753,343...112,797,627
Ensembl chr 3:112,752,865...112,797,733
G
HCN1
hyperpolarization activated cyclic nucleotide gated potassium channel 1
ISO
protein:increased expression:neuron:
RGD
PMID:19815055
RGD:9693680
NCBI chr16:29,439,294...29,808,855
Ensembl chr16:29,439,264...29,808,993
G
HCN2
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
ISO
protein:increased expression:neuron:
RGD
PMID:19815055
RGD:9693680
NCBI chr 2:77,708,159...77,730,881
Ensembl chr 2:77,708,162...77,730,881
G
HCN3
hyperpolarization activated cyclic nucleotide gated potassium channel 3
ISO
protein:increased expression:neuron:
RGD
PMID:19815055
RGD:9693680
NCBI chr 4:94,545,919...94,560,105
Ensembl chr 4:94,547,416...94,560,106
G
HDAC1
histone deacetylase 1
ISO
protein:increased activity:renal cortex:
RGD
PMID:19553350
RGD:9590229
NCBI chr 6:88,749,611...88,785,220
Ensembl chr 6:88,749,634...88,785,411
G
HDAC2
histone deacetylase 2
ISO
protein:increased activity:renal cortex:
RGD
PMID:19553350
RGD:9590229
NCBI chr 1:79,867,713...79,901,597
Ensembl chr 1:79,863,094...79,901,585
G
HDAC4
histone deacetylase 4
ISO
protein:increased activity:renal cortex:
RGD
PMID:19553350
RGD:9590229
NCBI chr15:138,378,237...138,657,266
Ensembl chr15:138,381,635...138,614,301
G
HGF
hepatocyte growth factor
ISO
protein:increased expression:kidney
RGD
PMID:16297324
RGD:2313568
NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ISO
protein:increased expression:sciatic nerve (rat)
RGD
PMID:15663958
RGD:8694461
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
G
HK1
hexokinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr14:72,383,328...72,460,927
Ensembl chr14:72,351,246...72,460,924
G
HMBS
hydroxymethylbilane synthase
ISO
protein:decreased activity:liver (rat)
RGD
PMID:6688350
RGD:4144808
NCBI chr 9:46,300,039...46,308,681
Ensembl chr 9:46,300,050...46,308,868
G
HMGB1
high mobility group box 1
ISO
protein:increased expression, altered localization:retina, cytoplasm associated with Endotoxemia;protein:increased expression:serum
RGD
PMID:19959191 PMID:23261684
RGD:10402069 RGD:2316737
NCBI chr11:7,195,556...7,321,071
G
HMGCL
3-hydroxy-3-methylglutaryl-CoA lyase
ISO
protein:increased activity:liver (rat)
RGD
PMID:5667251
RGD:2326171
NCBI chr 6:81,611,516...81,630,454
Ensembl chr 6:81,611,422...81,630,429
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:15111316
RGD:2313760
NCBI chr 2:84,380,245...84,401,117
Ensembl chr 2:84,380,224...84,402,957
G
HMGCS1
3-hydroxy-3-methylglutaryl-CoA synthase 1
ISO
protein:increased expression:pancreas
RGD
PMID:18452227
RGD:2302233
NCBI chr16:27,936,225...27,957,261
Ensembl chr16:27,936,218...27,957,193
G
HMOX1
heme oxygenase 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:15734859 PMID:16123366 PMID:16959961 PMID:18375438 PMID:19804535
RGD:1582713
G
HNF4A
hepatocyte nuclear factor 4 alpha
ISO
protein:increased expression:liver: mRNA:decreased expression:kidney, liver
RGD
PMID:18184923 PMID:19179483
RGD:12904769 RGD:2301838
NCBI chr17:46,783,772...46,847,505
Ensembl chr17:46,783,777...46,847,500
G
HNRNPA2B1
heterogeneous nuclear ribonucleoprotein A2/B1
ISO
protein:increased expression:urinary bladder (rat)
RGD
PMID:18337374
RGD:9685410
NCBI chr18:46,205,164...46,215,861
Ensembl chr18:46,205,418...46,215,856
G
HNRNPK
heterogeneous nuclear ribonucleoprotein K
treatment
ISO
RGD
PMID:16837467
RGD:10002795
NCBI chr10:30,975,639...30,987,955
Ensembl chr10:30,975,702...30,987,956
G
HP
haptoglobin
ISO
protein:increased expression:serum
RGD
PMID:11072799
RGD:1626381
NCBI chr 6:14,980,382...14,985,245
G
HPRT1
hypoxanthine phosphoribosyltransferase 1
ISO
protein:decreased activity:liver (rat)
RGD
PMID:3043317
RGD:5135485
NCBI chr X:110,321,144...110,357,902
Ensembl chr X:110,321,204...110,357,894
G
HRAS
HRas proto-oncogene, GTPase
ISO
mRNA, protein:increased expression:retina blood vessel
RGD
PMID:18514235
RGD:2314841
NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14697232
NCBI chr 9:133,231,451...133,278,396
Ensembl chr 9:133,231,451...133,278,396
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:21104931
RGD:5686396
G
HSPD1
heat shock protein family D (Hsp60) member 1
ISO
RGD
PMID:17280490
RGD:1624229
NCBI chr15:101,360,355...101,373,498
Ensembl chr15:101,360,094...101,373,526
G
HSPG2
heparan sulfate proteoglycan 2
ISO
mRNA:decreased expression:retina
RGD
PMID:9068943
RGD:1624265
NCBI chr 6:79,849,691...79,958,283
Ensembl chr 6:79,849,698...79,958,334
G
HTR2A
5-hydroxytryptamine receptor 2A
ISO
protein:increased expression:lung
RGD
PMID:21521772
RGD:5135278
NCBI chr11:20,555,939...20,620,225
Ensembl chr11:20,555,963...20,619,625
G
IAPP
islet amyloid polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 5:52,046,570...52,051,475
Ensembl chr 5:52,046,573...52,050,446
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:aorta protein:increased expression:serum
CTD RGD
PMID:14871415 PMID:18093596 PMID:18413153 PMID:20136425 PMID:20388520 PMID:24513509 More...
RGD:2306987 RGD:2306988 RGD:8547703
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
ID1
inhibitor of DNA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr17:35,316,518...35,317,742
Ensembl chr17:35,316,514...35,317,736
G
IDE
insulin degrading enzyme
ISO
protein:decreased expression:cerebral cortex
RGD
PMID:29940507
RGD:13792791
NCBI chr14:103,992,035...104,106,571
Ensembl chr14:103,992,039...104,106,576
G
IFNAR1
interferon alpha and beta receptor subunit 1
ISO
RGD
PMID:27999109
RGD:12910492
NCBI chr13:196,925,731...196,951,398
Ensembl chr13:196,925,734...196,952,239
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:retina mRNA:increased expression:pancreas
CTD RGD
PMID:18789669 PMID:20213480 PMID:21340626
RGD:2311492 RGD:5147915
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IGF1
insulin like growth factor 1
ISO
protein:decreased expression:oviduct CTD Direct Evidence: therapeutic protein:decreased expression:cerebellum, serum protein:decreased expression:heart mRNA,protein:decreased expression:corpus cavernosum:
RGD CTD
PMID:18676006 PMID:19382144 PMID:20555424 PMID:22133301 PMID:24632065
RGD:10046054 RGD:2306671 RGD:2311502 RGD:4142788
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein:decreased expression:oviduct protein:decreased phosphorylation:heart
RGD
PMID:18676006 PMID:20555424
RGD:2311502 RGD:4142788
NCBI chr 1:137,383,623...137,691,038
Ensembl chr 1:137,387,825...137,691,058
G
IGF2
insulin like growth factor 2
treatment
ISO
protein:increased expression:multiple DNA, mRNA:hypermethylation, decreased expression mRNA:decreased expression:brain protein:increased expression:oviduct
RGD
PMID:10686593 PMID:17184497 PMID:18676006 PMID:18724775 PMID:23364485
RGD:10402565 RGD:2311502 RGD:2311511 RGD:2311513 RGD:5509973
NCBI chr 2:1,469,183...1,496,417
G
IGF2R
insulin like growth factor 2 receptor
ISO
protein:increased expression:oviduct
RGD
PMID:18676006
RGD:2311502
NCBI chr 1:7,369,485...7,472,480
Ensembl chr 1:7,368,103...7,472,548
G
IGFBP3
insulin like growth factor binding protein 3
treatment
ISO
mRNA, protein:increased expression:penis protein:increased expression:skeletal muscle
RGD
PMID:16180585 PMID:18068478 PMID:25582342
RGD:12743617 RGD:2289159 RGD:2313766
NCBI chr18:50,002,921...50,009,425
Ensembl chr18:50,003,022...50,010,690
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
ISO
protein:increased phosphorylation:liver
RGD
PMID:20362663
RGD:7495777
NCBI chr17:11,289,607...11,348,557
Ensembl chr17:11,289,690...11,348,549
G
IL10
interleukin 10
ISO
protein:increase expression:serum
RGD
PMID:18779928 PMID:18787467
RGD:2308945 RGD:2308946
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL17A
interleukin 17A
ISO
protein:increased expression:gingiva (rat)
RGD
PMID:21826658
RGD:9068940
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
G
IL1A
interleukin 1 alpha
ISO
protein:increased expression:heart
RGD
PMID:20555424
RGD:4142788
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,119
G
IL1RN
interleukin 1 receptor antagonist
ISO
human gene in a rat model
RGD
PMID:8037760 PMID:17221214 PMID:19545727
RGD:6907397 RGD:6907425 RGD:8551855
G
IL2
interleukin 2
ISO
protein:increased expression:retina
RGD
PMID:20213480
RGD:5147915
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
IL2RA
interleukin 2 receptor subunit alpha
ISO
RGD
PMID:18503494
RGD:2311530
NCBI chr10:64,948,149...65,001,320
Ensembl chr10:64,948,563...65,001,142
G
IL4
interleukin 4
treatment
ISO
RGD
PMID:25191525
RGD:10402795
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
G
IL4R
interleukin 4 receptor
ISO
RGD
PMID:12165974
RGD:4889983
NCBI chr 3:19,526,343...19,576,792
Ensembl chr 3:19,523,564...19,576,544
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:extracellular space (rat) protein:increased expression:heart protein:increased expression:blood
CTD RGD
PMID:18976114 PMID:19328014 PMID:20555424 PMID:22138235 PMID:24582317
RGD:11049554 RGD:2306984 RGD:2307252 RGD:4142788
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
INSIG1
insulin induced gene 1
ISO
RGD
PMID:16327801
RGD:2308858
NCBI chr18:2,885,494...2,898,758
Ensembl chr18:2,885,612...2,898,767
G
INSR
insulin receptor
disease_progression treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver nuclei, liver cell membrane (rat) protein:altered activity:liver plasma membrane mRNA, protein:increased expression:liver, adipose tissue (rat) protein:decreased expression:kidney protein:decreased expression:erythrocyte (rat)
CTD RGD
PMID:1280238 PMID:2180315 PMID:9243097 PMID:17855644 PMID:18376071 PMID:18638371 PMID:22138235 PMID:23874448 More...
RGD:10403045 RGD:14981592 RGD:15036814 RGD:2290475 RGD:2307025 RGD:2307339
NCBI chr 2:71,797,209...71,939,923
Ensembl chr 2:71,797,204...71,936,104
G
IRS1
insulin receptor substrate 1
treatment
ISO
mRNA, protein:decreased expression:multiple CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:22138235 PMID:22820932 PMID:22983684
RGD:7207061 RGD:7207063
NCBI chr15:128,245,846...128,307,321
Ensembl chr15:128,245,846...128,307,284
G
IRS2
insulin receptor substrate 2
ISO
CTD Direct Evidence: marker/mechanism protein:decreased phosphorylation:heart
CTD RGD
PMID:20555424 PMID:25808216
RGD:4142788
NCBI chr11:76,626,158...76,654,639
Ensembl chr11:76,626,179...76,653,881
G
ISG15
ISG15 ubiquitin like modifier
ISO
RGD
PMID:20973890
RGD:5490977
NCBI chr 6:63,363,201...63,364,211
Ensembl chr 6:63,363,173...63,364,208
G
ITGA3
integrin subunit alpha 3
ISO
protein:decreased expression:renal cortex (rat)
RGD
PMID:20525748
RGD:2325818
NCBI chr12:26,234,769...26,269,327
Ensembl chr12:26,235,258...26,269,324
G
ITGB1
integrin subunit beta 1
ISO
protein:decreased expression:epidermal stem cell (rat)
RGD
PMID:20187441
RGD:2325322
NCBI chr10:56,078,393...56,130,608
Ensembl chr10:56,078,396...56,173,326
G
ITGB3
integrin subunit beta 3
ISO
protein:increased expression:aorta:
RGD
PMID:12606526
RGD:8693385
NCBI chr12:16,694,466...16,752,228
Ensembl chr12:16,693,514...16,752,292
G
JAK3
Janus kinase 3
ISO
protein:increased expression:retina
RGD
PMID:21575160
RGD:11533943
NCBI chr 2:59,905,901...59,926,504
Ensembl chr 2:59,905,919...59,926,495
G
KCNA2
potassium voltage-gated channel subfamily A member 2
ISO
RGD
PMID:17982915
RGD:7242761
NCBI chr 4:109,534,923...109,570,172
Ensembl chr 4:109,557,973...109,560,998
G
KCNA5
potassium voltage-gated channel subfamily A member 5
ISO
RGD
PMID:17982915
RGD:7242761
NCBI chr 5:65,439,336...65,442,207
Ensembl chr 5:65,439,336...65,442,207
G
KCNE2
potassium voltage-gated channel subfamily E regulatory subunit 2
ISO
mRNA:decreased expression:left heart ventricle
RGD
PMID:19267230
RGD:7243942
NCBI chr13:197,979,749...197,980,974
Ensembl chr13:197,980,145...197,980,516
G
KCNJ11
potassium inwardly rectifying channel subfamily J member 11
ISO
protein:decreased expression:brain CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16123366 PMID:23785408
RGD:7296920
NCBI chr 2:41,756,637...41,760,340
Ensembl chr 2:41,757,356...41,765,555
G
KCNMA1
potassium calcium-activated channel subfamily M alpha 1
ISO
mRNA, protein:decreased expression:aorta, smooth muscle
RGD
PMID:24589593
RGD:10412030
NCBI chr14:79,345,382...80,106,337
Ensembl chr14:79,352,005...80,106,295
G
KCNMB1
potassium calcium-activated channel subfamily M regulatory beta subunit 1
ISO
protein:decreased expression:aorta, smooth muscle
RGD
PMID:24589593
RGD:10412030
NCBI chr16:53,616,532...53,631,197
Ensembl chr16:53,618,603...53,631,195
G
KCNN4
potassium calcium-activated channel subfamily N member 4
ameliorates
ISO
mRNA, protein:increased expression:aorta, smooth muscle
RGD
PMID:24589593 PMID:29167619
RGD:10412030 RGD:401784495
NCBI chr 6:50,580,016...50,593,518
Ensembl chr 6:50,580,022...50,593,544
G
KDM6A
lysine demethylase 6A
ISO
RGD
PMID:31266808
RGD:151665138
NCBI chr X:39,953,764...40,154,197
Ensembl chr X:39,953,814...40,154,029
G
KDR
kinase insert domain receptor
ISO
mRNA:decreased expression:heart mRNA:decreased expression:skeletal muscle mRNA:increased expression:retina
RGD
PMID:16741021 PMID:16816123 PMID:22121831
RGD:2313724 RGD:2313725 RGD:5684538
NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
G
KHK
ketohexokinase
ISO
RGD
PMID:6088170
RGD:2302253
NCBI chr 3:112,021,163...112,031,615
Ensembl chr 3:112,021,108...112,031,620
G
KIF1A
kinesin family member 1A
ISO
mRNA:increased expression:hippocampus
RGD
PMID:23776493
RGD:11059542
NCBI chr15:139,610,624...139,694,841
Ensembl chr15:139,610,627...139,694,826
G
KIF5B
kinesin family member 5B
ISO
mRNA:increased expression:hippocampus
RGD
PMID:23776493
RGD:11059542
NCBI chr10:42,637,105...42,693,551
Ensembl chr10:42,637,109...42,693,491
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
ISO
protein:increased expression:pancreas
RGD
PMID:17235568
RGD:2311225
NCBI chr 8:41,402,334...41,492,306
Ensembl chr 8:41,402,043...41,493,734
G
KLK1
kallikrein 1
ISO
mRNA:decreased expression:myocardium
RGD
PMID:10604522
RGD:1641812
NCBI chr 6:55,570,632...55,576,398
Ensembl chr 6:55,570,635...55,576,636
G
KMT5C
lysine methyltransferase 5C
ISO
mRNA:increased expression:retina
RGD
PMID:21357467
RGD:9586742
NCBI chr 6:59,517,058...59,524,551
Ensembl chr 6:59,517,098...59,524,550
G
LCN2
lipocalin 2
ISO
mRNA:increased expression:retina (rat) protein:increased expression:urine
RGD
PMID:15623795 PMID:23085980
RGD:2316515 RGD:7245484
NCBI chr 1:268,609,975...268,614,651
Ensembl chr 1:268,609,887...268,614,644
G
LDLR
low density lipoprotein receptor
ISO
mRNA:decreased expression:liver
RGD
PMID:18054320
RGD:2324626
NCBI chr 2:69,828,348...69,864,823
Ensembl chr 2:69,828,332...69,864,827
G
LEP
leptin
onset
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19428774 PMID:19491210 PMID:20695765 PMID:28242381 PMID:31313498 PMID:31483951 More...
RGD:2311124 RGD:2311126 RGD:5128579
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
G
LEPR
leptin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15093691 PMID:16427799 PMID:17065336 PMID:19452630 PMID:19478208 PMID:20567778 PMID:22933112 PMID:24263156 PMID:26939912 PMID:27151219 PMID:30635400 PMID:35472412 PMID:36066211 More...
NCBI chr 6:146,802,297...146,896,152
Ensembl chr 6:146,801,954...146,895,995
G
LGALS3
galectin 3
treatment
ISO
RGD
PMID:21249158
RGD:9685210
NCBI chr 1:184,478,639...184,496,155
Ensembl chr 1:184,478,710...184,497,951
G
LIPC
lipase C, hepatic type
ISO
protein:decreased activity:liver (rat)
RGD
PMID:1868959 PMID:18758746
RGD:2307432 RGD:2308849
NCBI chr 1:113,433,684...113,604,139
Ensembl chr 1:113,433,687...113,583,963
G
LITAF
lipopolysaccharide induced TNF factor
ISO
protein:increased expression:retina
RGD
PMID:21575160
RGD:11533943
NCBI chr 3:31,482,605...31,576,211
Ensembl chr 3:31,482,353...31,579,082
G
LOC100518330
serotonin N-acetyltransferase
ISO
RGD
PMID:18624957
RGD:2301030
NCBI chr12:5,042,897...5,047,626
Ensembl chr12:5,042,897...5,044,505
G
LOC100625897
lactase-phlorizin hydrolase
ISO
RGD
PMID:16021836
RGD:1600251
NCBI chr15:16,094,277...16,154,467
G
LOC110256000
membrane primary amine oxidase-like
ISO
protein:increased expression:kidney, serum CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:2218072 PMID:12606817 PMID:14977883 PMID:19635478
RGD:2313819 RGD:2313824 RGD:2313828
NCBI chr12:19,996,324...20,007,006
G
LOC110258578
interleukin-1 beta-like
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:skeletal muscle
CTD RGD
PMID:12123627 PMID:17669395 PMID:23197974
RGD:1626620 RGD:7175529
G
LOC110260333
hydroxymethylglutaryl-CoA synthase, mitochondrial-like
ISO
protein:increased expression:liver (rat)
RGD
PMID:7902069
RGD:2326135
NCBI chr 4:101,385,486...101,404,273
Ensembl chr 4:101,385,512...101,443,405
G
LPIN1
lipin 1
ISO
mRNA:increased expression:skeletal muscle
RGD
PMID:14718385
RGD:1641826
NCBI chr 3:124,940,557...125,074,137
Ensembl chr 3:124,940,561...125,074,122
G
LPL
lipoprotein lipase
treatment
ISO
RGD
PMID:18780778 PMID:27158912
RGD:13794379 RGD:2313303
NCBI chr14:4,104,761...4,134,964
Ensembl chr14:4,104,772...4,135,814
G
LRP2
LDL receptor related protein 2
ISO
protein:decreased expression:kidney, proximal convoluted tubule, apical plasma membrane
RGD
PMID:11685557
RGD:1641843
NCBI chr15:75,565,299...75,754,604
Ensembl chr15:75,565,303...75,716,694
G
LTBP1
latent transforming growth factor beta binding protein 1
ISO
RGD
PMID:17574405
RGD:2302087
NCBI chr 3:106,300,748...106,724,538
Ensembl chr 3:106,300,750...106,724,737
G
MAFA
MAF bZIP transcription factor A
treatment
ISO
RGD
PMID:28487936
RGD:13506743
NCBI chr 4:1,090,018...1,093,600
Ensembl chr 4:1,091,263...1,092,818
G
MAP2K3
mitogen-activated protein kinase kinase 3
ISO
mRNA:increased expression:kidney, glomerulus
RGD
PMID:11473637
RGD:7495813
NCBI chr12:61,396,337...61,417,333
Ensembl chr12:61,396,369...61,417,321
G
MAP2K6
mitogen-activated protein kinase kinase 6
ISO
mRNA:increased expression:kidney, glomerulus
RGD
PMID:11473637
RGD:7495813
NCBI chr12:10,891,445...11,018,617
Ensembl chr12:10,894,966...11,018,641
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18342293
NCBI chr 1:27,380,143...27,600,500
Ensembl chr 1:27,380,142...27,600,493
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
ISO
protein:increased activity:serum:
RGD
PMID:28724746
RGD:151356966
NCBI chr10:40,714,004...40,746,390
Ensembl chr10:40,713,847...40,742,462
G
MAPK1
mitogen-activated protein kinase 1
ISO
protein:decreased phosphorylation:cornea
RGD
PMID:21330660 PMID:22045654
RGD:5131482 RGD:7243969
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
ISO
protein:decreased phosphorylation:cornea
RGD
PMID:21330660
RGD:5131482
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MAPT
microtubule associated protein tau
treatment
ISO
RGD
PMID:28400135
RGD:13800903
NCBI chr12:17,098,259...17,211,483
Ensembl chr12:17,095,587...17,211,373
G
MAS1
MAS1 proto-oncogene, G protein-coupled receptor
ISO
mRNA:increased expression:renal cortex (rat)
RGD
PMID:18679036
RGD:2313799
NCBI chr 1:7,527,566...7,542,110
Ensembl chr 1:7,527,861...7,528,838
G
MBP
myelin basic protein
ISO
RGD
PMID:23667870
RGD:7327197
NCBI chr 1:147,649,516...147,685,289
Ensembl chr 1:147,590,865...147,685,290
G
MDM2
MDM2 proto-oncogene
ISO
protein:increased degradation:myocardium
RGD
PMID:23530877
RGD:10412313
NCBI chr 5:33,105,717...33,137,602
Ensembl chr 5:33,105,759...33,137,739
G
MEF2A
myocyte enhancer factor 2A
ISO
mRNA:increased expression:heart
RGD
PMID:18413674
RGD:2312263
NCBI chr 1:138,398,270...138,508,639
Ensembl chr 1:138,341,158...138,511,314
G
MEF2C
myocyte enhancer factor 2C
ISO
mRNA:increased expression:heart
RGD
PMID:18413674
RGD:2312263
NCBI chr 2:96,122,407...96,296,927
Ensembl chr 2:96,124,168...96,296,810
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
mRNA, protein:increased expression:kidney, tubule, epithelium (rat)
RGD
PMID:8997394
RGD:2317555
NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512
G
MFGE8
milk fat globule EGF and factor V/VIII domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21505870
NCBI chr 7:54,539,970...54,554,885
Ensembl chr 7:54,539,970...54,571,747
G
MFN2
mitofusin 2
treatment
ISO
protein:increased expression:heart, mitochondrion (rat)
RGD
PMID:27998959 PMID:28483572
RGD:12910731 RGD:12910739
NCBI chr 6:72,026,512...72,056,439
Ensembl chr 6:72,028,499...72,056,438
G
MIF
macrophage migration inhibitory factor
ISO
protein:increased expression:pancreatic islet
RGD
PMID:15790730
RGD:1641951
NCBI chr14:49,840,303...49,841,063
Ensembl chr14:49,840,305...49,841,068
G
MMP1
matrix metallopeptidase 1
ISO
protein:increased expression:periodontal ligament, alveolar bone of mandible (rat)
RGD
PMID:20082587
RGD:7207377
NCBI chr 9:33,411,738...33,420,205
Ensembl chr 9:33,411,065...33,420,076
G
MMP2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21963884
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
G
MMP9
matrix metallopeptidase 9
treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:retina protein:increased expression:kidney
RGD CTD
PMID:17569353 PMID:21963884 PMID:22191573 PMID:23089644 PMID:23423566
RGD:2290354 RGD:8547881 RGD:8547974
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
MPO
myeloperoxidase
ISO
protein:increased activity:liver: CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18436980 PMID:20388520
RGD:2317971
NCBI chr12:34,557,031...34,570,091
Ensembl chr12:34,556,408...34,567,904
G
MT-CO2
mitochondrially encoded cytochrome c oxidase II
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr MT:8,203...8,890
Ensembl chr MT:8,203...8,890
G
MT-CYB
mitochondrially encoded cytochrome b
ISO
mRNA:decreased expression:heart
RGD
PMID:15126286
RGD:1578536
NCBI chr MT:15,342...16,481
Ensembl chr MT:15,342...16,481
G
MT-ND1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr MT:3,922...4,876
Ensembl chr MT:3,922...4,876
G
MTHFR
methylenetetrahydrofolate reductase
ISO
protein:decreased activity:kidney (rat)
RGD
PMID:9836532
RGD:6893689
NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,637...71,881,820
G
MTOR
mechanistic target of rapamycin kinase
ISO
protein:hyperphosphorylation:muscle
RGD
PMID:28536139
RGD:13506787
NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
G
MTR
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
protein:decreased activity:liver
RGD
PMID:18936199
RGD:7207081
NCBI chr14:54,546,978...54,652,780
Ensembl chr14:54,546,978...54,652,763
G
MYC
MYC proto-oncogene, bHLH transcription factor
ISO
mRNA:increased expression:renal cortex (rat)
RGD
PMID:18030501
RGD:7207459
NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078
G
NAMPT
nicotinamide phosphoribosyltransferase
ISO
protein:decreased expression:fat cell
RGD
PMID:18410550
RGD:2311099
NCBI chr 9:106,119,896...106,162,126
Ensembl chr 9:106,119,899...106,294,586
G
NCF1
neutrophil cytosolic factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14871415 PMID:16380483
NCBI chr 3:11,820,367...11,834,394
Ensembl chr 3:11,820,266...11,839,354
G
NCF2
neutrophil cytosolic factor 2
ISO
protein:altered localization:glomerulus protein:increased expression:heart, membrane fraction
RGD
PMID:14514646 PMID:18061195
RGD:2314434 RGD:2314451
NCBI chr 9:124,776,516...124,813,358
Ensembl chr 9:124,776,534...124,812,923
G
NDUFS2
NADH:ubiquinone oxidoreductase core subunit S2
ISO
protein:decreased expression:dorsal root ganglia (rat)
RGD
PMID:20876714
RGD:6484699
NCBI chr 4:89,246,958...89,257,090
Ensembl chr 4:89,246,960...89,257,085
G
NDUFS3
NADH:ubiquinone oxidoreductase core subunit S3
ISO
mRNA, protein:decreased expression:brain protein:decreased expression:dorsal root ganglia (rat)
RGD
PMID:20876714 PMID:22387129
RGD:13824971 RGD:6484699
NCBI chr 2:15,031,147...15,036,880
Ensembl chr 2:15,031,149...15,036,880
G
NEFH
neurofilament heavy chain
treatment
ISO
RGD
PMID:12941778
RGD:9698428
NCBI chr14:46,559,698...46,568,686
Ensembl chr14:46,559,860...46,568,088
G
NEFM
neurofilament medium chain
treatment
ISO
RGD
PMID:12941778
RGD:9698428
NCBI chr14:8,955,346...8,967,211
G
NEUROD1
neuronal differentiation 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr15:87,175,629...87,179,953
Ensembl chr15:87,175,765...87,179,959
G
NEUROG3
neurogenin 3
ISO
RGD
PMID:19819964
RGD:2313774
NCBI chr14:72,604,203...72,606,362
Ensembl chr14:72,604,467...72,606,360
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
protein:increased localization:blood, mononuclear cell, nucleus
RGD
PMID:22869588 PMID:23331247 PMID:24740568
RGD:10412694 RGD:10412720 RGD:7244270
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
G
NFKB2
nuclear factor kappa B subunit 2
ISO
RGD
PMID:18633731
RGD:2298775
NCBI chr14:113,406,412...113,414,177
Ensembl chr14:113,406,004...113,414,169
G
NFKBIA
NFKB inhibitor alpha
treatment
ISO
protein:decreased expression:kidney
RGD
PMID:20188823 PMID:22483164
RGD:10413864 RGD:10413873
NCBI chr 7:64,508,119...64,510,754
Ensembl chr 7:64,507,822...64,511,277
G
NGF
nerve growth factor
treatment
ISO
mRNA, protein:decreased expression:sciatic nerve protein:decreased processing:hippocampus protein:increased expression:retina
RGD
PMID:19149268 PMID:21136036 PMID:25728260 PMID:26282349
RGD:2303795 RGD:402463971 RGD:402463972 RGD:5144144
NCBI chr 4:105,256,691...105,307,843
Ensembl chr 4:105,256,749...105,307,837
G
NGFR
nerve growth factor receptor
ISO
protein:increased expression:retina protein:decreased expression:telencephalon
RGD
PMID:21136036 PMID:26282349
RGD:402463971 RGD:5144144
NCBI chr12:25,699,410...25,720,355
Ensembl chr12:25,699,427...25,720,356
G
NKX6-1
NK6 homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 8:134,137,064...134,143,524
Ensembl chr 8:134,138,097...134,144,254
G
NOS1
nitric oxide synthase 1
ISO
protein:decreased dimerization:stomach
RGD
PMID:17347455
RGD:1642144
NCBI chr14:35,112,898...35,299,297
Ensembl chr14:35,113,184...35,295,944
G
NOS2
nitric oxide synthase 2
no_association
ISO
associated with Infarction, Middle Cerebral Artery; protein:increased expression:brain (rat) CTD Direct Evidence: marker/mechanism protein:increased expression:renal glomerulus (rat)
RGD CTD
PMID:9349594 PMID:16380483 PMID:16959961 PMID:21993016
RGD:5509105 RGD:5509107
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
G
NOS3
nitric oxide synthase 3
treatment
ISO
protein:decreased expression:thoracic aorta (mouse) protein:increased expression:heart CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11696579 PMID:14871415 PMID:15490108 PMID:16959961 PMID:18266981 PMID:18287592 PMID:18825362 PMID:19478208 PMID:21050844 PMID:22191573 PMID:22933112 PMID:28976888 More...
RGD:13450939 RGD:2292100 RGD:4892007 RGD:7777108
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
G
NOX4
NADPH oxidase 4
ISO
protein:increased expression:aorta
RGD
PMID:19686728
RGD:2324658
NCBI chr 9:22,622,105...22,776,691
Ensembl chr 9:22,624,212...22,776,534
G
NPC1L1
NPC1 like intracellular cholesterol transporter 1
ISO
mRNA:increased expression:intestine, liver
RGD
PMID:17292734
RGD:1642185
NCBI chr18:50,726,854...50,757,676
Ensembl chr18:50,726,922...50,757,649
G
NPPA
natriuretic peptide A
ISO
protein:increased expression:plasma, kidney, heart; protein:decreased expression:retina
RGD
PMID:15789000 PMID:17151304
RGD:1580773 RGD:7248602
NCBI chr 6:71,919,557...71,921,345
Ensembl chr 6:71,918,845...71,921,405
G
NPPB
natriuretic peptide B
ISO
protein:increased expression:atrium myocardium, plasma
RGD
PMID:17151299
RGD:1642199
NCBI chr 6:71,930,374...71,931,843
Ensembl chr 6:71,930,382...71,932,254
G
NPY
neuropeptide Y
ISO
protein:increased expression:paraventricular nucleus of hypothalamus
RGD
PMID:21042571
RGD:10448960
NCBI chr18:47,985,796...47,993,726
Ensembl chr18:47,985,725...47,992,667
G
NPY1R
neuropeptide Y receptor Y1
ISO
RGD
PMID:18201831
RGD:10448967
NCBI chr 8:52,152,649...52,163,080
Ensembl chr 8:52,152,646...52,162,328
G
NPY2R
neuropeptide Y receptor Y2
ISO
RGD
PMID:18201831
RGD:10448967
NCBI chr 8:74,039,959...74,048,398
Ensembl chr 8:74,039,616...74,047,817
G
NQO1
NAD(P)H quinone dehydrogenase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23458895
NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590
G
NR1H3
nuclear receptor subfamily 1 group H member 3
ISO
DNA:hypomethylation:promoter
RGD
PMID:21136146
RGD:13831298
NCBI chr 2:15,315,283...15,336,785
Ensembl chr 2:15,315,282...15,334,820
G
NR1H4
nuclear receptor subfamily 1 group H member 4
ISO
mRNA:decreased expression:liver
RGD
PMID:15047603
RGD:1625080
NCBI chr 5:83,607,222...83,732,668
Ensembl chr 5:83,604,294...83,684,604
G
NR1I3
nuclear receptor subfamily 1 group I member 3
treatment
ISO
RGD
PMID:20636876
RGD:9835393
NCBI chr 4:89,226,314...89,231,781
Ensembl chr 4:89,226,690...89,236,431
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
protein:increased expression:placenta
RGD
PMID:21744335
RGD:12879479
NCBI chr 2:144,822,937...144,956,451
Ensembl chr 2:144,822,939...144,956,451
G
NRP1
neuropilin 1
ISO
mRNA:decreased expression:skeletal muscle
RGD
PMID:16816123
RGD:2313725
NCBI chr10:56,280,673...56,430,832
Ensembl chr10:56,280,665...56,430,777
G
NT5E
5'-nucleotidase ecto
ISO
protein:increased expression:cerebral cortex, synaptosome (rat)
RGD
PMID:19723569
RGD:5134343
NCBI chr 1:54,400,786...54,450,743
Ensembl chr 1:54,400,810...54,448,742
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
protein:increased tyrosine nitration, decreased tyrosine phosphorylation:retina
RGD
PMID:21136036 PMID:22044876
RGD:5144144 RGD:5684337
NCBI chr 4:93,219,509...93,237,944
Ensembl chr 4:93,219,516...93,255,981
G
NTRK3
neurotrophic receptor tyrosine kinase 3
ISO
mRNA:decreased expression:dorsal root ganglion
RGD
PMID:9541170
RGD:2325654
NCBI chr 1:191,535,262...191,941,675
Ensembl chr 1:191,535,301...191,925,327
G
OGG1
8-oxoguanine DNA glycosylase
ISO
protein:altered localization:pancreatic islet
RGD
PMID:15677345 PMID:18599524 PMID:18676009
RGD:2317137 RGD:8657146 RGD:8657153
NCBI chr13:66,038,669...66,045,478
G
OGT
O-linked N-acetylglucosamine (GlcNAc) transferase
treatment
ISO
RGD
PMID:15561949
RGD:9590198
NCBI chr X:57,521,091...57,558,467
Ensembl chr X:57,521,098...57,558,515
G
OPRK1
opioid receptor kappa 1
ISO
protein:increased expression:sciatic nerve, peroneal nerve:
RGD
PMID:16924480
RGD:9834947
NCBI chr 4:77,399,298...77,429,025
Ensembl chr 4:77,399,183...77,426,879
G
OPRM1
opioid receptor mu 1
ISO
RGD
PMID:16901587
RGD:2316626
NCBI chr 1:12,634,125...12,702,295
Ensembl chr 1:12,528,672...12,702,443
G
OSBP
oxysterol binding protein
ISO
protein:increased tyrosine phosphorylation:aorta
RGD
PMID:18230613
RGD:2291921
NCBI chr 2:11,876,294...11,911,660
Ensembl chr 2:11,876,324...11,911,656
G
OTC
ornithine transcarbamylase
ISO
protein:decreased activity:small intestine (rat)
RGD
PMID:9628242
RGD:4144123
NCBI chr X:34,322,398...34,391,711
Ensembl chr X:34,322,298...34,391,821
G
OXCT1
3-oxoacid CoA-transferase 1
ISO
protein:decreased activity:heart, mitochondrion (rat)
RGD
PMID:3548709
RGD:2326100
NCBI chr16:26,514,497...26,659,739
Ensembl chr16:26,512,401...26,659,808
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
RGD
PMID:18657544
RGD:2312287
NCBI chr10:14,203,157...14,241,164
Ensembl chr10:14,203,160...14,241,196
G
PAX6
paired box 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 2:28,971,565...29,001,149
Ensembl chr 2:28,978,287...29,001,200
G
PC
pyruvate carboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 2:5,566,608...5,587,797
Ensembl chr 2:5,518,517...5,587,797
G
PCK1
phosphoenolpyruvate carboxykinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17651728 PMID:20363216
RGD:2311641
NCBI chr17:57,930,507...57,936,523
Ensembl chr17:57,930,432...57,936,522
G
PCSK1
proprotein convertase subtilisin/kexin type 1
ISO
mRNA, protein:increased expression:spleen (mouse) mRNA, protein:increased expression:spleen, spleen white pulp (rat) protein:increased expression:pancreatic alpha cell (mouse)
RGD
PMID:11730986 PMID:17698597
RGD:2308905 RGD:2308931
NCBI chr 2:103,004,794...103,050,707
Ensembl chr 2:103,004,794...103,050,839
G
PCSK2
proprotein convertase subtilisin/kexin type 2
ISO
mRNA:increased expression:spleen CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11730986 PMID:16123366
RGD:2308905
NCBI chr17:25,681,424...25,920,690
Ensembl chr17:25,681,197...25,923,004
G
PDE3A
phosphodiesterase 3A
ISO
mRNA, protein:increased expression:mesenteric artery
RGD
PMID:12793980
RGD:2300416
NCBI chr 5:52,413,503...52,737,771
Ensembl chr 5:52,409,882...52,738,406
G
PDE5A
phosphodiesterase 5A
ISO
RGD
PMID:19542492
RGD:2314461
NCBI chr 8:104,270,858...104,420,955
Ensembl chr 8:104,270,881...104,420,953
G
PDGFB
platelet derived growth factor subunit B
ISO
mRNA:increased expression:retina mRNA:increased expression:glomerulus mRNA: increased expression: mesenteric artery mRNA:decreased expression:retina
RGD
PMID:8094359 PMID:9763208 PMID:12606528 PMID:14685146 PMID:21367419
RGD:10449499 RGD:1581759 RGD:2311648 RGD:2311650 RGD:6483042
Ensembl chr 5:8,986,462...9,007,435
G
PDGFRB
platelet derived growth factor receptor beta
ISO
protein:increased expression:glomerulus
RGD
PMID:10802145
RGD:2311654
NCBI chr 2:151,155,753...151,192,818
Ensembl chr 2:151,155,756...151,192,647
G
PDK4
pyruvate dehydrogenase kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr 9:75,246,956...75,260,134
Ensembl chr 9:75,246,002...75,260,134
G
PDP2
pyruvate dehydrogenase phosphatase catalytic subunit 2
ISO
RGD
PMID:12765946
RGD:1582364
NCBI chr 6:27,565,423...27,572,868
Ensembl chr 6:27,565,450...27,575,455
G
PDX1
pancreatic and duodenal homeobox 1
ISO
protein:increased expression:pancreatic delta cell (rat) CTD Direct Evidence: marker/mechanism protein:increased expression:pancreas (rat)
RGD CTD
PMID:14988244 PMID:15561947 PMID:16123366 PMID:17226789 PMID:17235568 PMID:17460716 More...
RGD:1357906 RGD:2311224 RGD:2311225 RGD:2311226 RGD:2311311
NCBI chr11:5,303,609...5,309,063
Ensembl chr11:5,303,609...5,309,063
G
PDYN
prodynorphin
ISO
protein:increased expression:sciatic nerve, peroneal nerve, tibial nerve, footpad skin:
RGD
PMID:16924480
RGD:9834947
NCBI chr17:33,505,075...33,521,534
Ensembl chr17:33,505,079...33,521,532
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
protein:decreased expression:corpus callosum, endothelium (rat)
RGD
PMID:21967314
RGD:6771179
NCBI chr12:14,667,643...14,723,296
Ensembl chr12:14,649,044...14,723,293
G
PEMT
phosphatidylethanolamine N-methyltransferase
ISO
protein:increased expression:liver
RGD
PMID:17116711
RGD:1642370
NCBI chr12:60,880,367...60,919,279
G
PFAS
phosphoribosylformylglycinamidine synthase
ISO
protein:increased activity:liver (rat)
RGD
PMID:3043317
RGD:5135485
NCBI chr12:53,458,401...53,477,254
G
PFKM
phosphofructokinase, muscle
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563825
NCBI chr 5:78,475,473...78,525,052
Ensembl chr 5:78,476,123...78,526,997
G
PGF
placental growth factor
ISO
mRNA, protein:decreased expression:placenta, trophoblast cell
RGD
PMID:17917370
RGD:6483782
NCBI chr 7:98,149,510...98,162,784
Ensembl chr 7:98,148,994...98,162,741
G
PHKA1
phosphorylase kinase regulatory subunit alpha 1
ISO
RGD
PMID:11692172
RGD:1599897
NCBI chr X:58,456,097...58,583,216
Ensembl chr X:58,455,939...58,583,216
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
ISO
protein:increased expression:gastrocnemius (rat)
RGD
PMID:18430054
RGD:2307338
NCBI chr16:46,434,757...46,523,626
Ensembl chr16:46,511,521...46,523,609
G
PKLR
pyruvate kinase L/R
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16900249 PMID:20363216
RGD:1625589
NCBI chr 4:94,536,978...94,546,561
Ensembl chr 4:94,537,019...94,546,555
G
PLCB3
phospholipase C beta 3
ISO
protein:decreased expression:heart left ventricle
RGD
PMID:15362504
RGD:2314509
NCBI chr 2:7,844,931...7,860,183
Ensembl chr 2:7,843,340...7,860,193
G
PLCG1
phospholipase C gamma 1
ISO
protein:increased tyrosine phosphorylation:lens
RGD
PMID:17612968
RGD:2299877
NCBI chr17:43,810,003...43,844,553
Ensembl chr17:43,810,048...43,844,554
G
PNMT
phenylethanolamine N-methyltransferase
ISO
protein:increased expression:adrenal gland (rat)
RGD
PMID:16396986
RGD:5130724
NCBI chr12:22,648,396...22,651,520
Ensembl chr12:22,648,398...22,649,999
G
POLG
DNA polymerase gamma, catalytic subunit
ISO
mRNA,protein:decreased expression:retina,mitochondrion:
RGD
PMID:22229649 PMID:22743328
RGD:8694093 RGD:8694187
NCBI chr 7:54,889,150...54,907,167
Ensembl chr 7:54,889,157...54,906,844
G
POLG2
DNA polymerase gamma 2, accessory subunit
ISO
mRNA,protein:decreased expression:retina,mitochondrion:
RGD
PMID:22229649
RGD:8694187
NCBI chr12:14,582,075...14,601,576
Ensembl chr12:14,582,544...14,601,570
G
PON1
paraoxonase 1
ISO
RGD
PMID:18358245
RGD:2313268
NCBI chr 9:74,943,646...74,974,720
Ensembl chr 9:74,926,048...74,974,723
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12967931 PMID:14563825 PMID:23090186
NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,741...3,364,239
G
PPARD
peroxisome proliferator activated receptor delta
ISO
mRNA, protein:decreased expression:heart
RGD
PMID:18573863
RGD:2313781
NCBI chr 7:31,222,533...31,295,221
Ensembl chr 7:31,222,585...31,295,211
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism mRNA:altered expression:aorta, kidney cortex, retina protein:decreased expression:retina
CTD RGD
PMID:12967931 PMID:16123366 PMID:18641696 PMID:18806296 PMID:21757225
RGD:2301844 RGD:2301849
NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944
G
PPARGC1A
PPARG coactivator 1 alpha
treatment
ISO
mRNA:decreased expression:pancreatic islet CTD Direct Evidence: marker/mechanism protein:decreased expression:dorsal root ganglia (mouse)
RGD CTD
PMID:14563825 PMID:18270681 PMID:19520786 PMID:22561641 PMID:23272147
RGD:2311391 RGD:2311445 RGD:7241845 RGD:7242175
NCBI chr 8:17,841,844...18,527,953
Ensembl chr 8:17,841,844...17,946,992
G
PPAT
phosphoribosyl pyrophosphate amidotransferase
ISO
protein:increased activity:kidney (rat)
RGD
PMID:2451505
RGD:5135016
NCBI chr 8:55,652,194...55,701,077
Ensembl chr 8:55,654,377...55,701,077
G
PRKAA2
protein kinase AMP-activated catalytic subunit alpha 2
treatment
ISO
RGD
PMID:32535406
RGD:401850547
NCBI chr 6:155,683,392...155,754,283
Ensembl chr 6:155,681,784...155,754,278
G
PRKCA
protein kinase C alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12198386
NCBI chr12:12,882,287...13,268,647
Ensembl chr12:12,882,064...13,263,554
G
PRKCB
protein kinase C beta
ISO
protein:increased expression:myocardium
RGD
PMID:17250813
RGD:1625511
NCBI chr 3:21,995,227...22,383,628
Ensembl chr 3:21,995,231...22,383,264
G
PRKCD
protein kinase C delta
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:kidney
CTD RGD
PMID:11576956 PMID:12198386
RGD:1642532
NCBI chr13:35,290,835...35,323,245
Ensembl chr13:35,290,610...35,323,356
G
PRKCE
protein kinase C epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12198386
NCBI chr 3:94,351,277...94,864,549
Ensembl chr 3:94,349,889...94,866,306
G
PRKCI
protein kinase C iota
ISO
protein:increased expression:ventricle myocardium, membrane fraction
RGD
PMID:14691046
RGD:2314944
NCBI chr13:108,913,018...108,997,934
Ensembl chr13:108,913,173...108,997,931
G
PRKG1
protein kinase cGMP-dependent 1
treatment
ISO
protein:decreased expression:aorta
RGD
PMID:15939056 PMID:20186099
RGD:7775064 RGD:7777110
NCBI chr14:97,558,531...98,793,080
Ensembl chr14:97,558,533...98,793,010
G
PRKRA
protein activator of interferon induced protein kinase EIF2AK2
ISO
RGD
PMID:21897745
RGD:7777145
NCBI chr15:84,134,273...84,156,596
Ensembl chr15:84,133,687...84,156,508
G
PSMB9
proteasome 20S subunit beta 9
ISO
mRNA:increased expression:hippocampus (rat)
RGD
PMID:20968039
RGD:9850284
NCBI chr 7:25,072,133...25,077,508
Ensembl chr 7:25,062,367...25,077,523
G
PTGIS
prostaglandin I2 synthase
treatment
ISO
RGD
PMID:8888351
RGD:401960094
NCBI chr17:51,153,151...51,200,515
Ensembl chr17:51,153,154...51,200,300
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
protein:decreased expression:spinal cord
RGD
PMID:12086957
RGD:727386
NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:sciatic nerve CTD Direct Evidence: marker/mechanism protein:increased expression:lung
RGD CTD
PMID:14514642 PMID:17720896 PMID:18706904 PMID:21414306 PMID:21521772
RGD:1642588 RGD:2300222 RGD:5135278
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
PTPN1
protein tyrosine phosphatase non-receptor type 1
ISO
protein:increased activity:retina (mouse)
RGD
PMID:19029027
RGD:401965415
NCBI chr17:52,017,100...52,086,747
Ensembl chr17:52,017,130...52,086,736
G
PTPRN
protein tyrosine phosphatase receptor type N
severity
ISO
RGD
PMID:19513530
RGD:2313594
NCBI chr15:121,329,284...121,349,228
Ensembl chr15:121,329,287...121,349,168
G
PTPRU
protein tyrosine phosphatase receptor type U
ISO
protein:decreased expression:glomerulus
RGD
PMID:16539708
RGD:1642656
NCBI chr 6:86,137,743...86,228,148
Ensembl chr 6:86,137,737...86,228,145
G
PYGM
glycogen phosphorylase, muscle associated
ISO
protein:increased expression:sarcoplasmic reticulum
RGD
PMID:11692172
RGD:1599897
NCBI chr 2:7,409,330...7,421,256
Ensembl chr 2:7,409,116...7,421,254
G
QDPR
quinoid dihydropteridine reductase
ISO
protein:decreased activity:brain (rat)
RGD
PMID:2758679
RGD:5128601
NCBI chr 8:12,529,500...12,549,471
Ensembl chr 8:12,529,512...12,549,603
G
RAMP2
receptor activity modifying protein 2
ISO
mRNA:increased expression:kidney
RGD
PMID:14717924
RGD:1642701
NCBI chr12:20,092,204...20,094,426
Ensembl chr12:20,092,196...20,094,469
G
RAP1B
RAP1B, member of RAS oncogene family
ISO
protein:increased expression:renal glomerulus (rat)
RGD
PMID:12196513
RGD:10041023
NCBI chr 5:32,910,181...32,961,972
Ensembl chr 5:32,910,259...32,964,870
G
RASGRF1
Ras protein specific guanine nucleotide releasing factor 1
ISO
protein:decreased expression:brain, membrane (rat)
RGD
PMID:19002579
RGD:10003129
NCBI chr 7:48,121,415...48,246,749
Ensembl chr 7:48,121,419...48,246,749
G
RBFOX2
RNA binding fox-1 homolog 2
ISO
mRNA:splice variant: heart (mouse) protein:increased expression:heart, cytoplasm (mouse)
RGD
PMID:24151077 PMID:27239029
RGD:329845874 RGD:329848997
NCBI chr 5:11,633,523...11,905,325
Ensembl chr 5:11,633,541...11,903,094
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
protein:increased expression:nucleus, skeletal muscle, liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18500427 PMID:18633731 PMID:22138235
RGD:2298775 RGD:2298780
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
G
REN
renin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18829990
NCBI chr 9:64,809,143...64,822,605
Ensembl chr 9:64,809,146...64,822,658
G
RGN
regucalcin
ISO
protein:decreased expression:liver
RGD
PMID:9062895
RGD:9590177
NCBI chr X:41,725,660...41,749,736
Ensembl chr X:41,726,526...41,749,381
G
RHOA
ras homolog family member A
ISO
RGD
PMID:17589825
RGD:1642825
NCBI chr13:31,918,484...31,991,207
Ensembl chr13:31,918,834...31,986,607
G
RPE65
retinoid isomerohydrolase RPE65
ISO
mRNA:decreased expression:retina (rat)
RGD
PMID:21862641
RGD:9585653
NCBI chr 6:144,206,078...144,229,471
Ensembl chr 6:144,206,078...144,229,467
G
RYR2
ryanodine receptor 2
ISO
RGD
PMID:17027851
RGD:1599247
NCBI chr14:53,652,140...54,406,691
Ensembl chr14:53,652,485...54,192,063
G
S100A6
S100 calcium binding protein A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr 4:96,098,264...96,099,686
Ensembl chr 4:96,098,525...96,099,684
G
S100B
S100 calcium binding protein B
ISO
protein:increased expression:cerebellum, cerebral cortex, hippocampus protein:altered expression:hippocampus, astrocyte
RGD
PMID:14583344 PMID:18708122
RGD:5508821 RGD:5508836
G
S1PR2
sphingosine-1-phosphate receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22406263
NCBI chr 2:69,050,396...69,057,270
Ensembl chr 2:69,049,270...69,057,270
G
S1PR4
sphingosine-1-phosphate receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22406263
NCBI chr 2:75,394,737...75,399,914
Ensembl chr 2:75,394,740...75,398,169
G
S1PR5
sphingosine-1-phosphate receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22406263
NCBI chr 2:69,293,537...69,299,408
Ensembl chr 2:69,293,546...69,298,377
G
SCAP
SREBF chaperone
ISO
RGD
PMID:20973890
RGD:5490977
NCBI chr13:30,253,262...30,320,625
Ensembl chr13:30,253,268...30,320,526
G
SCD
stearoyl-CoA desaturase
treatment
ISO
RGD
PMID:32535406
RGD:401850547
NCBI chr14:111,461,560...111,478,033
Ensembl chr14:111,461,569...111,478,020
G
SCP2
sterol carrier protein 2
treatment
ISO
RGD
PMID:7628371
RGD:9850252
NCBI chr 6:159,191,045...159,314,985
G
SERPINC1
serpin family C member 1
treatment
ISO
RGD
PMID:22309505 PMID:24671746
RGD:11035271 RGD:11035293
NCBI chr 9:116,181,988...116,193,100
Ensembl chr 9:116,181,670...116,193,201
G
SERPINE1
serpin family E member 1
ISO
protein:increased expression:heart (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20630999 PMID:21757225
RGD:8547862
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
G
SERPINF1
serpin family F member 1
ISO
protein:decreased expression:platelet
RGD
PMID:19237211
RGD:2312338
NCBI chr12:47,949,004...47,959,471
Ensembl chr12:47,948,510...47,959,470
G
SI
sucrase-isomaltase
ISO
protein:increased expression:small intestine mucosa
RGD
PMID:12940455
RGD:1625543
NCBI chr13:104,296,281...104,379,558
Ensembl chr13:104,296,283...104,379,478
G
SIRT1
sirtuin 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22179968 PMID:23090186 PMID:23792339
RGD:9586012
NCBI chr14:71,091,167...71,126,351
Ensembl chr14:71,091,167...71,123,297
G
SLC1A3
solute carrier family 1 member 3
treatment
ISO
RGD
PMID:23595285
RGD:401794586
NCBI chr16:21,873,691...21,965,315
Ensembl chr16:21,873,691...21,964,990
G
SLC22A1
solute carrier family 22 member 1
ISO
RGD
PMID:14718608
RGD:2317435
NCBI chr 1:7,340,442...7,365,543
Ensembl chr 1:7,340,126...7,365,520
G
SLC22A2
solute carrier family 22 member 2
ISO
protein:decreased expression:kidney
RGD
PMID:19356064
RGD:2312728
NCBI chr 1:7,289,278...7,323,418
Ensembl chr 1:7,289,831...7,323,146
G
SLC28A2
solute carrier family 28 member 2
ISO
RGD
PMID:16014043
RGD:2317455
NCBI chr 1:126,472,500...126,511,207
Ensembl chr 1:126,472,525...126,511,095
G
SLC28A3
solute carrier family 28 member 3
ISO
RGD
PMID:16014043
RGD:2317455
NCBI chr10:30,663,060...30,730,766
Ensembl chr10:30,669,904...30,729,301
G
SLC29A1
solute carrier family 29 member 1
ISO
mRNA:decreased expression:cardiac muscle cell
RGD
PMID:16873415
RGD:2316941
NCBI chr 7:39,217,974...39,234,683
Ensembl chr 7:39,218,051...39,234,685
G
SLC2A2
solute carrier family 2 member 2
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:kidney
CTD RGD
PMID:16123366 PMID:19433262
RGD:2312358
NCBI chr13:109,592,595...109,614,105
Ensembl chr13:109,587,258...109,638,510
G
SLC2A3
solute carrier family 2 member 3
ISO
mRNA, protein:decreased expression:brain
RGD
PMID:17935675
RGD:2313617
NCBI chr 5:62,963,635...63,041,955
G
SLC2A4
solute carrier family 2 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11947963 PMID:14563825 PMID:18266981 PMID:19252289 PMID:22138235
RGD:2313621
NCBI chr12:52,628,746...52,634,965
Ensembl chr12:52,628,450...52,634,967
G
SLC37A4
solute carrier family 37 member 4
ISO
protein:increased expression:liver
RGD
PMID:10567346
RGD:1625641
NCBI chr 9:46,247,278...46,254,068
Ensembl chr 9:46,247,284...46,254,031
G
SLC38A2
solute carrier family 38 member 2
ISO
RGD
PMID:11798158
RGD:9999213
NCBI chr 5:77,113,491...77,127,715
Ensembl chr 5:77,113,494...77,127,650
G
SLC8A1
solute carrier family 8 member A1
ISO
mRNA, protein:decreased expression:cardiac muscle cell
RGD
PMID:10944172
RGD:1642714
NCBI chr 3:99,823,503...100,257,306
Ensembl chr 3:99,897,162...100,244,759
G
SLC9A1
solute carrier family 9 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20003708
NCBI chr 6:84,373,921...84,426,447
Ensembl chr 6:84,372,649...84,426,997
G
SLC9A3
solute carrier family 9 member A3
ISO
CTD Direct Evidence: marker/mechanism protein:increased activity:kidney cortex
CTD RGD
PMID:16244498 PMID:20003708
RGD:1625673
NCBI chr16:79,625,555...79,704,084
Ensembl chr16:79,666,825...79,700,658
G
SMAD1
SMAD family member 1
severity
ISO
protein:increased expression:glomerulus, urine
RGD
PMID:16482100
RGD:1643228
NCBI chr 8:82,907,557...82,987,909
Ensembl chr 8:82,908,527...82,968,994
G
SMARCA4
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
treatment
ISO
RGD
PMID:23853776
RGD:9586347
NCBI chr 2:69,717,175...69,810,301
Ensembl chr 2:69,662,238...69,810,295
G
SMPD1
sphingomyelin phosphodiesterase 1
ISO
protein:decreased expression:gastrocnemius
RGD
PMID:14983401
RGD:1601347
NCBI chr 9:3,324,091...3,328,493
Ensembl chr 9:3,324,442...3,328,457
G
SNAP25
synaptosome associated protein 25
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16123366
NCBI chr17:19,096,115...19,227,580
Ensembl chr17:19,141,464...19,227,576
G
SOAT2
sterol O-acyltransferase 2
ISO
RGD
PMID:15242859
RGD:1581191
NCBI chr 5:18,358,941...18,371,262
Ensembl chr 5:18,358,673...18,371,264
G
SOCS3
suppressor of cytokine signaling 3
susceptibility
ISO
mRNA, protein:increased expression:retina
RGD
PMID:17562326 PMID:18356406
RGD:2298911 RGD:2313787
NCBI chr12:3,643,832...3,647,015
Ensembl chr12:3,643,929...3,647,009
G
SOD1
superoxide dismutase 1
ISO
protein:increased expression:hippocampus (rat) associated with alcohol use disorder; protein:decreased activity;testis, epididymis (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20924670 PMID:23090186 PMID:25541261
RGD:405255664 RGD:8655956
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
G
SOD2
superoxide dismutase 2
ISO
protein:increased activity:testes CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:15855331 PMID:19891634 PMID:23090186
RGD:2317382
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
G
SORD
sorbitol dehydrogenase
ISO
protein:increased expression:liver
RGD
PMID:15064821
RGD:1601360
NCBI chr 1:126,659,198...126,701,084
Ensembl chr 1:126,655,156...126,701,138
G
SOX2
SRY-box transcription factor 2
ISO
RGD
PMID:23828673
RGD:8661677
NCBI chr13:119,668,476...119,669,435
Ensembl chr13:119,668,476...119,669,435
G
SPP1
secreted phosphoprotein 1
ISO
RGD
PMID:16528250
RGD:1581322
NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
G
SREBF1
sterol regulatory element binding transcription factor 1
treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:renal proximal tubule, epithelial cell
CTD RGD
PMID:10900012 PMID:19048273 PMID:23090186 PMID:32535406
RGD:2308804 RGD:401850547
NCBI chr12:60,733,967...60,750,951
Ensembl chr12:60,733,907...60,751,267
G
SSTR1
somatostatin receptor 1
ISO
RGD
PMID:7956902
RGD:2325008
NCBI chr 7:61,890,560...61,900,567
Ensembl chr 7:61,890,563...61,894,978
G
SSTR2
somatostatin receptor 2
ISO
RGD
PMID:7956902
RGD:2325008
NCBI chr12:7,783,401...7,789,483
Ensembl chr12:7,783,431...7,789,488
G
SSTR3
somatostatin receptor 3
ISO
RGD
PMID:7956902
RGD:2325008
NCBI chr 5:10,581,814...10,593,796
Ensembl chr 5:10,581,912...10,589,982
G
SSTR5
somatostatin receptor 5
ISO
RGD
PMID:7956902
RGD:2325008
NCBI chr 3:40,756,465...40,758,111
Ensembl chr 3:40,756,457...40,762,895
G
STAR
steroidogenic acute regulatory protein
ISO
mRNA:decreased expression:sciatic nerve (rat)
RGD
PMID:20826654
RGD:4145530
NCBI chr15:48,377,597...48,385,398
Ensembl chr15:48,377,521...48,385,462
G
STAT1
signal transducer and activator of transcription 1
ISO
protein:increased tyrosine phosphorylation:glomerulus
RGD
PMID:14678947
RGD:1600105
NCBI chr15:95,593,201...95,646,324
Ensembl chr15:95,593,211...95,646,260
G
STAT3
signal transducer and activator of transcription 3
ISO
protein:increased tyrosine phosphorylation:aorta endothelium
RGD
PMID:18230613 PMID:22660795
RGD:2291921 RGD:8694292
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
STAT4
signal transducer and activator of transcription 4
ISO
RGD
PMID:10553062
RGD:7207889
NCBI chr15:95,656,206...95,764,099
Ensembl chr15:95,656,077...95,763,472
G
STAT5B
signal transducer and activator of transcription 5B
ISO
RGD
PMID:17003334
RGD:2291940
NCBI chr12:20,498,103...20,574,365
Ensembl chr12:20,508,404...20,574,266
G
STRA6
signaling receptor and transporter of retinol STRA6
ISO
protein:decreased expression:optic cup (rat)
RGD
PMID:28734946
RGD:155631297
NCBI chr 7:59,317,930...59,347,274
Ensembl chr 7:59,318,011...59,347,266
G
STS
steroid sulfatase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24497646
NCBI chr X:3,926,027...4,076,900 NCBI chr Y:2,747,102...2,828,322
G
TERT
telomerase reverse transcriptase
ISO
RGD
PMID:20031167
RGD:2316310
NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421
G
TF
transferrin
ISO
RGD
PMID:17081048
RGD:1601532
NCBI chr13:74,930,655...74,970,599
Ensembl chr13:74,930,655...74,972,763
G
TGFB1
transforming growth factor beta 1
ISO
protein:increased expression:urine CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15855808 PMID:17177138 PMID:23090186
RGD:1601583
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
G
TGFB2
transforming growth factor beta 2
ISO
protein:increased expression:parotid gland
RGD
PMID:17574405
RGD:2302087
NCBI chr10:8,306,136...8,435,307
Ensembl chr10:8,305,539...8,390,341
G
TH
tyrosine hydroxylase
ISO
protein:increased expression:seminal vesicle
RGD
PMID:17151307
RGD:1601629
NCBI chr 2:1,499,628...1,506,180
Ensembl chr 2:1,499,620...1,506,170
G
THBS1
thrombospondin 1
ISO
RGD
PMID:17640965
RGD:2317942
NCBI chr 1:131,728,781...131,746,098
Ensembl chr 1:131,728,784...131,746,115
G
TIMM44
translocase of inner mitochondrial membrane 44
ISO
protein:decreased expression:retina
RGD
PMID:23255365
RGD:13463486
NCBI chr 2:71,271,778...71,287,795
Ensembl chr 2:71,271,805...71,287,817
G
TIMP1
TIMP metallopeptidase inhibitor 1
ISO
protein:increased expression:kidney CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17192464 PMID:17569353 PMID:21963884
RGD:2290354 RGD:2312467
NCBI chr X:42,103,251...42,106,289
Ensembl chr X:42,102,172...42,106,296
G
TIMP2
TIMP metallopeptidase inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21963884
NCBI chr12:3,254,794...3,300,835
Ensembl chr12:3,254,493...3,300,834
G
TIMP3
TIMP metallopeptidase inhibitor 3
ISO
mRNA:increased expression:glomerulus
RGD
PMID:8840279
RGD:2312482
NCBI chr 5:12,185,816...12,242,599
Ensembl chr 5:12,185,818...12,242,581
G
TJP1
tight junction protein 1
ISO
protein:decreased expression:glomerulus
RGD
PMID:16567508
RGD:2325150
NCBI chr 1:144,930,387...145,195,857
Ensembl chr 1:144,930,370...145,195,836
G
TLR2
toll like receptor 2
ISO
RGD
PMID:16740310 PMID:17707128
RGD:2312491 RGD:2312684
NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
G
TLR4
toll like receptor 4
ISO
RGD
PMID:16740310
RGD:2312491
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
TNC
tenascin C
ISO
RGD
PMID:17999372
RGD:4889609
NCBI chr 1:255,533,235...255,630,381
Ensembl chr 1:255,533,238...255,630,376
G
TNF
tumor necrosis factor
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver protein:increased expression:heart
CTD RGD
PMID:12123627 PMID:12193562 PMID:19220660 PMID:19478208 PMID:20388520 PMID:20555424 PMID:21481476 PMID:22138235 PMID:24374093 PMID:24513509 More...
RGD:10450575 RGD:2312478 RGD:4142788 RGD:5131250
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
CTD Direct Evidence: therapeutic protein:increased expression:liver (rat)
CTD RGD
PMID:12193562 PMID:21481476
RGD:5131250
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
human protein in rat model
RGD
PMID:21481476
RGD:5131250
NCBI chr 6:72,195,420...72,231,146
Ensembl chr 6:72,195,435...72,231,147
G
TNFSF10
TNF superfamily member 10
ISO
RGD
PMID:12577054 PMID:18649770 PMID:19572802
RGD:2312737 RGD:2312738 RGD:2312744
NCBI chr13:111,021,952...111,103,060
Ensembl chr13:110,983,298...111,038,324
G
TOMM40
translocase of outer mitochondrial membrane 40
ISO
protein:decreased expression:retina
RGD
PMID:23255365
RGD:13463486
NCBI chr 6:51,359,948...51,369,932
Ensembl chr 6:51,359,595...51,369,908
G
TOMM70
translocase of outer mitochondrial membrane 70
ISO
protein:decreased expression:retina
RGD
PMID:23255365
RGD:13463486
NCBI chr13:158,577,026...158,629,878
Ensembl chr13:158,577,379...158,628,262
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21078376 PMID:23792339 PMID:24828139
RGD:8662307
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
TP63
tumor protein p63
ISO
protein:increased expression:prostate gland
RGD
PMID:20041964
RGD:11568648
NCBI chr13:127,115,990...127,347,082
Ensembl chr13:127,116,105...127,347,068
G
TPI1
triosephosphate isomerase 1
ISO
protein:decreased expression:retina
RGD
PMID:17465459
RGD:5147874
NCBI chr 5:63,839,473...63,842,853
Ensembl chr 5:63,838,506...63,843,134
G
TREX2
three prime repair exonuclease 2
ISO
RGD
PMID:20973890
RGD:5490977
NCBI chr X:124,234,736...124,244,193
Ensembl chr X:124,234,738...124,238,598
G
TRPC1
transient receptor potential cation channel subfamily C member 1
ISO
mRNA:decreased expression:kidney, liver
RGD
PMID:18184923
RGD:2301838
NCBI chr13:83,436,343...83,498,419
Ensembl chr13:83,436,395...83,498,478
G
TSC2
TSC complex subunit 2
ISO
protein:increased threonine phosphorylation:cortex of kidney
RGD
PMID:18599524
RGD:8657153
NCBI chr 3:39,898,924...39,935,579
Ensembl chr 3:39,898,925...39,937,371
G
TWNK
twinkle mtDNA helicase
ISO
mRNA,protein:decreased expression:retina,mitochondrion:
RGD
PMID:22229649 PMID:22743328
RGD:8694093 RGD:8694187
NCBI chr14:112,068,463...112,076,169
Ensembl chr14:112,069,925...112,075,792
G
TXN
thioredoxin
ISO
mRNA:altered expression:myocardium (rat)
RGD
PMID:20571744
RGD:5133714
NCBI chr 1:251,264,180...251,278,000
Ensembl chr 1:251,263,175...251,277,988
G
TXN2
thioredoxin 2
ISO
mRNA:altered expression:myocardium (rat) mRNA:increased expression:glomerulus
RGD
PMID:15039483 PMID:20571744
RGD:2306161 RGD:5133714
NCBI chr 5:11,264,470...11,289,388
Ensembl chr 5:11,264,645...11,283,395
G
TXNIP
thioredoxin interacting protein
ISO
protein:increased expression:kidney
RGD
PMID:17675577
RGD:1642749
NCBI chr 4:99,348,589...99,351,760
Ensembl chr 4:99,348,490...99,352,755
G
TXNRD1
thioredoxin reductase 1
ISO
mRNA:altered expression:myocardium (rat)
RGD
PMID:20571744
RGD:5133714
NCBI chr 5:80,170,334...80,213,889
Ensembl chr 5:80,172,260...80,236,219
G
TXNRD2
thioredoxin reductase 2
ISO
mRNA:altered expression:myocardium (rat)
RGD
PMID:20571744
RGD:5133714
NCBI chr14:51,355,731...51,385,096
Ensembl chr14:51,356,831...51,383,262
G
UBA52
ubiquitin A-52 residue ribosomal protein fusion product 1
ISO
mRNA:increased expression:kidney (mouse)
RGD
PMID:12171997
RGD:11352735
NCBI chr 2:59,238,802...59,241,512
Ensembl chr 2:59,238,906...59,240,274
G
UCHL5
ubiquitin C-terminal hydrolase L5
ISO
RGD
PMID:23500140
RGD:9588239
NCBI chr10:725,688...761,633
Ensembl chr10:725,561...763,985
G
UCK2
uridine-cytidine kinase 2
ISO
protein:decreased activity:heart, skeletal muscle
RGD
PMID:221781
RGD:2317214
NCBI chr 4:84,838,793...84,919,231
Ensembl chr 4:84,838,802...84,919,236
G
UCP2
uncoupling protein 2
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:kidney
CTD RGD
PMID:14563825 PMID:16123366 PMID:19227473
RGD:2313501
NCBI chr 9:8,358,559...8,364,552
Ensembl chr 9:8,358,025...8,365,547
G
UCP3
uncoupling protein 3
susceptibility
ISO
mRNA:increased expression:skeletal muscle
RGD
PMID:10868941 PMID:12079841
RGD:2313520 RGD:2313524
NCBI chr 9:8,378,023...8,389,452
Ensembl chr 9:8,378,021...8,386,211
G
UMOD
uromodulin
ISO
protein:increased expression:urine
RGD
PMID:10925066
RGD:2324705
NCBI chr 3:25,473,048...25,492,286
Ensembl chr 3:25,473,162...25,492,278
G
UMPS
uridine monophosphate synthetase
ISO
protein:decreased activity:mammary gland (rat) protein:decreased activity:liver (rat)
RGD
PMID:1476792 PMID:3907307
RGD:5132278 RGD:5132591
NCBI chr13:135,611,857...135,650,656
Ensembl chr13:135,610,058...135,650,603
G
UPRT
uracil phosphoribosyltransferase homolog
ISO
protein:decreased activity:mammary gland (rat)
RGD
PMID:1476792
RGD:5132591
NCBI chr X:60,426,955...60,448,174
Ensembl chr X:60,426,975...60,451,480
G
UTS2R
urotensin 2 receptor
ISO
RGD
PMID:16267137
RGD:2306839
NCBI chr12:695,765...700,678
G
VCAM1
vascular cell adhesion molecule 1
ISO
mRNA, protein:increased expression:kidney mRNA:increased expression:aorta
RGD
PMID:18093596 PMID:18983856
RGD:2306988 RGD:2312764
NCBI chr 4:117,496,914...117,511,211
Ensembl chr 4:117,496,920...117,511,222
G
VDAC1
voltage dependent anion channel 1
ISO
protein:increased expression:kidney
RGD
PMID:19634143
RGD:10003054
NCBI chr 2:136,302,188...136,334,461
Ensembl chr 2:136,302,191...136,396,301
G
VEGFA
vascular endothelial growth factor A
ISO
mRNA:decreased expression:heart CTD Direct Evidence: marker/mechanism mRNA:decreased expression:skeletal muscle
RGD CTD
PMID:16741021 PMID:16816123 PMID:19934008 PMID:22191573
RGD:2313724 RGD:2313725 RGD:7421582
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
VEGFB
vascular endothelial growth factor B
ISO
mRNA:decreased expression:skeletal muscle
RGD
PMID:16816123
RGD:2313725
NCBI chr 2:7,872,873...7,876,149
Ensembl chr 2:7,872,870...7,876,118
G
VIP
vasoactive intestinal peptide
ISO
RGD
PMID:21129425
RGD:5685622
NCBI chr 1:13,611,786...13,620,250
Ensembl chr 1:13,611,311...13,620,269
G
VIPR1
vasoactive intestinal peptide receptor 1
ISO
RGD
PMID:21129425
RGD:5685622
NCBI chr13:26,036,610...26,073,168
Ensembl chr13:26,036,629...26,075,691
G
VLDLR
very low density lipoprotein receptor
ISO
protein:decreased expression:heart, skeletal muscle
RGD
PMID:15878964
RGD:1625575
NCBI chr 1:219,178,501...219,210,332
Ensembl chr 1:219,173,507...219,210,343
G
VWF
von Willebrand factor
ISO
protein:increased expression:plasma
RGD
PMID:17546272
RGD:1625712
NCBI chr 5:64,516,627...64,655,938
Ensembl chr 5:64,519,186...65,002,452
G
WDR35
WD repeat domain 35
ISO
mRNA:increased expression:kidney (rat)
RGD
PMID:20224876
RGD:11553923
NCBI chr 3:118,209,112...118,279,050
Ensembl chr 3:118,209,139...118,269,452
G
XDH
xanthine dehydrogenase
ISO
protein:increased expression:brain, heart, kidney
RGD
PMID:14532905
RGD:1304441
NCBI chr 3:107,987,060...108,052,043
Ensembl chr 3:107,987,126...108,053,169
G
YWHAH
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18342293
NCBI chr14:48,544,031...48,556,496
Ensembl chr14:48,544,173...48,556,490
G
CBL
Cbl proto-oncogene
treatment
ISO
RGD
PMID:20890046
RGD:11038805
NCBI chr 9:46,416,937...46,512,855
Ensembl chr 9:46,416,938...46,512,834
G
CBX7
chromobox 7
ISO
RGD
PMID:25434821
RGD:11352713
NCBI chr 5:9,070,312...9,090,467
Ensembl chr 5:9,070,353...9,087,634
G
CDKN2A
cyclin dependent kinase inhibitor 2A
ISO
RGD
PMID:10090949
RGD:11251764
NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
G
FGFR1
fibroblast growth factor receptor 1
treatment
ISO
RGD
PMID:22781593
RGD:11352669
NCBI chr15:48,053,895...48,106,634
Ensembl chr15:48,053,340...48,106,724
G
IL1A
interleukin 1 alpha
treatment
ISO
RGD
PMID:2117483
RGD:11051972
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,119
G
LAT2
linker for activation of T cells family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chr 3:11,353,213...11,372,100
Ensembl chr 3:11,352,579...11,372,092
G
NRAS
NRAS proto-oncogene, GTPase
induced
ISO
DNA:transversion mutation, loss of heterozygosity:cds:
RGD
PMID:9142215
RGD:11535063
NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
G
PTPN11
protein tyrosine phosphatase non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr14:39,202,165...39,292,041
Ensembl chr14:39,202,169...39,292,003
G
RUNX1
RUNX family transcription factor 1
treatment
ISO
RGD
PMID:19236814
RGD:11251683
NCBI chr13:198,371,835...198,635,648
Ensembl chr13:198,371,837...198,638,189
G
ABCB11
ATP binding cassette subfamily B member 11
ISO
RGD
PMID:15853769
RGD:1598580
NCBI chr15:75,402,296...75,487,092
Ensembl chr15:75,402,396...75,486,403
G
ADSL
adenylosuccinate lyase
ISO
protein:increased activity:liver (rat)
RGD
PMID:2937404
RGD:1598766
NCBI chr 5:8,027,799...8,045,480
Ensembl chr 5:8,025,508...8,047,603
G
AFP
alpha fetoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24012840 PMID:32961231
NCBI chr 8:69,677,690...69,698,864
Ensembl chr 8:69,677,690...69,698,864
G
AGPS
alkylglycerone phosphate synthase
ISO
RGD
PMID:7407223
RGD:1598794
NCBI chr15:83,146,063...83,285,905
Ensembl chr15:83,146,002...83,391,984
G
ALAS2
5'-aminolevulinate synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr X:47,871,519...47,896,041
Ensembl chr X:47,871,523...47,896,000
G
APOA4
apolipoprotein A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 9:44,201,587...44,204,072
Ensembl chr 9:44,201,508...44,204,206
G
APOC2
apolipoprotein C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 6:51,404,219...51,406,302
G
ARID1A
AT-rich interaction domain 1A
disease_progression
ISO
RGD
PMID:26569409
RGD:11344640
NCBI chr 6:84,049,729...84,124,302
Ensembl chr 6:84,049,087...84,123,349
G
ARRB2
arrestin beta 2
ISO
mRNA, protein:increased expression:liver (rat)
RGD
PMID:21167192
RGD:5509890
NCBI chr12:52,161,776...52,170,362
Ensembl chr12:52,161,778...52,170,342
G
ATP7A
ATPase copper transporting alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr X:61,972,544...62,110,058
Ensembl chr X:61,972,991...62,110,048
G
ATP7B
ATPase copper transporting beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr11:15,892,549...15,942,070
Ensembl chr11:15,876,612...15,942,064
G
BAK1
BCL2 antagonist/killer 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 7:29,808,849...29,815,345
G
BBC3
BCL2 binding component 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 6:53,037,103...53,046,902
Ensembl chr 6:53,037,104...53,046,887
G
BCL2
BCL2 apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10426811 PMID:28100771
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
BCL2L1
BCL2 like 1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10426811 PMID:22414765 PMID:28100771
RGD:11353865
NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694
G
BIRC5
baculoviral IAP repeat containing 5
ISO
mRNA, protein:increased expression:liver
RGD
PMID:18246794
RGD:2293125
NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215
G
CA3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 4:51,227,485...51,237,861
Ensembl chr 4:51,227,485...51,237,844
G
CAD
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
ISO
protein:increased activity:liver (rat)
RGD
PMID:13618893
RGD:5132586
NCBI chr 3:111,887,017...111,914,511
Ensembl chr 3:111,887,020...111,914,492
G
CCL20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30603057
NCBI chr15:129,172,743...129,176,069
G
CCNB1
cyclin B1
ISO
mRNA:increased expression:liver
RGD
PMID:17342310
RGD:2315991
NCBI chr16:47,338,239...47,348,385
Ensembl chr16:47,338,110...47,348,377
G
CCND1
cyclin D1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17055752 PMID:28100771
RGD:2289139
NCBI chr 2:3,621,242...3,633,380
Ensembl chr 2:3,621,246...3,633,296
G
CCNDBP1
cyclin D1 binding protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16501603
NCBI chr 1:128,253,111...128,269,534
Ensembl chr 1:128,253,035...128,269,452
G
CCNG1
cyclin G1
ISO
RGD
PMID:27982046
RGD:151361200
NCBI chr16:60,349,255...60,356,737
Ensembl chr16:60,349,258...60,356,738
G
CCNG2
cyclin G2
ISO
RGD
PMID:27982046
RGD:151361200
NCBI chr 8:72,790,394...72,800,553
Ensembl chr 8:72,791,703...72,800,551
G
CD40LG
CD40 ligand
ISO
RGD
PMID:19035311
RGD:5491179
NCBI chr X:111,778,666...111,788,901
Ensembl chr X:111,778,493...111,789,709
G
CD63
CD63 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 5:21,172,275...21,176,225
Ensembl chr 5:21,172,283...21,176,232
G
CDH1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20118494 PMID:25319454
NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986
G
CDKN1A
cyclin dependent kinase inhibitor 1A
ISO
protein:decreased expression:liver:
RGD
PMID:8640740
RGD:8662309
NCBI chr 7:32,354,776...32,363,771
Ensembl chr 7:32,359,455...32,363,761
G
CDKN1B
cyclin dependent kinase inhibitor 1B
disease_progression
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:19533683
RGD:2315050
NCBI chr 5:59,731,224...59,735,831
Ensembl chr 5:59,731,206...59,735,831
G
CDKN1C
cyclin dependent kinase inhibitor 1C
disease_progression
ISO
mRNA:increased expression:liver (rat) protein:increased expression:liver (rat) protein:decreased expression:liver (rat)
RGD
PMID:3965145 PMID:19533683 PMID:26606000
RGD:11354707 RGD:152998958 RGD:2315050
NCBI chr 2:2,019,391...2,022,092
Ensembl chr 2:2,019,830...2,021,853
G
COPS5
COP9 signalosome subunit 5
ISO
protein:increased expression:liver (rat)
RGD
PMID:26606000
RGD:11354707
NCBI chr 4:67,740,528...67,758,153
Ensembl chr 4:67,739,251...67,758,150
G
CP
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr13:89,396,713...89,463,540
Ensembl chr13:89,396,708...89,463,476
G
CPS1
carbamoyl-phosphate synthase 1
severity
ISO
mRNA:decreased expression:liver
RGD
PMID:3387993
RGD:2303406
NCBI chr15:113,210,038...113,339,086
Ensembl chr15:113,150,157...113,339,078
G
CTNNB1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11280770 PMID:20118494 PMID:21147764
NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 8:71,665,541...71,670,236
Ensembl chr 8:71,663,501...71,670,271
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
mRNA:increased expression:liver
RGD
PMID:22687991
RGD:7296954
NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11376689 PMID:21147764
NCBI chr 7:58,779,529...58,786,155
Ensembl chr 7:58,779,475...58,786,100
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18056438
NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817
G
CYP2F1
cytochrome P450 family 2 subfamily F member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 6:49,014,912...49,032,207
Ensembl chr 6:49,017,008...49,029,388
G
DHODH
dihydroorotate dehydrogenase (quinone)
ISO
protein:increased activity:liver (rat)
RGD
PMID:6331524
RGD:5132618
NCBI chr 6:14,942,898...14,956,000
Ensembl chr 6:14,942,933...14,955,997
G
DTYMK
deoxythymidylate kinase
ISO
protein:increased activity:tumor (rat)
RGD
PMID:6244089
RGD:5133686
NCBI chr15:140,248,071...140,255,803
Ensembl chr15:140,248,079...140,255,805
G
ENO2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2910524
NCBI chr 5:63,799,927...63,809,067
Ensembl chr 5:63,799,930...63,809,410
G
EPHX1
epoxide hydrolase 1
ISO
RGD
PMID:7260898
RGD:11252158
NCBI chr10:13,757,489...13,773,071
Ensembl chr10:13,751,881...13,773,072
G
ESR1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35044086
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
G
F12
coagulation factor XII
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 2:80,527,451...80,544,835
Ensembl chr 2:80,527,446...80,544,828
G
FAS
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FOXM1
forkhead box M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15082532
NCBI chr 5:67,246,219...67,263,215
Ensembl chr 5:67,245,694...67,263,211 Ensembl chr 5:67,245,694...67,263,211
G
GJB1
gap junction protein beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:1336494 PMID:18308698
RGD:7349398
NCBI chr X:57,241,990...57,249,496
Ensembl chr X:57,242,045...57,249,885
G
GJB2
gap junction protein beta 2
ISO
RGD
PMID:1336494
RGD:7349398
NCBI chr11:774,090...781,252
Ensembl chr11:775,166...775,846
G
GLUL
glutamate-ammonia ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20118494 PMID:21147764
NCBI chr 9:123,751,551...123,762,575
Ensembl chr 9:123,748,380...123,762,545
G
GRP
gastrin releasing peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2910524
NCBI chr 1:161,708,815...161,721,986
Ensembl chr 1:161,708,812...161,721,782
G
HAT1
histone acetyltransferase 1
ISO
protein:increased expression:liver
RGD
PMID:17182829
RGD:2316578
NCBI chr15:78,022,147...78,079,669
Ensembl chr15:78,022,207...78,079,608
G
HGF
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11896611
NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
G
HRAS
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7955063 PMID:20118494 PMID:21147764 PMID:27517622
NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501
G
HTR2C
5-hydroxytryptamine receptor 2C
ISO
protein:increased expression:brainstem, cerebral cortex
RGD
PMID:17258772
RGD:1624998
NCBI chr X:94,053,415...94,313,352
Ensembl chr X:94,053,456...94,313,355
G
IGF2
insulin like growth factor 2
treatment
ISO
RGD
PMID:22425635
RGD:10402567
NCBI chr 2:1,469,183...1,496,417
G
IGF2R
insulin like growth factor 2 receptor
ISO
RGD
PMID:9652747 PMID:15057872
RGD:2311623 RGD:2311630
NCBI chr 1:7,369,485...7,472,480
Ensembl chr 1:7,368,103...7,472,548
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30737368
NCBI chr X:125,035,575...125,056,445
Ensembl chr X:125,036,508...125,056,453
G
IL6
interleukin 6
disease_progression
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (mouse)
CTD RGD
PMID:26297436 PMID:26569409
RGD:11344640
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
INSR
insulin receptor
disease_progression
ISO
associated with Diabetes Mellitus, Experimental;protein:increased expression:cytoplasm,liver (rat)
RGD
PMID:15520221
RGD:2306052
NCBI chr 2:71,797,209...71,939,923
Ensembl chr 2:71,797,204...71,936,104
G
JAK2
Janus kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
KAT6A
lysine acetyltransferase 6A
ISO
protein:increased expression:liver (rat)
RGD
PMID:17083329
RGD:2312274
NCBI chr17:11,002,818...11,109,974
G
KDR
kinase insert domain receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
G
KRAS
KRAS proto-oncogene, GTPase
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (rat)
CTD RGD
PMID:8603461 PMID:19533683
RGD:2315050
NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
G
LOC100739163
glutathione S-transferase P-like
ISO
protein:increased expression:liver (rat)
RGD
PMID:3965145 PMID:12016164
RGD:152998958 RGD:2317823
NCBI chr 2:4,978,761...4,982,233
G
LOC100739508
glutathione S-transferase P-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2563599 PMID:3124819 PMID:7585603 PMID:20188851
NCBI chr 2:5,005,498...5,009,247
G
MAP2K1
mitogen-activated protein kinase kinase 1
ISO
associated with Diabetes Mellitus, Experimental;protein:increased expression:liver
RGD
PMID:15520221
RGD:2306052
NCBI chr 1:164,381,892...164,469,313
Ensembl chr 1:164,381,845...164,471,226
G
MAPK1
mitogen-activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr18:29,426,044...29,541,526
Ensembl chr18:29,426,048...29,541,512
G
MFGE8
milk fat globule EGF and factor V/VIII domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 7:54,539,970...54,554,885
Ensembl chr 7:54,539,970...54,571,747
G
MIR10A
microRNA mir-10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr12:24,833,644...24,833,723
Ensembl chr12:24,833,627...24,833,730
G
MIR125A
microRNA mir-125a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 6:58,331,566...58,331,645
Ensembl chr 6:58,331,566...58,331,645
G
MIR145
microRNA mir-145
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 2:150,580,126...150,580,211
Ensembl chr 2:150,580,126...150,580,211
G
MIR151
microRNA mir-151
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 4:2,849,041...2,849,120
Ensembl chr 4:2,849,038...2,849,130
G
MIR181C
microRNA mir-181c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 2:65,279,950...65,280,036
Ensembl chr 2:65,279,944...65,280,040
G
MIR183
microRNA mir-183
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr18:18,982,269...18,982,338
Ensembl chr18:18,982,269...18,982,338
G
MIR186
microRNA mir-186
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 6:141,943,328...141,943,409
Ensembl chr 6:141,943,328...141,943,409
G
MIR18A
microRNA mir-18a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr11:60,734,791...60,734,882
Ensembl chr11:60,734,791...60,734,882
G
MIR193A
microRNA mir-193a
ISO
miRNA:decreased expression:liver (mouse)
RGD
PMID:30165047
RGD:153323340
NCBI chr12:43,336,969...43,337,048
Ensembl chr12:43,336,969...43,337,048
G
MIR195
microRNA mir-195
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr12:52,422,039...52,422,118
Ensembl chr12:52,422,039...52,422,118
G
MIR206
microRNA mir-206
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 7:45,976,293...45,976,372
Ensembl chr 7:45,976,293...45,976,372
G
MIR212
microRNA mir-212
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr12:48,163,054...48,163,135
Ensembl chr12:48,163,046...48,163,145
G
MIR221
microRNA mir-221
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:40,571,068...40,571,137
Ensembl chr X:40,571,068...40,571,137
G
MIR30A
microRNA mir-30a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:51,412,827...51,412,933
Ensembl chr 1:51,412,827...51,412,933
G
MIR30B
microRNA mir-30b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 4:6,952,794...6,952,869
Ensembl chr 4:6,952,794...6,952,869
G
MIR30D
microRNA mir-30d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 4:6,948,669...6,948,747
Ensembl chr 4:6,948,669...6,948,747
G
MIR30E
microRNA mir-30e
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 6:170,429,841...170,429,920
Ensembl chr 6:170,429,841...170,429,920
G
MIR331
microRNA mir-331
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:88,028,339...88,028,418
Ensembl chr 5:88,028,339...88,028,418
G
MIR335
microRNA mir-335
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr18:18,341,580...18,341,659
Ensembl chr18:18,341,568...18,341,659
G
MIR339-2
microRNA mir-339-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 1:164,025,972...164,026,057
Ensembl chr 1:164,025,972...164,026,057
G
MIR383
microRNA mir-383
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr17:2,698,041...2,698,122
Ensembl chr17:2,698,041...2,698,122
G
MIR505
microRNA mir-505
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:114,563,942...114,564,021
Ensembl chr X:114,563,942...114,564,021
G
MIR652
microRNA mir-652
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:90,166,525...90,166,607
Ensembl chr X:90,166,516...90,166,613
G
MIR671
microRNA mir-671
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr18:5,989,378...5,989,457
Ensembl chr18:5,989,355...5,989,466
G
MIR708
microRNA mir-708
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 9:13,780,171...13,780,250
Ensembl chr 9:13,780,171...13,780,250
G
MIR98
microRNA mir-98
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr X:46,302,381...46,302,460
Ensembl chr X:46,302,381...46,302,460
G
MIR99B
microRNA mir-99b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 6:58,332,211...58,332,280
Ensembl chr 6:58,332,205...58,332,284
G
MIRLET7D
microRNA let-7d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 3:43,468,501...43,468,596
Ensembl chr 3:43,468,501...43,468,596
G
MIRLET7E
microRNA let-7e
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 6:58,332,042...58,332,121
Ensembl chr 6:58,332,036...58,332,120
G
MIRLET7I
microRNA let-7i
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21035526
NCBI chr 5:27,252,802...27,252,886
Ensembl chr 5:27,252,787...27,252,894
G
MMP2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression, increased activity:liver
RGD CTD
PMID:19528495 PMID:19539802 PMID:30603057
RGD:2325734 RGD:2325736
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
G
MMP9
matrix metallopeptidase 9
ISO
mRNA, protein:increased expression, increased activity:liver
RGD
PMID:19528495 PMID:19539802
RGD:2325734 RGD:2325736
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
MPEG1
macrophage expressed 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 2:12,194,303...12,196,594
Ensembl chr 2:12,194,327...12,198,351
G
MYC
MYC proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (rat)
CTD RGD
PMID:3335218 PMID:9079223 PMID:11280770 PMID:18560566
RGD:10059623
NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078
G
NOS2
nitric oxide synthase 2
ISO
protein:increased expression:liver
RGD
PMID:10383909
RGD:2325277
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
G
NOTCH1
notch receptor 1
ISO
protein:increased expression:liver
RGD
PMID:18942116
RGD:2325310
G
NQO1
NAD(P)H quinone dehydrogenase 1
ISO
mRNA, protein:increased expression:liver (rat)
RGD
PMID:27867096
RGD:13442478
NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590
G
NR1H4
nuclear receptor subfamily 1 group H member 4
susceptibility
ISO
RGD
PMID:17283114
RGD:14701032
NCBI chr 5:83,607,222...83,732,668
Ensembl chr 5:83,604,294...83,684,604
G
NR1I3
nuclear receptor subfamily 1 group I member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17172636 PMID:24769335 PMID:25656644
NCBI chr 4:89,226,314...89,231,781
Ensembl chr 4:89,226,690...89,236,431
G
NRAS
NRAS proto-oncogene, GTPase
ISO
human gene in mouse model
RGD
PMID:16286660
RGD:14975105
NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
G
PEMT
phosphatidylethanolamine N-methyltransferase
ISO
protein:decreased expression:liver
RGD
PMID:7929120
RGD:1642378
NCBI chr12:60,880,367...60,919,279
G
PLCL1
phospholipase C like 1
disease_progression
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:19533683
RGD:2315050
NCBI chr15:101,602,336...102,424,225
Ensembl chr15:101,840,806...101,951,106
G
PML
PML nuclear body scaffold
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20377131
NCBI chr 7:59,405,044...59,450,155
Ensembl chr 7:59,405,053...59,450,105
G
PPAT
phosphoribosyl pyrophosphate amidotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:761203
NCBI chr 8:55,652,194...55,701,077
Ensembl chr 8:55,654,377...55,701,077
G
PPP2CA
protein phosphatase 2 catalytic subunit alpha
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:2562181
RGD:8693574
NCBI chr 2:136,497,780...136,522,630
Ensembl chr 2:136,494,541...136,522,646
G
PRDX1
peroxiredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27517622
NCBI chr 6:165,847,390...165,859,918
Ensembl chr 6:165,824,395...165,861,442
G
PTGR1
prostaglandin reductase 1
ISO
mRNA, protein:increased expression:liver
RGD
PMID:24853774
RGD:14401713
NCBI chr 1:252,373,272...252,395,948
Ensembl chr 1:252,373,282...252,395,948
G
RAD51
RAD51 recombinase
ISO
protein:decreased expression:liver
RGD
PMID:17219426
RGD:2292638
NCBI chr 1:130,592,414...130,640,326
Ensembl chr 1:130,586,665...130,640,136
G
RB1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17854601
NCBI chr11:19,186,754...19,317,642
Ensembl chr11:19,186,761...19,317,690
G
RGN
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr X:41,725,660...41,749,736
Ensembl chr X:41,726,526...41,749,381
G
RIDA
reactive intermediate imine deaminase A homolog
ISO
protein:increased expression:liver (rat)
RGD
PMID:12939504
RGD:9685719
NCBI chr 4:38,656,270...38,665,863
Ensembl chr 4:38,656,319...38,670,987
G
RRAS2
RAS related 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147764
NCBI chr 2:44,890,129...44,961,003
G
RRM1
ribonucleotide reductase catalytic subunit M1
ISO
RGD
PMID:15224347
RGD:2316863
NCBI chr 9:6,026,151...6,065,211
Ensembl chr 9:6,025,073...6,065,143
G
RXRA
retinoid X receptor alpha
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:17786350
RGD:1643105
NCBI chr 1:273,698,842...273,797,622
Ensembl chr 1:273,705,505...273,797,620
G
SERPINA1
serpin family A member 1
ISO
RGD
PMID:10569800
RGD:1626391
NCBI chr 7:115,604,282...115,616,915
Ensembl chr 7:115,583,043...115,614,645
G
SLC31A1
solute carrier family 31 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23792645
NCBI chr 1:253,868,389...253,893,135
Ensembl chr 1:253,868,332...253,894,449
G
SLC7A5
solute carrier family 7 member 5
ISO
mRNA:increased expression:liver
RGD
PMID:17498859
RGD:151357003
NCBI chr 6:1,545,940...1,574,298
Ensembl chr 6:1,545,944...1,574,285
G
SNX27
sorting nexin 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36029209
NCBI chr 4:97,533,643...97,620,816
Ensembl chr 4:97,525,181...97,620,788
G
SOCS1
suppressor of cytokine signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15197228
NCBI chr 3:31,879,143...31,883,041
Ensembl chr 3:31,881,225...31,884,967
G
SOX4
SRY-box transcription factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147764
NCBI chr 7:16,886,834...16,895,488
Ensembl chr 7:16,891,319...16,892,752
G
SPP1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
G
SQLE
squalene epoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr 4:14,669,789...14,700,152
Ensembl chr 4:14,669,791...14,700,126
G
STAT3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26297436 PMID:28100771
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
TEK
TEK receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11956651
NCBI chr 1:195,938,177...196,052,294
Ensembl chr 1:195,937,432...196,051,980
G
TGFA
transforming growth factor alpha
ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9079223 PMID:16734725
RGD:2317490
NCBI chr 3:71,948,232...72,054,257
Ensembl chr 3:71,948,137...72,050,474
G
TGFB1
transforming growth factor beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28100771
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
G
TK1
thymidine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11420682
NCBI chr12:3,785,997...3,794,824
Ensembl chr12:3,786,031...3,795,917
G
TNF
tumor necrosis factor
treatment disease_progression
ISO
Morris hepatoma protein:increased expression:blood serum (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9063767 PMID:26569409 PMID:28100771
RGD:11344640 RGD:14696818
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10626228 PMID:28100771
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
TSC22D1
TSC22 domain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15833021 PMID:17533171
NCBI chr11:22,518,792...22,634,411
Ensembl chr11:22,518,795...22,634,407
G
VIM
vimentin
ISO
RGD
PMID:19199359
RGD:6480440
NCBI chr10:43,516,441...43,526,172
Ensembl chr10:43,517,307...43,526,170
G
XDH
xanthine dehydrogenase
ISO
protein:decreased expression:liver
RGD
PMID:3460692
RGD:13210515
NCBI chr 3:107,987,060...108,052,043
Ensembl chr 3:107,987,126...108,053,169
G
ABCB1
ATP-binding cassette, sub-family B (MDR/TAP), member 1
ISO
RGD
PMID:19654309
RGD:2315553
NCBI chr 9:93,049,955...93,146,469
G
ABCG2A
ATP binding cassette subfamily G member 2A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22767648
NCBI chr 8:130,853,414...130,945,388
Ensembl chr 8:130,889,684...130,945,393
G
ACSL1
acyl-CoA synthetase long chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr15:45,866,858...45,936,327
Ensembl chr15:45,866,857...45,963,729
G
ACTB
actin beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:4,084,275...4,090,383
Ensembl chr 3:4,082,216...4,090,356
G
ACTG1
actin gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr12:1,320,355...1,323,219
Ensembl chr12:1,313,641...1,323,217
G
ACTN4
actinin alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 6:47,493,834...47,565,999
Ensembl chr 6:47,493,919...47,565,998
G
ADCY5
adenylate cyclase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr13:136,965,746...137,133,795
Ensembl chr13:136,972,801...137,135,347
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
disease_progression treatment
ISO
RGD
PMID:19447866 PMID:22246620
RGD:8694414 RGD:8694468
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
G
AFP
alpha fetoprotein
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16322315
NCBI chr 8:69,677,690...69,698,864
Ensembl chr 8:69,677,690...69,698,864
G
AGT
angiotensinogen
treatment
ISO
RGD
PMID:20837666
RGD:5129167
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
G
AGTR1
angiotensin II receptor type 1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8389152 PMID:18421211
RGD:2292665
NCBI chr13:88,934,873...88,980,317
Ensembl chr13:88,934,868...88,983,105
G
AGTR2
angiotensin II receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8389152
NCBI chr X:95,267,709...95,272,237
Ensembl chr X:95,269,300...95,270,388
G
AKT1
AKT serine/threonine kinase 1
ISO
RGD
PMID:17210696
RGD:2315600
G
AKT2
AKT serine/threonine kinase 2
ISO
RGD
PMID:17210696
RGD:2315600
NCBI chr 6:48,555,785...48,620,472
Ensembl chr 6:48,555,795...48,587,919
G
ALCAM
activated leukocyte cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942
RGD:2306898
NCBI chr13:153,794,991...153,998,241
Ensembl chr13:153,794,993...153,998,208
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
ISO
mRNA:increased expression:mammary gland tumor (rat)
RGD
PMID:18959458
RGD:2313895
NCBI chr11:7,371,328...7,438,111
Ensembl chr11:7,411,644...7,438,108
G
ANTXR1
ANTXR cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:22085271
RGD:9684855
NCBI chr 3:73,157,744...73,398,379
Ensembl chr 3:73,157,747...73,398,379
G
ANXA1
annexin A1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12376462 PMID:16316942
RGD:2306898
NCBI chr 1:226,414,200...226,431,963
Ensembl chr 1:226,414,306...226,432,279
G
ANXA4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:72,623,311...72,654,591
Ensembl chr 3:72,622,358...72,694,212
G
APAF1
apoptotic peptidase activating factor 1
ISO
RGD
PMID:14973070
RGD:2325748
NCBI chr 5:85,166,616...85,258,751
Ensembl chr 5:85,166,628...85,258,364
G
APOE
apolipoprotein E
ISO
RGD
PMID:22469977
RGD:7771597
NCBI chr 6:51,373,113...51,375,333
Ensembl chr 6:51,372,292...51,375,330
G
AQP1
aquaporin 1 (Colton blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr18:42,063,482...42,076,741
Ensembl chr18:42,063,485...42,076,746
G
AR
androgen receptor
ISO
RGD
PMID:12150826
RGD:6482679
NCBI chr X:53,609,113...53,806,778
Ensembl chr X:53,609,176...53,800,677
G
AREG
amphiregulin
ISO
mRNA:increased expression:mammary gland protein:increased expression:mammary gland
RGD
PMID:10225449 PMID:18421211
RGD:2292663 RGD:2292665
NCBI chr 8:70,417,935...70,428,106
Ensembl chr 8:70,417,923...70,428,102
G
ARHGAP5
Rho GTPase activating protein 5
disease_progression
ISO
mRNA:increased expression:mammary gland
RGD
PMID:10939588 PMID:19703301
RGD:126848766 RGD:2316183
NCBI chr 7:67,494,237...67,631,461
Ensembl chr 7:67,494,941...67,594,197
G
ATP5IF1
ATP synthase inhibitory factor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 6:85,307,242...85,309,211
Ensembl chr 6:85,307,189...85,309,215
G
AURKA
aurora kinase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12124350
NCBI chr17:56,954,838...56,972,435
G
BAD
BCL2 associated agonist of cell death
severity treatment
ISO
RGD
PMID:20732338 PMID:23404339
RGD:10053670 RGD:10053708
NCBI chr 2:7,831,192...7,842,864
Ensembl chr 2:7,830,920...7,842,863
G
BAK1
BCL2 antagonist/killer 1
ISO
RGD
PMID:19222350
RGD:2315700
NCBI chr 7:29,808,849...29,815,345
G
BARD1
BRCA1 associated RING domain 1
ISO
RGD
PMID:18443292
RGD:2293149
NCBI chr15:117,049,483...117,135,889
Ensembl chr15:117,047,845...117,175,851
G
BASP1
brain abundant membrane attached signal protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr16:6,384,322...6,440,507
G
BAX
BCL2 associated X, apoptosis regulator
severity treatment
ISO
RGD
PMID:20732338 PMID:23404339
RGD:10053670 RGD:10053708
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:22668016 PMID:23404339
RGD:10053670 RGD:10054128
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
BCL2L1
BCL2 like 1
treatment
ISO
RGD
PMID:23404339
RGD:10053670
NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694
G
BGN
biglycan
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35234341
NCBI chr X:124,282,048...124,295,450
Ensembl chr X:124,275,305...124,295,445
G
BRCA1
BRCA1 DNA repair associated
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12203372 PMID:17505536 PMID:18443292 PMID:22767648
RGD:1599502 RGD:2293149 RGD:2293155
NCBI chr12:19,788,087...19,854,515
Ensembl chr12:19,786,020...19,854,668
G
BST2
bone marrow stromal cell antigen 2
disease_progression
ISO
RGD
PMID:23806386
RGD:14398495
NCBI chr 2:60,305,306...60,308,295
Ensembl chr 2:60,305,283...60,309,697
G
CA9
carbonic anhydrase 9
ISO
RGD
PMID:17280655
RGD:2293194
NCBI chr 1:236,393,727...236,400,994
Ensembl chr 1:236,394,306...236,400,822
G
CAD
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
disease_progression
ISO
protein:increased expression:mammary gland
RGD
PMID:6030068
RGD:2303540
NCBI chr 3:111,887,017...111,914,511
Ensembl chr 3:111,887,020...111,914,492
G
CAPZB
capping actin protein of muscle Z-line subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 6:77,780,682...77,912,653
Ensembl chr 6:77,780,682...77,912,617
G
CASK
calcium/calmodulin dependent serine protein kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr X:37,166,973...37,535,723
Ensembl chr X:37,167,577...37,536,160
G
CASP1
caspase 1, apoptosis-related cysteine peptidase
treatment
ISO
RGD
PMID:10557324
RGD:2315886
NCBI chr 9:35,188,066...35,199,364
Ensembl chr 9:35,186,420...35,200,328
G
CASP3
caspase 3
treatment severity
ISO
RGD
PMID:20732338 PMID:23404339 PMID:26699876
RGD:10053670 RGD:10053708 RGD:13782283
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CASP7
caspase 7
treatment
ISO
RGD
PMID:23404339 PMID:23979166 PMID:26699876
RGD:10053670 RGD:13209143 RGD:13782283
NCBI chr14:124,017,776...124,050,369
Ensembl chr14:124,019,164...124,050,365
G
CASP8
caspase 8
severity
ISO
RGD
PMID:20732338
RGD:10053708
NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
G
CASP9
caspase 9
severity treatment
ISO
RGD
PMID:17297389 PMID:20012353 PMID:20732338 PMID:26699876
RGD:10053708 RGD:13782283 RGD:2315928 RGD:2315933
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
G
CAV1
caveolin 1
treatment onset
ISO
protein:decreased expression:mammary gland
RGD
PMID:9685399 PMID:15334058 PMID:15355971
RGD:2289100 RGD:2289106 RGD:8661780
NCBI chr18:29,648,120...29,682,451
Ensembl chr18:29,649,992...29,682,465
G
CCNA2
cyclin A2
ISO
protein:increased expression:mammary gland
RGD
PMID:10713672
RGD:2293347
NCBI chr 8:102,260,346...102,266,274
Ensembl chr 8:102,260,215...102,266,309
G
CCNB1
cyclin B1
ISO
RGD
PMID:11146550
RGD:2315939
NCBI chr16:47,338,239...47,348,385
Ensembl chr16:47,338,110...47,348,377
G
CCND1
cyclin D1
ISO
protein:decreased expression:mammary gland mRNA, protein:increased expression:mammary gland (rat) mRNA:increased expression:mammary gland (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12376462 PMID:12602925 PMID:12649181 PMID:14522882 PMID:16316942 PMID:17440082 More...
RGD:2289336 RGD:2289337 RGD:2292404 RGD:2296037 RGD:2306898
NCBI chr 2:3,621,242...3,633,380
Ensembl chr 2:3,621,246...3,633,296
G
CCND3
cyclin D3
ISO
mRNA, protein:increased expression:mammary gland
RGD
PMID:12853979 PMID:16311245
RGD:2316015 RGD:2316020
NCBI chr 7:37,087,336...37,182,462
Ensembl chr 7:37,082,097...37,181,366
G
CCNE1
cyclin E1
ISO
protein:decreased expression:mammary gland
RGD
PMID:12602925 PMID:12649181
RGD:2289336 RGD:2289337
NCBI chr 6:39,919,541...39,933,224
Ensembl chr 6:39,919,624...39,933,363
G
CCNH
cyclin H
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland
CTD RGD
PMID:12606953
RGD:9590264
NCBI chr 2:94,980,938...95,019,053
Ensembl chr 2:94,980,941...95,018,634
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:21621198
RGD:6893427
NCBI chr13:29,251,950...29,286,470
Ensembl chr13:29,285,012...29,376,343
G
CCR5
C-C motif chemokine receptor 5
ISO
RGD
PMID:14597737 PMID:22637726
RGD:8551810 RGD:8551813
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
G
CD274
CD274 molecule
treatment
ISO
RGD
PMID:29043842
RGD:40886270
NCBI chr 1:216,646,378...216,792,731
Ensembl chr 1:216,660,041...216,792,724
G
CD40
CD40 molecule
ISO
RGD
PMID:21137078
RGD:8547744
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
G
CD44
CD44 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 2:25,788,699...25,884,209
Ensembl chr 2:25,788,703...25,884,153
G
CDC25A
cell division cycle 25A
ISO
RGD
PMID:16951165 PMID:17283130 PMID:17638870
RGD:2754551 RGD:2764000 RGD:2771824
G
CDC42
cell division cycle 42
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 6:80,035,034...80,089,243
Ensembl chr 6:80,035,123...80,089,233
G
CDH1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986
G
CDH13
cadherin 13
severity
ISO
RGD
PMID:18316604
RGD:2293540
NCBI chr 6:4,809,752...5,832,188
Ensembl chr 6:4,808,255...5,832,415
G
CDK2
cyclin dependent kinase 2
ISO
RGD
PMID:16924466
RGD:2293558
NCBI chr 5:21,365,723...21,372,170
Ensembl chr 5:21,365,764...21,372,168
G
CDK4
cyclin dependent kinase 4
susceptibility
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:mammary gland
CTD RGD
PMID:12376462 PMID:14522882 PMID:16413469 PMID:25221644
RGD:2293577 RGD:2293581
NCBI chr 5:23,039,206...23,041,959
Ensembl chr 5:23,038,891...23,042,061
G
CDK6
cyclin dependent kinase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25221644
NCBI chr 9:72,510,858...72,765,631
Ensembl chr 9:72,518,101...72,764,129
G
CDKL2
cyclin dependent kinase like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25333262
NCBI chr 8:71,231,148...71,260,902
Ensembl chr 8:71,231,152...71,260,815
G
CDKN1B
cyclin dependent kinase inhibitor 1B
treatment
ISO
protein:increased expression:mammary gland
RGD
PMID:15844214 PMID:22651929
RGD:10045559 RGD:2293626
NCBI chr 5:59,731,224...59,735,831
Ensembl chr 5:59,731,206...59,735,831
G
CDKN2A
cyclin dependent kinase inhibitor 2A
disease_progression
ISO
RGD
PMID:18060046 PMID:20681787
RGD:2289674 RGD:8552689
NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
G
CDS1
CDP-diacylglycerol synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:133,959,250...134,041,258
Ensembl chr 8:133,959,247...134,041,258
G
CLU
clusterin
disease_progression
ISO
RGD
PMID:23099883
RGD:8699504
NCBI chr14:11,336,585...11,352,569
Ensembl chr14:11,336,595...11,349,764
G
CNN3
calponin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:122,504,450...122,528,351
Ensembl chr 4:122,504,433...122,528,348
G
COL18A1
collagen type XVIII alpha 1 chain
severity
ISO
RGD
PMID:10766159
RGD:70690
NCBI chr13:207,907,835...207,984,082
Ensembl chr13:207,940,948...207,982,938
G
COL5A1
collagen type V alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:273,934,219...274,083,264
Ensembl chr 1:273,971,971...274,085,111
G
CSF1
colony stimulating factor 1
ISO
RGD
PMID:15205327
RGD:2293710
NCBI chr 4:110,178,466...110,198,232
Ensembl chr 4:110,178,475...110,197,900
G
CSN2
casein beta
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:9879772 PMID:16316942
RGD:2306898
NCBI chr 8:66,914,231...66,922,636
Ensembl chr 8:66,915,923...66,922,636
G
CSN3
casein kappa
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942
RGD:2306898
NCBI chr 8:67,099,131...67,109,112
Ensembl chr 8:67,099,131...67,106,987
G
CSNK2A1
casein kinase 2 alpha 1
ISO
RGD
PMID:11827167
RGD:727632
NCBI chr17:34,692,960...34,748,067
G
CTNNB1
catenin beta 1
ISO
protein:increased expression:mammary gland DNA:missense mutations: :p.S33Y, p.S45F
RGD
PMID:17510243 PMID:18060046
RGD:2289674 RGD:2289816
NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311
G
DBI
diazepam binding inhibitor, acyl-CoA binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr15:24,895,575...24,900,710
Ensembl chr15:24,895,522...24,906,372
G
DDR1
discoidin domain receptor tyrosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21283680 PMID:29298894
RGD:151347446
NCBI chr 7:23,371,358...23,391,585
Ensembl chr 7:23,373,845...23,391,584
G
DES
desmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr15:121,428,539...121,435,426
Ensembl chr15:121,427,642...121,435,423
G
DIO1
iodothyronine deiodinase 1
ISO
RGD
PMID:11765219
RGD:727335
NCBI chr 6:158,376,744...158,392,745
Ensembl chr 6:158,375,602...158,392,754
G
DNMT3B
DNA methyltransferase 3 beta
treatment
ISO
RGD
PMID:24447120
RGD:9588304
NCBI chr17:36,345,715...36,386,076
Ensembl chr17:36,345,816...36,386,072
G
DUSP1
dual specificity phosphatase 1
treatment
ISO
RGD
PMID:20837666
RGD:5129167
NCBI chr16:51,457,924...51,461,095
Ensembl chr16:51,458,020...51,461,086
G
DUSP6
dual specificity phosphatase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:93,303,058...93,307,510
Ensembl chr 5:93,302,975...93,307,504
G
EEF1A1
eukaryotic translation elongation factor 1 alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:92,421,235...92,425,053
Ensembl chr 1:92,421,230...92,425,044
G
EFEMP1
EGF containing fibulin extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:85,407,677...85,473,251
Ensembl chr 3:85,407,677...85,473,252
G
EGFR
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:2523869 PMID:8603490 PMID:17203220
RGD:2289979
NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
G
EIF5A
eukaryotic translation initiation factor 5A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr12:52,659,040...52,664,686
G
ENO1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 6:69,385,879...69,401,664
Ensembl chr 6:69,385,879...69,401,151
G
EPCAM
epithelial cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:93,169,800...93,185,221
Ensembl chr 3:93,168,852...93,185,653
G
EPHX1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr10:13,757,489...13,773,071
Ensembl chr10:13,751,881...13,773,072
G
EPO
erythropoietin
treatment
ISO
RGD
PMID:12118093
RGD:11041669
NCBI chr 3:8,620,508...8,622,936
Ensembl chr 3:8,620,508...8,622,936
G
EPOR
erythropoietin receptor
treatment
ISO
RGD
PMID:12118093
RGD:11041669
NCBI chr 2:70,063,601...70,068,821
Ensembl chr 2:70,063,519...70,068,821
G
ERBB2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism Androgen-dependent
CTD RGD
PMID:1913683 PMID:8603490 PMID:12150826 PMID:17203220 PMID:25221644
RGD:2289920 RGD:2289979 RGD:6482679
NCBI chr12:22,591,621...22,621,384
Ensembl chr12:22,590,725...22,621,351
G
ERBB3
erb-b2 receptor tyrosine kinase 3
ISO
RGD
PMID:17203220
RGD:2289979
NCBI chr 5:21,474,218...21,495,040
Ensembl chr 5:21,474,475...21,495,038
G
ERBB4
erb-b2 receptor tyrosine kinase 4
ISO
RGD
PMID:17203220
RGD:2289979
NCBI chr15:113,966,573...115,096,984
Ensembl chr15:113,974,437...115,096,565
G
ESR1
estrogen receptor 1
susceptibility
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:epithelial cell, nucleus
RGD CTD
PMID:11759285 PMID:15637090 PMID:18055862
RGD:2290019 RGD:8552983 RGD:8553057
NCBI chr 1:14,217,032...14,604,906
Ensembl chr 1:14,217,036...14,493,363
G
ESR2
estrogen receptor 2
treatment
ISO
protein:increased expression:epithelial cell, nucleus CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15637090 PMID:24078029
RGD:7364911 RGD:8552983
NCBI chr 1:193,823,666...193,907,330
Ensembl chr 1:193,829,560...193,906,565
G
EZR
ezrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:8,403,362...8,452,750
Ensembl chr 1:8,403,453...8,452,742
G
F11R
F11 receptor
ISO
RGD
PMID:22120722
RGD:7488922
NCBI chr 4:89,425,101...89,447,889
Ensembl chr 4:89,425,018...89,449,599
G
FABP4
fatty acid binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:55,096,400...55,101,209
Ensembl chr 4:55,096,404...55,101,896
G
FAS
Fas cell surface death receptor
ISO
RGD
PMID:18094967
RGD:2290047
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FBXO10
F-box protein 10
ISO
RGD
PMID:17404222
RGD:1601189
NCBI chr 1:238,232,855...238,308,661
Ensembl chr 1:238,232,867...238,308,625
G
FGF10
fibroblast growth factor 10
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18421211
RGD:2292665
NCBI chr16:28,695,465...28,779,953
Ensembl chr16:28,695,470...28,777,509
G
FGF7
fibroblast growth factor 7
ISO
RGD
PMID:9000125
RGD:2301094
NCBI chr 1:122,215,878...122,278,705
Ensembl chr 1:122,215,882...122,277,750
G
FGF8
fibroblast growth factor 8
ISO
RGD
PMID:9840935
RGD:2301098
NCBI chr14:112,808,215...112,814,225
Ensembl chr14:112,808,162...112,814,248
G
FLT3
fms related receptor tyrosine kinase 3
ISO
RGD
PMID:10498246
RGD:2302211
NCBI chr11:5,370,475...5,455,439
Ensembl chr11:5,370,496...5,455,358
G
FN1
fibronectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr15:117,658,158...117,737,145
Ensembl chr15:117,658,099...117,731,014
G
FRMPD1
FERM and PDZ domain containing 1
ISO
RGD
PMID:17404222
RGD:1601189
NCBI chr 1:238,371,311...238,511,714
Ensembl chr 1:238,371,336...238,511,715
G
FURIN
furin, paired basic amino acid cleaving enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 7:53,455,634...53,472,791
Ensembl chr 7:53,460,017...53,472,787
G
G0S2
G0/G1 switch 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 9:133,287,065...133,288,066
Ensembl chr 9:133,287,325...133,287,742
G
GATA3
GATA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:63,367,684...63,397,977
Ensembl chr10:63,367,663...63,388,859
G
GATM
glycine amidinotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:126,361,968...126,378,705
Ensembl chr 1:126,361,945...126,380,871
G
GDA
guanine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:225,425,389...225,589,835
Ensembl chr 1:225,403,138...225,589,827
G
GNAI2
G protein subunit alpha i2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr13:32,705,326...32,733,804
Ensembl chr13:32,705,321...32,733,794
G
GSK3B
glycogen synthase kinase 3 beta
treatment
ISO
RGD
PMID:28810530
RGD:13792729
NCBI chr13:140,136,109...140,370,197
Ensembl chr13:140,136,158...140,369,569
G
GSN
gelsolin
ISO
mRNA:decreased expression
RGD
PMID:8895730
RGD:1599869
NCBI chr 1:261,295,711...261,372,848
Ensembl chr 1:261,307,008...261,372,848
G
GSS
glutathione synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr17:38,316,199...38,342,253
Ensembl chr17:38,312,720...38,342,298
G
H2AX
H2A.X variant histone
treatment
ISO
RGD
PMID:22384017
RGD:7240549
NCBI chr 9:46,308,824...46,310,494
Ensembl chr 9:46,309,653...46,310,084
G
H3-3B
H3.3 histone B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr12:5,632,326...5,634,977
Ensembl chr12:5,632,365...5,634,726
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment
ISO
RGD
PMID:17280655
RGD:2293194
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
G
HMOX1
heme oxygenase 1
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:16319139 PMID:23215791
RGD:10755708
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:19,485,033...19,491,418
Ensembl chr 5:19,485,096...19,491,417
G
HNRNPAB
heterogeneous nuclear ribonucleoprotein A/B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15538050
NCBI chr 2:80,186,998...80,194,155
G
HP
haptoglobin
treatment
ISO
RGD
PMID:23880232
RGD:11041861
NCBI chr 6:14,980,382...14,985,245
G
HRAS
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism DNA:mutation: :p.G12E (rat)
CTD RGD
PMID:8185828 PMID:11376698 PMID:19652463
RGD:2314834
NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501
G
ID1
inhibitor of DNA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr17:35,316,518...35,317,742
Ensembl chr17:35,316,514...35,317,736
G
ID3
inhibitor of DNA binding 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 6:81,422,541...81,424,169
Ensembl chr 6:81,422,546...81,424,075
G
ID4
inhibitor of DNA binding 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14633621
NCBI chr 7:15,281,535...15,284,895
Ensembl chr 7:15,281,757...15,282,839
G
IGF1
insulin like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15217511 PMID:15528971 PMID:17584969 PMID:23342276
RGD:8549490
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14999141
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL18BP
interleukin 18 binding protein
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18959458
RGD:2313895
NCBI chr 9:6,586,602...6,596,423
Ensembl chr 9:6,488,808...6,591,333
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a mouse model
RGD
PMID:21890879
RGD:6771361
G
IL6ST
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr16:35,101,304...35,151,832
Ensembl chr16:35,101,306...35,192,220
G
ILK
integrin linked kinase
ISO
late onset development of tumors in transgenic mice overexpressing human ILK in mammary glands
RGD
PMID:11704830
RGD:2301733
NCBI chr 9:3,145,647...3,152,097
Ensembl chr 9:3,145,608...3,159,858
G
INSIG1
insulin induced gene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr18:2,885,494...2,898,758
Ensembl chr18:2,885,612...2,898,767
G
ITGB3
integrin subunit beta 3
ISO
protein:increased expression:mammary gland:
RGD
PMID:22022542
RGD:8693386
NCBI chr12:16,694,466...16,752,228
Ensembl chr12:16,693,514...16,752,292
G
KDR
kinase insert domain receptor
ISO
inhibition prevents DMBA-induced atypical ductal hyperplasia and carcinoma in situ
RGD
PMID:15170218 PMID:19888452
RGD:2291936 RGD:5684399
NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
ISO
DNA:mutation (rat)
RGD
PMID:18445266
RGD:2302172
NCBI chr 8:41,402,334...41,492,306
Ensembl chr 8:41,402,043...41,493,734
G
KITLG
KIT ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:94,016,992...94,110,219
Ensembl chr 5:94,017,387...94,110,214
G
KRT5
keratin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:17,862,047...17,868,397
Ensembl chr 5:17,862,051...17,868,402
G
KRT7
keratin 7
ISO
RGD
PMID:8570173
RGD:2317439
NCBI chr 5:17,553,192...17,570,582
Ensembl chr 5:17,555,728...17,570,581
G
KRT71
keratin 71
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:17,895,714...17,905,194
Ensembl chr 5:17,895,718...17,905,181
G
LEP
leptin
treatment
ISO
RGD
PMID:22246620
RGD:8694468
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
G
LGALS7
galectin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 6:47,588,983...47,604,520
G
LHCGR
luteinizing hormone/choriogonadotropin receptor
ISO
mRNA:splice variant (rat)
RGD
PMID:15044717
RGD:2302177
NCBI chr 3:91,964,415...92,023,821
Ensembl chr 3:91,964,415...92,021,398
G
LIN7A
lin-7 homolog A, crumbs cell polarity complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:100,533,630...100,686,709
Ensembl chr 5:100,538,065...100,674,551
G
LNPEP
leucyl and cystinyl aminopeptidase
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum
CTD RGD
PMID:16619500
RGD:1582109
NCBI chr 2:103,568,366...103,659,589
Ensembl chr 2:103,567,602...103,661,070
G
LOC100624785
tubulin beta-2A chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:1,910,585...1,914,668
Ensembl chr 7:1,910,269...1,914,761
G
LOC100737977
tumor necrosis factor receptor superfamily member 10B-like
ISO
RGD
PMID:17671220
RGD:2290495
NCBI chr14:7,344,788...7,371,086
G
LOC110259958
hemoglobin subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:41,482,353...41,483,564
G
LPL
lipoprotein lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr14:4,104,761...4,134,964
Ensembl chr14:4,104,772...4,135,814
G
LSR
lipolysis stimulated lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 6:44,759,091...44,773,378
Ensembl chr 6:44,759,073...44,773,379
G
MAP2K3
mitogen-activated protein kinase kinase 3
ISO
RGD
PMID:24233520
RGD:7495808
NCBI chr12:61,396,337...61,417,333
Ensembl chr12:61,396,369...61,417,321
G
MAP2K7
mitogen-activated protein kinase kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21317887
NCBI chr 2:71,299,010...71,308,432
Ensembl chr 2:71,298,325...71,308,124
G
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
RGD
PMID:29435821
RGD:13800872
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
RGD
PMID:29435821
RGD:13800872
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MDH2
malate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:10,120,121...10,132,705
Ensembl chr 3:10,120,083...10,132,752
G
MGP
matrix Gla protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 5:57,665,272...57,669,360
Ensembl chr 5:57,665,248...57,669,764
G
MIF
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr14:49,840,303...49,841,063
Ensembl chr14:49,840,305...49,841,068
G
MIR155
microRNA mir-155
ISO
RGD
PMID:20354188 PMID:29643534
RGD:21079418 RGD:21403681
NCBI chr13:189,138,822...189,138,902
Ensembl chr13:189,138,822...189,138,902
G
MMP1
matrix metallopeptidase 1
treatment
ISO
RGD
PMID:19622769
RGD:8549722
NCBI chr 9:33,411,738...33,420,205
Ensembl chr 9:33,411,065...33,420,076
G
MMP13
matrix metallopeptidase 13
severity
ISO
RGD
PMID:18698413
RGD:2306081
NCBI chr 9:33,549,003...33,616,700
Ensembl chr 9:33,549,008...33,561,162
G
MMP15
matrix metallopeptidase 15
ISO
mRNA:increased expression:mammary gland
RGD
PMID:15895410
RGD:2314949
NCBI chr 6:19,890,867...19,912,941
Ensembl chr 6:19,891,107...19,912,913
G
MMP2
matrix metallopeptidase 2
treatment
ISO
protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19725228 PMID:23359979 PMID:28574600
RGD:2325823 RGD:8657038
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
G
MMP7
matrix metallopeptidase 7
onset
ISO
RGD
PMID:9850086
RGD:9685350
NCBI chr 9:33,214,590...33,225,080
Ensembl chr 9:33,214,594...33,225,080
G
MMP9
matrix metallopeptidase 9
treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland
CTD RGD
PMID:19725228 PMID:21283680 PMID:23359979
RGD:2325823 RGD:8657038
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
MPZL1
myelin protein zero like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:83,235,712...83,309,620
Ensembl chr 4:83,235,714...83,316,405
G
MRC2
mannose receptor C-type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr12:16,059,759...16,119,571
Ensembl chr12:16,059,768...16,119,571
G
MT-CO1
mitochondrially encoded cytochrome c oxidase I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr MT:6,511...8,055
Ensembl chr MT:6,511...8,055
G
MTOR
mechanistic target of rapamycin kinase
ISO
RGD
PMID:22349822
RGD:10040957
NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
G
MUC1
mucin 1, cell surface associated
treatment
ISO
RGD
PMID:23015160
RGD:7349374
NCBI chr 4:94,626,317...94,631,194
G
MYC
MYC proto-oncogene, bHLH transcription factor
treatment
ISO
RGD
PMID:22384017
RGD:7240549
NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078
G
NCOA1
nuclear receptor coactivator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21080969
NCBI chr 3:113,997,214...114,251,080
Ensembl chr 3:113,999,253...114,250,298
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:22072621
RGD:10412719
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
G
NOTCH4
notch receptor 4
ISO
RGD
PMID:15531924
RGD:2299154
NCBI chr 7:24,231,293...24,256,281
Ensembl chr 7:24,231,293...24,256,281
G
NSMF
NMDA receptor synaptonuclear signaling and neuronal migration factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
G
NUDT1
nudix hydrolase 1
ISO
mRNA:increased expression:mammary gland
RGD
PMID:12036445
RGD:724605
NCBI chr 3:1,567,417...1,575,801
Ensembl chr 3:1,566,915...1,576,234
G
OXT
oxytocin/neurophysin I prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8647655 PMID:15089975
NCBI chr17:32,605,586...32,606,449
Ensembl chr17:32,605,586...32,606,546
G
PADI4
peptidyl arginine deiminase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 6:75,935,909...75,966,275
Ensembl chr 6:75,935,889...75,966,293
G
PAK4
p21 (RAC1) activated kinase 4
ISO
RGD
PMID:20697354
RGD:7775027
NCBI chr 6:47,869,604...47,914,185
Ensembl chr 6:47,869,577...47,914,182
G
PARP1
poly(ADP-ribose) polymerase 1
treatment
ISO
RGD
PMID:23404339
RGD:10053670
NCBI chr10:14,203,157...14,241,164
Ensembl chr10:14,203,160...14,241,196
G
PCNA
proliferating cell nuclear antigen
ISO
mRNA,protein:increased expression:mammary gland:
RGD
PMID:2567593
RGD:10448972
NCBI chr17:14,137,746...14,142,584
Ensembl chr17:14,136,886...14,142,744
G
PCP4
Purkinje cell protein 4
ISO
mRNA,protein:increased expression:cytoplasm:
RGD
PMID:19480007
RGD:9850273
NCBI chr13:203,412,479...203,479,216
Ensembl chr13:203,412,479...203,479,209
G
PDGFA
platelet derived growth factor subunit A
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland (rat) mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462 PMID:16316942
RGD:2292404 RGD:2306898
NCBI chr 3:296,399...322,967
Ensembl chr 3:301,584...321,712
G
PEBP1
phosphatidylethanolamine binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr14:34,523,901...34,530,238
G
PGAM1
phosphoglycerate mutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr14:108,822,782...108,832,818
Ensembl chr14:108,822,812...108,833,058
G
PGR
progesterone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15637090
NCBI chr 9:32,035,684...32,129,776
Ensembl chr 9:32,035,684...32,129,221
G
PHB1
prohibitin 1
ISO
mRNA, protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12376462
RGD:2292404
NCBI chr12:25,596,520...25,609,693
Ensembl chr12:25,596,523...25,609,706
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr16:46,434,757...46,523,626
Ensembl chr16:46,511,521...46,523,609
G
PIN1
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
ISO
RGD
PMID:22064478
RGD:8693420
NCBI chr 2:68,715,898...68,729,471
Ensembl chr 2:68,715,880...68,729,870
G
PKM
pyruvate kinase M1/2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:60,971,807...61,032,780
Ensembl chr 7:60,975,667...61,004,316 Ensembl chr 7:60,975,667...61,004,316
G
PLAU
plasminogen activator, urokinase
disease_progression
ISO
RGD
PMID:18052026
RGD:6484140
NCBI chr14:76,629,313...76,635,173
Ensembl chr14:76,629,299...76,635,172
G
PLK2
polo like kinase 2
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462
RGD:2292404
NCBI chr16:37,299,116...37,305,114
Ensembl chr16:37,299,119...37,305,114
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11137312
NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,741...3,364,239
G
PRDX2
peroxiredoxin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:66,207,829...66,211,474
Ensembl chr 2:66,207,828...66,212,009
G
PRL
prolactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:17,451,367...17,463,771
Ensembl chr 7:17,451,367...17,463,710
G
PRLR
prolactin receptor
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942
RGD:2306898
NCBI chr16:20,637,568...20,655,881
Ensembl chr16:20,618,875...20,810,140
G
PSMA4
proteasome 20S subunit alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:47,440,576...47,448,599
Ensembl chr 7:47,434,919...47,448,891
G
PSME1
proteasome activator subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:75,161,830...75,164,531
Ensembl chr 7:75,160,766...75,164,810
G
PTBP1
polypyrimidine tract binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:77,551,562...77,563,153
Ensembl chr 2:77,551,562...77,563,134
G
PTEN
phosphatase and tensin homolog
onset
ISO
RGD
PMID:18381417
RGD:2292496
NCBI chr14:99,929,590...100,021,619
G
PTGER1
prostaglandin E receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11751431
NCBI chr 2:64,796,944...64,800,199
Ensembl chr 2:64,797,216...64,800,458
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
mRNA:increased expression:breast
RGD
PMID:18279516 PMID:18676768 PMID:21623034
RGD:2300118 RGD:2300130 RGD:5135030
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
PTK2
protein tyrosine kinase 2
disease_progression
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:15930288 PMID:18056629 PMID:24809783
RGD:2292554 RGD:2292560
NCBI chr 4:2,656,606...2,896,060
Ensembl chr 4:2,656,614...2,896,054
G
PTN
pleiotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr18:12,219,708...12,309,045
Ensembl chr18:12,219,787...12,309,044
G
PTPRB
protein tyrosine phosphatase receptor type B
treatment
ISO
RGD
PMID:23899555
RGD:151660352
NCBI chr 5:34,656,460...34,794,838
Ensembl chr 5:34,659,964...34,794,289
G
RAN
RAN, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr14:24,312,810...24,318,024
Ensembl chr14:24,311,577...24,317,789
G
RASA1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:94,879,615...94,992,725
Ensembl chr 2:94,878,911...94,993,450
G
RASGRF2
Ras protein specific guanine nucleotide releasing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:89,525,948...89,794,103
Ensembl chr 2:89,528,111...89,790,719
G
RB1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14522882
NCBI chr11:19,186,754...19,317,642
Ensembl chr11:19,186,761...19,317,690
G
RBP1
retinol binding protein 1
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462
RGD:2292404
NCBI chr13:80,380,958...80,407,328
Ensembl chr13:80,380,962...80,407,458
G
RBP4
retinol binding protein 4
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942
RGD:2306898
NCBI chr14:105,037,360...105,044,552
Ensembl chr14:105,037,464...105,044,765
G
RCN1
reticulocalbin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:28,696,528...28,714,083
Ensembl chr 2:28,696,661...28,709,672
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
protein:decreased expression:peritoneal macrophage
RGD
PMID:16288051
RGD:2298764
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
G
RELB
RELB proto-oncogene, NF-kB subunit
ISO
RGD
PMID:16260626
RGD:7777148
NCBI chr 6:51,444,670...51,480,350
Ensembl chr 6:51,444,664...51,480,319
G
RNPEP
arginyl aminopeptidase
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16619500
RGD:1582109
NCBI chr10:24,218,144...24,235,520
Ensembl chr10:24,218,139...24,235,518
G
RPL3
ribosomal protein L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:8,922,697...8,929,768
Ensembl chr 5:8,922,665...8,929,767
G
RPL6
ribosomal protein L6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr14:39,302,447...39,309,239
Ensembl chr14:39,303,350...39,309,236
G
RPS14
ribosomal protein S14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:151,430,047...151,433,951
Ensembl chr 2:151,430,049...151,433,856
G
RUNX1
RUNX family transcription factor 1
ISO
mRNA:increased expression:mammary gland
RGD
PMID:29435983
RGD:126779584
NCBI chr13:198,371,835...198,635,648
Ensembl chr13:198,371,837...198,638,189
G
RXRA
retinoid X receptor alpha
ISO
RGD
PMID:16344269
RGD:1643109
NCBI chr 1:273,698,842...273,797,622
Ensembl chr 1:273,705,505...273,797,620
G
S100A6
S100 calcium binding protein A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:96,098,264...96,099,686
Ensembl chr 4:96,098,525...96,099,684
G
S1PR1
sphingosine-1-phosphate receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:117,064,632...117,069,724
Ensembl chr 4:117,064,755...117,069,650
G
SCARB1
scavenger receptor class B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr14:28,301,421...28,393,568
Ensembl chr14:28,301,294...28,393,568
G
SCD
stearoyl-CoA desaturase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr14:111,461,560...111,478,033
Ensembl chr14:111,461,569...111,478,020
G
SELENOP
selenoprotein P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr16:27,537,885...27,547,863
Ensembl chr16:27,537,885...27,631,130
G
SGK1
serum/glucocorticoid regulated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:29,625,786...29,753,619
Ensembl chr 1:29,745,114...29,753,602
G
SLC12A2
solute carrier family 12 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:131,016,430...131,109,307
Ensembl chr 2:131,016,418...131,109,299
G
SLC25A10
solute carrier family 25 member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:1,191,242...1,197,439
Ensembl chr12:1,189,903...1,197,301
G
SNCG
synuclein gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr14:87,916,353...87,922,111
Ensembl chr14:87,904,659...87,922,095
G
SNRPD3
small nuclear ribonucleoprotein D3 polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr14:49,585,177...49,598,015
G
SOCS1
suppressor of cytokine signaling 1
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18381452 PMID:20354188
RGD:21079418 RGD:2298899
NCBI chr 3:31,879,143...31,883,041
Ensembl chr 3:31,881,225...31,884,967
G
SOCS3
suppressor of cytokine signaling 3
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18381452
RGD:2298899
NCBI chr12:3,643,832...3,647,015
Ensembl chr12:3,643,929...3,647,009
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23964924
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
G
SOX9
SRY-box transcription factor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr12:8,642,154...8,647,315
Ensembl chr12:8,642,158...8,647,315
G
SPINT2
serine peptidase inhibitor, Kunitz type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 6:47,181,772...47,210,564
Ensembl chr 6:47,181,768...47,210,559
G
SPP1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15318939
NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
G
SRSF2
serine and arginine rich splicing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr12:4,800,578...4,803,767
Ensembl chr12:4,800,624...4,801,675
G
STAT1
signal transducer and activator of transcription 1
ISO
RGD
PMID:11325527
RGD:2291895
NCBI chr15:95,593,201...95,646,324
Ensembl chr15:95,593,211...95,646,260
G
STAT3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942 PMID:17483332
RGD:2291914 RGD:2306898
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
STAT5A
signal transducer and activator of transcription 5A
susceptibility
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland (rat) mRNA:increased expression:mammary gland (rat) protein:increased tyrosine phosphorylation:mammary gland protein:altered localization:nucleus
CTD RGD
PMID:12082622 PMID:12376462 PMID:15609129 PMID:16316942 PMID:17173897 PMID:20181624 More...
RGD:151665819 RGD:2291927 RGD:2291932 RGD:2292404 RGD:2298539 RGD:2306898
NCBI chr12:20,474,221...20,498,785
Ensembl chr12:20,474,227...20,499,138
G
STAT6
signal transducer and activator of transcription 6
ISO
DNA:gene knockout::Balb/C-derived Stat6(-/-) mice resistant to growth of implanted Balb/C mammary tumors
RGD
PMID:11086031
RGD:2298563
NCBI chr 5:22,406,356...22,422,412
Ensembl chr 5:22,406,368...22,421,989
G
STC2
stanniocalcin 2
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18959458
RGD:2313895
NCBI chr16:50,989,676...51,001,412
Ensembl chr16:50,989,433...51,004,481
G
STMN1
stathmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 6:83,356,404...83,362,546
Ensembl chr 6:83,356,412...83,362,500
G
TDG
thymine DNA glycosylase
ISO
mRNA:increased expression:mammary gland tumor (mouse)
RGD
PMID:9794235
RGD:2317355
NCBI chr 5:80,473,233...80,492,295
Ensembl chr 5:80,473,234...80,492,287
G
TF
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9879772 PMID:16316942
NCBI chr13:74,930,655...74,970,599
Ensembl chr13:74,930,655...74,972,763
G
TFF1
trefoil factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr13:205,687,558...205,691,512
Ensembl chr13:205,687,560...205,691,460
G
TGFA
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8603490
NCBI chr 3:71,948,232...72,054,257
Ensembl chr 3:71,948,137...72,050,474
G
TGFB1
transforming growth factor beta 1
ISO
RGD
PMID:8466857
RGD:7394797
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
G
TGFBR1
transforming growth factor beta receptor 1
ISO
RGD
PMID:12808151
RGD:737735
NCBI chr 1:240,842,735...240,918,267
Ensembl chr 1:240,860,156...240,918,528
G
TGFBR2
transforming growth factor beta receptor 2
ISO
RGD
PMID:12808151
RGD:737735
NCBI chr13:16,784,370...16,875,828
Ensembl chr13:16,784,490...16,878,160
G
THBS1
thrombospondin 1
ISO
mRNA:increased expression:mammary gland
RGD
PMID:15459484
RGD:1626167
NCBI chr 1:131,728,781...131,746,098
Ensembl chr 1:131,728,784...131,746,115
G
THRSP
thyroid hormone responsive
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 9:12,479,913...12,484,323
Ensembl chr 9:12,479,907...12,488,557
G
TKT
transketolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr13:35,348,921...35,377,518
Ensembl chr13:35,348,915...35,377,587
G
TLE4
TLE family member 4, transcriptional corepressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:232,355,959...232,504,766
Ensembl chr 1:232,355,959...232,504,763
G
TNF
tumor necrosis factor
ISO
RGD
PMID:19755514
RGD:7401185
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
TNFSF10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21252285
NCBI chr13:111,021,952...111,103,060
Ensembl chr13:110,983,298...111,038,324
G
TP53
tumor protein p53
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17470299 PMID:18092324 PMID:24809783
RGD:2290539 RGD:2290577
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
TPM3
tropomyosin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 4:95,542,329...95,572,946
Ensembl chr 4:95,542,473...95,572,938
G
TRPS1
transcriptional repressor GATA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:22,905,627...23,162,862
Ensembl chr 4:22,905,637...23,159,546
G
TSC22D1
TSC22 domain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr11:22,518,792...22,634,411
Ensembl chr11:22,518,795...22,634,407
G
TXNIP
thioredoxin interacting protein
severity
ISO
mRNA:decreased expression:mammary gland
RGD
PMID:15170812
RGD:1642758
NCBI chr 4:99,348,589...99,351,760
Ensembl chr 4:99,348,490...99,352,755
G
TYMS
thymidylate synthetase
ISO
RGD
PMID:9635926
RGD:2315839
NCBI chr 6:105,642,730...105,660,279
Ensembl chr 6:105,642,381...105,660,578
G
UBE2I
ubiquitin conjugating enzyme E2 I
ISO
MCF-7 human breast cancer cell tumors grown in nude mice CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15735760 PMID:16316942
RGD:2301345
NCBI chr 3:40,556,556...40,586,382
G
UCP2
uncoupling protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 9:8,358,559...8,364,552
Ensembl chr 9:8,358,025...8,365,547
G
VAMP8
vesicle associated membrane protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:59,187,900...59,193,165
Ensembl chr 3:59,185,735...59,193,128
G
VDR
vitamin D receptor
ISO
RGD
PMID:15333467
RGD:8158073
NCBI chr 5:78,205,807...78,266,505
Ensembl chr 5:78,205,810...78,266,475
G
VEGFA
vascular endothelial growth factor A
treatment
ISO
human protein in a mouse model
RGD
PMID:21890879
RGD:6771361
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
WNT1
Wnt family member 1
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chr 5:15,010,607...15,015,007
Ensembl chr 5:15,010,786...15,014,998
G
WNT2
Wnt family member 2
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chr18:28,945,825...28,993,969
Ensembl chr18:28,946,326...28,993,961
G
WNT3
Wnt family member 3
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:9419423
RGD:2298848
NCBI chr12:17,627,291...17,681,197
Ensembl chr12:17,628,726...17,681,026
G
WNT3A
Wnt family member 3A
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chr 2:51,153,978...51,203,678
Ensembl chr 2:51,153,970...51,202,176
G
WNT5B
Wnt family member 5B
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chr 5:68,627,158...68,731,938
Ensembl chr 5:68,627,185...68,732,265
G
WNT6
Wnt family member 6
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chr15:120,901,471...120,917,359
Ensembl chr15:120,901,376...120,917,486
G
WNT7A
Wnt family member 7A
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chr13:70,538,802...70,602,464
Ensembl chr13:70,538,894...70,602,454
G
WNT7B
Wnt family member 7B
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298848 RGD:2298863
NCBI chr 5:3,521,412...3,572,322
Ensembl chr 5:3,521,288...3,572,314
G
XDH
xanthine dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:107,987,060...108,052,043
Ensembl chr 3:107,987,126...108,053,169
G
XIAP
X-linked inhibitor of apoptosis
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12766084
NCBI chr X:101,399,374...101,440,021
Ensembl chr X:101,399,812...101,440,013
G
XRCC3
X-ray repair cross complementing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
G
YWHAZ
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:35,975,513...36,009,909
Ensembl chr 4:35,975,508...36,009,887
G
ACSS1
acyl-CoA synthetase short chain family member 1
treatment
ISO
RGD
PMID:27539851
RGD:13831304
NCBI chr17:30,800,536...30,839,799
Ensembl chr17:30,800,427...30,839,742
G
ACSS2
acyl-CoA synthetase short chain family member 2
treatment
ISO
RGD
PMID:27539851
RGD:13831304
NCBI chr17:38,260,152...38,315,764
Ensembl chr17:38,260,147...38,315,757
G
ANTXR1
ANTXR cell adhesion molecule 1
treatment
ISO
RGD
PMID:19609240 PMID:19622764
RGD:9684925 RGD:9684939
NCBI chr 3:73,157,744...73,398,379
Ensembl chr 3:73,157,747...73,398,379
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29179997 PMID:29438700
NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553
G
CALR
calreticulin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16388313
NCBI chr 2:66,098,263...66,102,074
Ensembl chr 2:66,098,229...66,102,132
G
CCL20
C-C motif chemokine ligand 20
treatment
ISO
RGD
PMID:14500387
RGD:7483600
NCBI chr15:129,172,743...129,176,069
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
treatment
ISO
RGD
PMID:24041689
RGD:7411680
NCBI chr15:107,283,081...107,288,041
Ensembl chr15:107,282,927...107,289,103
G
EGR1
early growth response 1
ISO
mRNA, protein:increased expression:salivary gland (mouse)
RGD
PMID:19517020
RGD:5131885
NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
G
ESR2
estrogen receptor 2
severity
ISO
RGD
PMID:20354658
RGD:8694122
NCBI chr 1:193,823,666...193,907,330
Ensembl chr 1:193,829,560...193,906,565
G
HGF
hepatocyte growth factor
ISO
RGD
PMID:9823327
RGD:8548620
NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
G
IFNB1
interferon beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16417267
NCBI chr 1:201,850,935...201,851,495
Ensembl chr 1:201,850,935...201,851,495
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
ISO
RGD
PMID:19276165
RGD:7495758
NCBI chr17:11,289,607...11,348,557
Ensembl chr17:11,289,690...11,348,549
G
IL18
interleukin 18
treatment
ISO
RGD
PMID:12230493 PMID:17411412
RGD:8655870 RGD:8655901
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
G
IL1A
interleukin 1 alpha
treatment
ISO
RGD
PMID:8061895
RGD:7794735
NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,119
G
IL2
interleukin 2
ISO
RGD
PMID:11884028
RGD:8662950
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
KDM1A
lysine demethylase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29438700
NCBI chr 6:80,903,407...80,971,875
Ensembl chr 6:80,903,424...80,971,873
G
KDM4C
lysine demethylase 4C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29438700
NCBI chr 1:215,071,335...215,507,778
Ensembl chr 1:215,071,419...215,507,800
G
LOC110258578
interleukin-1 beta-like
ISO
RGD
PMID:1966551
RGD:7401226
G
MC1R
melanocortin 1 receptor
ISO
RGD
PMID:20126537
RGD:5687319
NCBI chr 6:181,225...182,187
Ensembl chr 6:181,225...182,187
G
PDCD1
programmed cell death 1
treatment
ISO
RGD
PMID:19208793
RGD:9589070
NCBI chr15:140,337,353...140,347,493
Ensembl chr15:140,336,258...140,347,478
G
PTEN
phosphatase and tensin homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29179997
NCBI chr14:99,929,590...100,021,619
G
PXN
paxillin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18492274
NCBI chr14:40,227,894...40,278,785
Ensembl chr14:40,227,895...40,278,734
G
TERT
telomerase reverse transcriptase
treatment
ISO
RGD
PMID:19903903
RGD:11038656
NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19878872
NCBI chr 1:270,761,641...270,906,708
Ensembl chr 1:270,761,668...270,906,708
G
AHR
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9496914
NCBI chr 9:86,511,866...86,555,950
Ensembl chr 9:86,511,369...86,555,943
G
ARL6IP5
ADP ribosylation factor like GTPase 6 interacting protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29545876
NCBI chr13:50,509,777...50,538,004
Ensembl chr13:50,509,519...50,538,966
G
ARNT
aryl hydrocarbon receptor nuclear translocator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9496914
NCBI chr 4:98,333,431...98,390,012
Ensembl chr 4:98,333,459...98,389,457
G
AXL
AXL receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26206560
NCBI chr 6:49,245,802...49,277,917
Ensembl chr 6:49,245,673...49,277,914
G
BCR
BCR activator of RhoGEF and GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19878872
NCBI chr14:49,208,662...49,322,109
Ensembl chr14:49,208,762...49,322,103
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553
G
BSG
basigin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21165561
NCBI chr 2:77,735,586...77,743,451
G
CCND1
cyclin D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chr 2:3,621,242...3,633,380
Ensembl chr 2:3,621,246...3,633,296
G
CCR5
C-C motif chemokine receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35072892
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
G
CDH1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27224422
NCBI chr 6:18,075,487...18,155,986
Ensembl chr 6:18,075,480...18,155,986
G
CDK4
cyclin dependent kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chr 5:23,039,206...23,041,959
Ensembl chr 5:23,038,891...23,042,061
G
CTCF
CCCTC-binding factor
ISO
human breast cancer cells in mouse model
RGD
PMID:21896759
RGD:151356745
NCBI chr 6:28,188,002...28,261,009
Ensembl chr 6:28,195,647...28,261,009
G
CTNNB1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35066776
NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311
G
DDR1
discoidin domain receptor tyrosine kinase 1
treatment
ISO
human cancer cells in mouse model
RGD
PMID:26719540
RGD:11520844
NCBI chr 7:23,371,358...23,391,585
Ensembl chr 7:23,373,845...23,391,584
G
ENO2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22613180
NCBI chr 5:63,799,927...63,809,067
Ensembl chr 5:63,799,930...63,809,410
G
ERBB2
erb-b2 receptor tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14612517
NCBI chr12:22,591,621...22,621,384
Ensembl chr12:22,590,725...22,621,351
G
ERGIC3
ERGIC and golgi 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27588471
NCBI chr17:38,884,830...38,899,140
Ensembl chr17:38,885,117...38,899,138
G
ESRRA
estrogen related receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34524571
NCBI chr 2:7,803,504...7,812,868
Ensembl chr 2:7,803,510...7,813,098
G
F2R
coagulation factor II thrombin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374729
NCBI chr 2:85,642,794...85,659,133
Ensembl chr 2:85,641,474...85,656,636
G
HDAC6
histone deacetylase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34524571
NCBI chr X:42,917,911...42,941,894
Ensembl chr X:42,917,964...42,941,887
G
HGF
hepatocyte growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21273587
NCBI chr 9:98,437,771...98,513,573
Ensembl chr 9:98,438,143...98,513,564
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28574600
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
G
HRAS
HRas proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3433577 PMID:11552296 PMID:26558449
NCBI chr 2:299,662...302,539
Ensembl chr 2:299,660...302,501
G
HRH2
histamine receptor H2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:6224980
NCBI chr 2:81,883,670...81,932,464
Ensembl chr 2:81,883,673...81,932,275
G
IFNB1
interferon beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2297754
NCBI chr 1:201,850,935...201,851,495
Ensembl chr 1:201,850,935...201,851,495
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15711825
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IGF2BP1
insulin like growth factor 2 mRNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:37246217
NCBI chr12:25,196,955...25,244,660
Ensembl chr12:25,197,058...25,243,272
G
IL12A
interleukin 12A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17332360
NCBI chr13:99,733,394...99,741,078
Ensembl chr13:99,733,394...99,741,078
G
IL12B
interleukin 12B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17332360
NCBI chr16:64,143,268...64,158,929
Ensembl chr16:64,143,268...64,158,929
G
IL2
interleukin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1949363 PMID:3495671 PMID:22306178
NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
G
ISG15
ISG15 ubiquitin like modifier
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506701
NCBI chr 6:63,363,201...63,364,211
Ensembl chr 6:63,363,173...63,364,208
G
ITGAV
integrin subunit alpha V
treatment
ISO
human cells in rat model
RGD
PMID:20841470
RGD:152998949
NCBI chr15:91,604,666...91,711,843
Ensembl chr15:91,604,676...91,711,851
G
KIF11
kinesin family member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17974955
NCBI chr14:104,125,839...104,177,381
Ensembl chr14:104,125,898...104,177,379
G
KRAS
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9205081 PMID:10813127 PMID:21311774 PMID:25851810 PMID:26390243
NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
G
LDHA
lactate dehydrogenase A
ISO
RGD
PMID:11085542
RGD:1600281
NCBI chr 2:40,814,163...40,827,284
Ensembl chr 2:40,814,169...40,826,715
G
LECT2
leukocyte cell derived chemotaxin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30453282
NCBI chr 2:138,109,537...138,120,285
Ensembl chr 2:138,109,351...138,124,464
G
MAPK15
mitogen-activated protein kinase 15
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36425765
NCBI chr 4:909,266...915,537
Ensembl chr 4:909,268...915,475
G
MAPK7
mitogen-activated protein kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29507229
NCBI chr12:60,144,138...60,148,743
Ensembl chr12:60,144,136...60,158,739
G
MIR143
microRNA mir-143
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28736328 PMID:31152816
NCBI chr 2:150,578,738...150,578,817
Ensembl chr 2:150,578,738...150,578,817
G
MIR381
microRNA mir-381
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28030816
G
MIR497
microRNA mir-497
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35066776
NCBI chr12:52,422,329...52,422,408
Ensembl chr12:52,422,330...52,422,411
G
MYCN
MYCN proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:37246217
NCBI chr 3:121,543,201...121,549,678
Ensembl chr 3:121,543,109...121,549,046
G
NQO1
NAD(P)H quinone dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:9496914 PMID:21034357
NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590
G
NRAS
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9205081
NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
G
PAK1
p21 (RAC1) activated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35066776
NCBI chr 9:11,830,095...11,973,074
Ensembl chr 9:11,830,095...12,020,415
G
PARG
poly(ADP-ribose) glycohydrolase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33044785
NCBI chr14:90,338,599...90,481,015
Ensembl chr14:90,338,510...90,480,989
G
PCNA
proliferating cell nuclear antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chr17:14,137,746...14,142,584
Ensembl chr17:14,136,886...14,142,744
G
PIP5K1A
phosphatidylinositol-4-phosphate 5-kinase type 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34755307
NCBI chr 4:98,012,941...98,062,166
Ensembl chr 4:98,012,945...98,056,815
G
POLR1H
RNA polymerase I subunit H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16609701
NCBI chr 7:22,626,871...22,631,557
Ensembl chr 7:22,626,846...22,631,545
G
POU5F1
POU class 5 homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35506701
NCBI chr 7:23,564,654...23,570,691
G
PRL
prolactin
treatment
ISO
RGD
PMID:26983879
RGD:152177690
NCBI chr 7:17,451,367...17,463,771
Ensembl chr 7:17,451,367...17,463,710
G
PRNP
prion protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21265952
NCBI chr17:13,694,195...13,705,126
Ensembl chr17:13,694,190...13,705,124
G
PUF60
poly(U) binding splicing factor 60
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21435101
NCBI chr 4:812,137...824,321
Ensembl chr 4:812,131...824,318
G
RASAL2
RAS protein activator like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34826200
NCBI chr 9:119,941,303...120,329,817
Ensembl chr 9:119,941,862...120,325,316
G
RB1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27137931
NCBI chr11:19,186,754...19,317,642
Ensembl chr11:19,186,761...19,317,690
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20932960
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
G
RICTOR
RPTOR independent companion of MTOR complex 2
disease_progression
ISO
RGD
PMID:24244675
RGD:152995458
NCBI chr16:24,109,934...24,250,019
Ensembl chr16:24,109,939...24,311,132
G
SPARC
secreted protein acidic and cysteine rich
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20164124
NCBI chr16:71,368,164...71,380,972
Ensembl chr16:71,357,586...71,381,161
G
SPP1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21852811
NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
G
STAT3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29507229
NCBI chr12:20,407,316...20,471,091
Ensembl chr12:20,407,233...20,472,992
G
STIM1
stromal interaction molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27863410
NCBI chr 9:6,066,612...6,270,090
Ensembl chr 9:6,066,617...6,270,575
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1674182 PMID:3361654 PMID:12627504
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
TNFSF10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17767197 PMID:24345465
NCBI chr13:111,021,952...111,103,060
Ensembl chr13:110,983,298...111,038,324
G
TOB1
transducer of ERBB2, 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12756225
NCBI chr12:27,116,579...27,119,906
Ensembl chr12:27,116,584...27,117,614
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12756225 PMID:27137931
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
G
TP63
tumor protein p63
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25739959
NCBI chr13:127,115,990...127,347,082
Ensembl chr13:127,116,105...127,347,068
G
TRIM47
tripartite motif containing 47
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31981573
NCBI chr12:5,535,259...5,539,721
Ensembl chr12:5,535,236...5,539,715
G
TXN
thioredoxin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28574600
NCBI chr 1:251,264,180...251,278,000
Ensembl chr 1:251,263,175...251,277,988
G
URI1
URI1 prefoldin like chaperone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21397856
NCBI chr 6:40,043,320...40,110,540
Ensembl chr 6:40,023,595...40,110,536
G
USP39
ubiquitin specific peptidase 39
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34822033
NCBI chr 3:59,121,381...59,156,597
Ensembl chr 3:59,121,048...59,156,442
G
VEGFA
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:20376344 PMID:20932960 PMID:28574600
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
ELANE
elastase, neutrophil expressed
treatment
ISO
RGD
PMID:18486906
RGD:10450567
NCBI chr 2:77,513,769...77,516,118
Ensembl chr 2:77,509,344...77,516,027
G
FGF21
fibroblast growth factor 21
treatment
ISO
RGD
PMID:19664632
RGD:10401870
NCBI chr 6:54,082,653...54,084,532
Ensembl chr 6:54,080,739...54,084,601
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
treatment
ISO
RGD
PMID:19195057
RGD:12791282
NCBI chr X:125,035,575...125,056,445
Ensembl chr X:125,036,508...125,056,453
G
TBXA2R
thromboxane A2 receptor
treatment
ISO
RGD
PMID:11341608
RGD:11059600
NCBI chr 2:75,068,413...75,081,305
Ensembl chr 2:75,068,698...75,087,731
G
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:14982483
RGD:6903857
NCBI chr13:88,934,873...88,980,317
Ensembl chr13:88,934,868...88,983,105
G
AGTR2
angiotensin II receptor type 2
ISO
RGD
PMID:14982483
RGD:6903857
NCBI chr X:95,267,709...95,272,237
Ensembl chr X:95,269,300...95,270,388
G
AIF1
allograft inflammatory factor 1
ISO
protein:decreased expression:brain (rat)
RGD
PMID:19070908
RGD:2313024
NCBI chr 7:23,711,752...23,731,191
Ensembl chr 7:23,726,787...23,731,671
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:24939579
RGD:13782350
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:24939579
RGD:13782350
NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
G
CASP9
caspase 9
treatment
ISO
RGD
PMID:24939579
RGD:13782350
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
G
CCN2
cellular communication network factor 2
ISO
protein:increased expression:kidney (rat)
RGD
PMID:19080126
RGD:2314603
NCBI chr 1:31,674,398...31,677,697
Ensembl chr 1:31,674,394...31,677,691
G
ENG
endoglin
ISO
protein:decreased expression:lung (rat) kidney
RGD
PMID:22151990 PMID:23022174
RGD:7248771 RGD:7257525
NCBI chr 1:268,309,379...268,343,861
Ensembl chr 1:268,309,400...268,343,783
G
FAS
Fas cell surface death receptor
ISO
mRNA:increased expression:testis (rat)
RGD
PMID:9927315
RGD:8662886
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
HIF1A
hypoxia inducible factor 1 subunit alpha
ISO
CTD Direct Evidence: therapeutic protein:increased expression:white matter of spinal cord (rat)
CTD RGD
PMID:15161688 PMID:23065176
RGD:9068912
NCBI chr 1:190,625,436...190,673,926
Ensembl chr 1:190,625,244...190,674,845
G
HMOX1
heme oxygenase 1
treatment
ISO
RGD
PMID:22247972
RGD:10755582
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
IGF2
insulin like growth factor 2
ISO
mRNA:increased expression:brain
RGD
PMID:11213353
RGD:5509971
NCBI chr 2:1,469,183...1,496,417
G
IL10
interleukin 10
treatment
ISO
protein:increased expression:plasma
RGD
PMID:23788042 PMID:23968122
RGD:11049496 RGD:7365012
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
G
LCN2
lipocalin 2
ISO
mRNA,protein:increased expression:liver, heart, kidney,spleen, serum,
RGD
PMID:23331620
RGD:126790570
NCBI chr 1:268,609,975...268,614,651
Ensembl chr 1:268,609,887...268,614,644
G
LOC110258578
interleukin-1 beta-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
G
MAPK1
mitogen-activated protein kinase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22247605
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
G
MAPK3
mitogen-activated protein kinase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22247605
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
MIR122
microRNA mir-122
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32422326
NCBI chr 1:162,329,776...162,329,860
Ensembl chr 1:162,329,767...162,329,860
G
NOS1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20726721
NCBI chr14:35,112,898...35,299,297
Ensembl chr14:35,113,184...35,295,944
G
PCNA
proliferating cell nuclear antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21931560
NCBI chr17:14,137,746...14,142,584
Ensembl chr17:14,136,886...14,142,744
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
mRNA:altered expression:jejunum, duodenum, ileum (rat)
RGD
PMID:22227376
RGD:6767294
NCBI chr12:14,667,643...14,723,296
Ensembl chr12:14,649,044...14,723,293
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:intestine
RGD
PMID:17699727
RGD:2290567
NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:intestine
RGD
PMID:17699727
RGD:2290567
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
G
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22247605
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11121210 PMID:20726721
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11121210
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
AGPS
alkylglycerone phosphate synthase
ISO
RGD
PMID:7407223
RGD:1598794
NCBI chr15:83,146,063...83,285,905
Ensembl chr15:83,146,002...83,391,984
G
ALB
albumin
ISO
mRNA,protein:decreased expression:liver,serum:
RGD
PMID:1900492
RGD:11035284
NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
G
EPO
erythropoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9743294
NCBI chr 3:8,620,508...8,622,936
Ensembl chr 3:8,620,508...8,622,936
G
IFNG
interferon gamma
treatment
ISO
RGD
PMID:2119881
RGD:10755752
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
KRAS
KRAS proto-oncogene, GTPase
ISO
A to T transversion; Gln to His substitution
RGD
PMID:11295286
RGD:1598680
NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
G
NRAS
NRAS proto-oncogene, GTPase
ISO
DNA:transversion:exon p.Q61L (human)
RGD
PMID:11295286
RGD:1598680
NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
G
SLC6A14
solute carrier family 6 member 14
ISO
mRNA, protein:increased expression:brush border epithelial cell
RGD
PMID:17006743
RGD:1625275
NCBI chr X:95,482,494...95,507,200
Ensembl chr X:95,482,456...95,527,369
G
AGAP2
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
ISO
RGD
PMID:21925531
RGD:13838850
NCBI chr 5:23,015,777...23,035,943
Ensembl chr 5:23,017,176...23,033,517
G
BECN1
beclin 1
treatment
ISO
RGD
PMID:23994218
RGD:11561923
NCBI chr12:20,041,914...20,054,249
Ensembl chr12:20,041,956...20,054,373
G
CCL5
C-C motif chemokine ligand 5
ISO
protein:increased expression:hippocampus, vasculature (rat)
RGD
PMID:20940264
RGD:4889880
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
G
CCR5
C-C motif chemokine receptor 5
treatment
ISO
RGD
PMID:20940264
RGD:4889880
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
G
DMD
dystrophin
ISO
RGD
PMID:9539217
RGD:12880363
NCBI chr X:27,028,223...29,650,728
Ensembl chr X:27,028,231...28,383,840
G
LOC100522678
cytochrome b-c1 complex subunit Rieske, mitochondrial
ISO
protein:increased expression:hippocampus
RGD
PMID:15730530
RGD:2303356
NCBI chr 6:39,366,761...39,373,876
Ensembl chr 6:39,364,890...39,373,872
G
LOC100739163
glutathione S-transferase P-like
treatment
ISO
RGD
PMID:22038365
RGD:10401935
NCBI chr 2:4,978,761...4,982,233
G
PDYN
prodynorphin
ISO
mRNA, protein:increased expression:frontal cortex, hippocamlpus, temporal cortex
RGD
PMID:10691294
RGD:401854253
NCBI chr17:33,505,075...33,521,534
Ensembl chr17:33,505,079...33,521,532
G
RASGRF1
Ras protein specific guanine nucleotide releasing factor 1
ISO
protein:decreased expression:dentate gyrus, hippocampus CA1, cerebral cortex (rat)
RGD
PMID:23200899
RGD:10003135
NCBI chr 7:48,121,415...48,246,749
Ensembl chr 7:48,121,419...48,246,749
G
RGS10
regulator of G protein signaling 10
ISO
RGD
PMID:12358788
RGD:13524540
NCBI chr14:129,386,717...129,424,150
Ensembl chr14:129,381,208...129,423,702
G
RGS4
regulator of G protein signaling 4
ISO
RGD
PMID:12358788
RGD:13524540
NCBI chr 4:87,383,336...87,390,478
Ensembl chr 4:87,383,345...87,390,893
G
RGS7
regulator of G protein signaling 7
ISO
RGD
PMID:12358788
RGD:13524540
NCBI chr10:11,950,897...12,322,382
Ensembl chr10:11,950,901...12,322,359
G
RGS8
regulator of G protein signaling 8
ISO
RGD
PMID:12358788
RGD:13524540
NCBI chr 9:123,937,721...124,053,927
Ensembl chr 9:123,955,241...124,047,648
G
SV2A
synaptic vesicle glycoprotein 2A
ISO
DNA:mutation:cds:p.L174Q(rat)
RGD
PMID:27265781
RGD:12792961
NCBI chr 4:99,138,319...99,153,153
Ensembl chr 4:99,138,342...99,153,149
G
BECN1
beclin 1
treatment
ISO
RGD
PMID:23589102
RGD:11561955
NCBI chr12:20,041,914...20,054,249
Ensembl chr12:20,041,956...20,054,373
G
BMP4
bone morphogenetic protein 4
ISO
RGD
PMID:19404941
RGD:9068434
NCBI chr 1:183,415,989...183,422,888
Ensembl chr 1:183,416,146...183,422,637
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:29621761
RGD:13782275
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
G
CASP6
caspase 6
treatment
ISO
RGD
PMID:29621761
RGD:13782275
NCBI chr 8:112,519,450...112,534,315
Ensembl chr 8:112,520,629...112,537,045
G
CASP7
caspase 7
treatment
ISO
RGD
PMID:29621761
RGD:13782275
NCBI chr14:124,017,776...124,050,369
Ensembl chr14:124,019,164...124,050,365
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:29621761
RGD:13782275
NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
G
COL1A1
collagen type I alpha 1 chain
treatment
ISO
RGD
PMID:25128628
RGD:11041187
NCBI chr12:26,379,087...26,397,180
Ensembl chr12:26,379,090...26,397,004
G
DDR2
discoidin domain receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:25975052
RGD:150429975
NCBI chr 4:87,749,738...87,911,818
Ensembl chr 4:87,756,168...87,911,296
G
FGFR1
fibroblast growth factor receptor 1
ISO
RGD
PMID:22833219
RGD:10402072
NCBI chr15:48,053,895...48,106,634
Ensembl chr15:48,053,340...48,106,724
G
FLT1
fms related receptor tyrosine kinase 1
ISO
RGD
PMID:23041435
RGD:10402106
NCBI chr11:5,620,698...5,797,095
Ensembl chr11:5,621,212...5,795,264
G
LRPAP1
LDL receptor related protein associated protein 1
ISO
mRNA:decreased expression:knee
RGD
PMID:24754147
RGD:10412054
NCBI chr 8:2,129,492...2,145,632
Ensembl chr 8:2,125,405...2,145,647
G
MAP1LC3A
microtubule associated protein 1 light chain 3 alpha
treatment
ISO
RGD
PMID:23589102
RGD:11561955
NCBI chr17:37,957,830...37,959,505
Ensembl chr17:37,957,507...37,959,505
G
MAPK3
mitogen-activated protein kinase 3
ISO
RGD
PMID:29364174
RGD:13800565
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
G
NCAM1
neural cell adhesion molecule 1
ISO
protein:decreased expression:skeletal joint
RGD
PMID:31742919
RGD:40924673
NCBI chr 9:40,628,602...40,960,605
Ensembl chr 9:40,628,631...40,960,591
G
SERPINF1
serpin family F member 1
severity
ISO
RGD
PMID:28122611
RGD:27226703
NCBI chr12:47,949,004...47,959,471
Ensembl chr12:47,948,510...47,959,470
G
ULK1
unc-51 like autophagy activating kinase 1
treatment
ISO
RGD
PMID:23589102
RGD:11561955
NCBI chr14:23,423,693...23,448,130
Ensembl chr14:23,423,698...23,448,136
G
DPYD
dihydropyrimidine dehydrogenase
treatment
ISO
RGD
PMID:8138551
RGD:11251753
NCBI chr 4:119,931,471...120,712,461
Ensembl chr 4:119,931,414...120,712,459
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all